| Article
|
description
|
| Vaccines against malaria
|
Scientific Article about Malaria in Biological Sciences Journal
|
| Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond
|
scientific article
|
| Advances and challenges in malaria vaccine development
|
scientific article
|
| Immune mechanisms in malaria: new insights in vaccine development
|
scientific article
|
| Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria
|
scientific article
|
| A review of malaria vaccine clinical projects based on the WHO rainbow table
|
scientific article
|
| Vaccines: from empirical development to rational design
|
scientific article
|
| Enhancing oral vaccine potency by targeting intestinal M cells
|
scientific article
|
| Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen
|
scientific article
|
| A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine
|
scientific article
|
| Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates
|
scientific article
|
| Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses
|
scientific article
|
| Rabbit as a novel animal model for hepatitis E virus infection and vaccine evaluation
|
scientific article
|
| Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant
|
scientific article
|
| Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza
|
scientific article
|
| Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice
|
scientific article
|
| Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus
|
scientific article
|
| Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial
|
scientific article
|
| Design and pre-clinical evaluation of a universal HIV-1 vaccine
|
scientific article
|
| A broken trust: lessons from the vaccine--autism wars
|
scientific article
|
| Vaccine adjuvants: mode of action
|
scientific article
|
| Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination
|
scientific article
|
| Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates
|
scientific article
|
| The effects of anti-vaccine conspiracy theories on vaccination intentions
|
scientific article
|
| A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection
|
scientific article
|
| Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine
|
scientific article
|
| A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses
|
scientific article
|
| Lack of association between measles virus vaccine and autism with enteropathy: a case-control study
|
scientific article
|
| A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India
|
scientific article
|
| Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults
|
scientific article
|
| Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine
|
scientific article
|
| Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study
|
scientific article
|
| The genome and transcriptome of Haemonchus contortus, a key model parasite for drug and vaccine discovery
|
scientific article
|
| Mining of vaccine-associated IFN-γ gene interaction networks using the Vaccine Ontology
|
scientific article
|
| DNA vaccine constructs against enterovirus 71 elicit immune response in mice
|
scientific article
|
| The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003
|
scientific article
|
| Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico
|
scientific article
|
| Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine
|
scientific article
|
| Vaccine-induced antibodies linked to bovine neonatal pancytopenia (BNP) recognize cattle major histocompatibility complex class I (MHC I)
|
scientific article
|
| Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development
|
scientific article
|
| Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown
|
scientific article
|
| A new insight into hepatitis C vaccine development
|
scientific article
|
| Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development
|
scientific article
|
| Chasing Jenner's vaccine: revisiting cowpox virus classification
|
scientific article
|
| An Emergent Poxvirus from Humans and Cattle in Rio de Janeiro State: Cantagalo Virus May Derive from Brazilian Smallpox Vaccine
|
scientific article
|
| Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates
|
scientific article
|
| Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly
|
scientific article
|
| A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease
|
scientific article
|
| Key steps in developing a cognitive vaccine against traumatic flashbacks: visuospatial Tetris versus verbal Pub Quiz
|
scientific article
|
| Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine
|
scientific article
|
| Preparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International Meeting
|
scientific article
|
| A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis
|
scientific article
|
| Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses
|
scientific article
|
| The use of nonhuman primate models in HIV vaccine development
|
scientific article
|
| Development of a new vaccine for the prevention of Lassa fever
|
scientific article
|
| The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan
|
scientific article
|
| The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets
|
scientific article
|
| An Octavalent Lyme Disease Vaccine Induces Antibodies That Recognize All Incorporated ospC Type-Specific Sequences
|
scientific article
|
| Wakefield's article linking MMR vaccine and autism was fraudulent
|
scientific article
|
| Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
|
scientific article published on May 1, 2003
|
| Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts
|
scientific article
|
| The Lyme vaccine: a cautionary tale
|
scientific article
|
| Current status of syphilis vaccine development: need, challenges, prospects
|
scientific article
|
| Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective
|
scientific article
|
| Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
|
scientific article
|
| VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
|
scientific article
|
| PUBLIC HEALTH: High Hopes and Dilemmas for a Cervical Cancer Vaccine
|
scientific article
|
| THE CULTIVATION OF VACCINE AND OTHER VIRUSES IN THE CHORIOALLANTOIC MEMBRANE OF CHICK EMBRYOS
|
scientific article
|
| Recent advances in Ebolavirus vaccine development
|
scientific article
|
| Anatomical and histological factors affecting intranasal drug and vaccine delivery
|
scientific article
|
| Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa
|
scientific article
|
| HSV-2: in pursuit of a vaccine
|
scientific article published in December 2011
|
| Zika highlights need for ethical framework for developing vaccines for pregnant women
|
scientific article
|
| Zika Virus: Diagnosis, Therapeutics, and Vaccine
|
scientific article
|
| Establishing a Global Vaccine-Development Fund
|
scientific article
|
| Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
|
scientific article
|
| Vaccines for preventing influenza in healthy adults
|
scientific article
|
| Vaccines for preventing pneumococcal infection in adults
|
scientific article (publication date: 31 January 2013)
|
| Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
|
scientific article
|
| Influenza vaccine for patients with chronic obstructive pulmonary disease
|
scientific article
|
| INFECTIOUS DISEASE. The race for a Zika vaccine is on
|
scientific article
|
| Zika vaccine misconceptions: A social media analysis
|
scientific article
|
| Yellow fever vaccine: an effective vaccine for travelers
|
scientific article
|
| Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
|
scientific article
|
| Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection
|
scientific article
|
| Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate
|
scientific article
|
| Conservation and variability of dengue virus proteins: implications for vaccine design
|
scientific article
|
| A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
|
scientific article
|
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
|
scientific article
|
| Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report
|
scientific article
|
| A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report
|
scientific article
|
| Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates
|
scientific article
|
| Smallpox vaccine: the good, the bad, and the ugly
|
scientific article
|
| Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate
|
scientific article
|
| Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
|
scientific article
|
| Immune correlates of vaccine protection against HIV-1 acquisition
|
scientific article
|
| Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine
|
scientific article
|
| Unpacking Vaccine Hesitancy Among Healthcare Providers
|
scientific article
|
| CpG Oligonucleotides as Cancer Vaccine Adjuvants
|
scientific article
|
| Vaccine Adjuvants: from 1920 to 2015 and Beyond
|
scientific article
|
| The mucosal immune system: From dentistry to vaccine development
|
scientific article
|
| Application of "Systems Vaccinology" to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines
|
scientific article
|
| Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field
|
scientific article
|
| Group B Streptococcus vaccine: state of the art
|
scientific article (publication date: May 2015)
|
| Dissecting the indirect effects caused by vaccines into the basic elements
|
scientific article (publication date: 2015)
|
| Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
|
scientific article
|
| A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy
|
scientific article
|
| Utilizing health information technology to improve vaccine communication and coverage
|
scientific article
|
| A maternal vaccine against group B Streptococcus: past, present, and future
|
scientific article
|
| Tregs in infection and vaccinology: heroes or traitors?
|
scientific article
|
| Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries
|
scientific article
|
| Protecting against plague: towards a next-generation vaccine
|
scientific article
|
| Recent strategies targeting HIV glycans in vaccine design
|
scientific article
|
| Advances in structure-based vaccine design
|
scientific article
|
| Beyond empiricism: informing vaccine development through innate immunity research
|
scientific article
|
| Calling the Shots: Immunization Finance Policies and Practices
|
Book published by National Academies Press
|
| Will there ever be a universal Staphylococcus aureus vaccine?
|
scientific article
|
| Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test
|
scientific article
|
| Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
|
scientific article
|
| Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies
|
scientific article
|
| Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review
|
scientific article
|
| Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework
|
Book published by National Academies Press
|
| Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases: The Short-Term and Long-Term Outcomes: Workshop Report
|
Book published by National Academies Press
|
| Opportunities in Biotechnology for Future Army Applications
|
Book published by National Academies Press
|
| Vaccine development for tuberculosis: current progress
|
scientific article
|
| Where does a Staphylococcus aureus vaccine stand?
|
scientific article
|
| Structural insights on the role of antibodies in HIV-1 vaccine and therapy
|
scientific article
|
| Setting the Course: A Strategic Vision for Immunization: Part 4: Summary of the Washington, D.C., Workshop
|
Book published by National Academies Press
|
| Progress toward a Staphylococcus aureus vaccine
|
scientific article
|
| A Blueprint for HIV Vaccine Discovery
|
scientific article
|
| Setting the Course: A Strategic Vision for Immunization Finance: Part 1: Summary of the Chicago Workshop
|
Book published by National Academies Press
|
| Systems biology applied to vaccine and immunotherapy development
|
scientific article
|
| Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data
|
scientific article (publication date: September 2003)
|
| An overview of current and potential use of information and communication technologies for immunization promotion among adolescents
|
scientific article
|
| Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade
|
scientific article
|
| A brief history of the global effort to develop a preventive HIV vaccine
|
scientific article
|
| Systems biology in vaccine design
|
scientific article
|
| Peptide Vaccine: Progress and Challenges
|
scientific article
|
| Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
|
Book published by National Academies Press
|
| A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
|
scientific article
|
| Hepatitis E, a vaccine-preventable cause of maternal deaths
|
scientific article
|
| Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates
|
scientific article
|
| Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary
|
Book published by National Academies Press
|
| Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine
|
scientific article
|
| Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic
|
scientific article
|
| Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines
|
scientific article
|
| Helminth parasite proteomics: from experimental models to human infections
|
scientific article
|
| Emerging Infectious Diseases from the Global to the Local Perspective: A Summary of a Workshop of the Forum on Emerging Infections
|
Book published by National Academies Press
|
| Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary
|
Book published by National Academies Press
|
| Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects
|
scientific article
|
| Production of EV71 vaccine candidates
|
scientific article
|
| New vaccines: challenges of discovery
|
scientific article
|
| Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #6
|
Book published by National Academies Press
|
| Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden
|
scientific article
|
| A systems biology approach to the effect of aging, immunosenescence and vaccine response
|
scientific article
|
| Strategies for addressing vaccine hesitancy - A systematic review
|
scientific article
|
| Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease
|
scientific article
|
| Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
|
scientific article
|
| Dendritic cells in antifungal immunity and vaccine design
|
scientific article
|
| Perspectives on Research with H5N1 Avian Influenza: Scientific Inquiry, Communication, Controversy: Summary of a Workshop
|
Book published by National Academies Press
|
| The Anthrax Vaccine: Is It Safe? Does It Work?
|
Book published by National Academies Press
|
| Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders
|
Book published by National Academies Press
|
| Vaccines for allergy
|
scientific article
|
| Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine
|
scientific article
|
| Vaccines for the 21st century
|
scientific article
|
| Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets
|
scientific article
|
| The impact of new vaccine introduction on immunization and health systems: a review of the published literature
|
scientific article
|
| Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
|
scientific article published in June 2013
|
| The Vaccine Safety Datalink: a model for monitoring immunization safety
|
scientific article published in May 2011
|
| Antibodies in HIV-1 vaccine development and therapy
|
scientific article
|
| Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report
|
Book published by National Academies Press
|
| Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine
|
scientific article
|
| Safety assessment of adjuvanted vaccines: Methodological considerations
|
scientific article
|
| Development of a vaccine against Staphylococcus aureus
|
scientific article
|
| Synthetic DNA vaccine strategies against persistent viral infections
|
scientific article
|
| Immune response to vaccine adjuvants during the first year of life
|
scientific article
|
| International Regulatory Harmonization Amid Globalization of Drug Development: Workshop Summary
|
Book published by National Academies Press
|
| The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine
|
scientific article
|
| HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design
|
scientific article
|
| Financing Vaccines in the 21st Century: Assuring Access and Availability
|
Book published by National Academies Press
|
| Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
|
scientific article
|
| Vaccination in the elderly
|
scientific article
|
| Prime-boost approaches to tuberculosis vaccine development
|
scientific article
|
| Emerging Viral Diseases: The One Health Connection: Workshop Summary
|
Book published by National Academies Press
|
| Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants
|
scientific article
|
| Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report 2
|
Book published by National Academies Press
|
| The non-specific effects of vaccines and other childhood interventions: the contribution of INDEPTH Health and Demographic Surveillance Systems
|
scientific article
|
| Vaccine against autoimmune disease: antigen-specific immunotherapy
|
scientific article
|
| Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
|
scientific article
|
| Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity
|
scientific article
|
| Vector transmission of leishmania abrogates vaccine-induced protective immunity
|
scientific article (publication date: June 2009)
|
| Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process
|
scientific article (publication date: March 2009)
|
| Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses
|
scientific article (publication date: 2010)
|
| Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
|
scientific article
|
| Development of a preventive vaccine for Ebola virus infection in primates
|
scientific article (publication date: 30 November 2000)
|
| Tick paralysis: development of a vaccine
|
scientific article (publication date: April 1999)
|
| Immunological concepts of vaccine adjuvant activity
|
scientific article (publication date: August 2000)
|
| Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation
|
scientific article (publication date: 2001)
|
| Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996)
|
scientific article (publication date: 2000)
|
| HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen
|
scientific article (publication date: 2003)
|
| THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. II. RELATIONSHIP OF POLIOMYELITIS TO CUTTER VACCINE
|
scientific article (publication date: July 1963)
|
| Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001
|
scientific article (publication date: 12 October 2001)
|
| Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses
|
scientific article (publication date: 6 August 1960)
|
| Association between thimerosal-containing vaccine and autism
|
scientific article (publication date: October 2003)
|
| Feline vaccine-associated fibrosarcoma: morphologic distinctions
|
scientific article (publication date: 2002)
|
| Overcoming immunity to a viral vaccine by DNA priming before vector boosting
|
scientific article
|
| Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
|
scientific article (publication date: 6 February 2002)
|
| Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
|
scientific article (publication date: 15 April 2006)
|
| Live, attenuated mumps-virus vaccine
|
scientific article
|
| HIV vaccine development by computer assisted design: the GAIA vaccine
|
scientific article (publication date: 18 March 2005)
|
| Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team
|
scientific article (publication date: June 1997)
|
| Polio eradication. Efficacy of inactivated poliovirus vaccine in India
|
scientific article (publication date: 22 August 2014)
|
| Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
|
scientific article published on 25 July 2009
|
| FDA approves shingles vaccine: herpes zoster vaccine targets older adults
|
scientific article
|
| Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial
|
scientific article
|
| A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
|
scientific article
|
| Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
|
scientific article
|
| Marketing HPV vaccine: implications for adolescent health and medical professionalism
|
scientific article
|
| A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene
|
scientific article (publication date: September 1993)
|
| Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
|
scientific article
|
| A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity
|
scientific article
|
| Active and passive immunity, vaccine types, excipients and licensing
|
scientific article
|
| Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine
|
scientific article
|
| Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey
|
scientific article
|
| Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review
|
scientific article
|
| Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?
|
scientific article
|
| Vaccine pharmacotherapy for the treatment of cocaine dependence
|
scientific article
|
| Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations
|
scientific article
|
| Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix
|
scientific article
|
| Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
|
scientific article
|
| Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women
|
scientific article
|
| Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
|
scientific article
|
| Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010
|
scientific article
|
| New genetic associations detected in a host response study to hepatitis B vaccine
|
scientific article
|
| Adverse events diagnosed within three days of vaccine administration in dogs
|
scientific article
|
| The safety profile of varicella vaccine: a 10-year review
|
scientific article
|
| Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group
|
scientific article
|
| Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States
|
scientific article
|
| A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG
|
scientific article
|
| Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection
|
scientific article
|
| Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine
|
scientific article
|
| FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)
|
scientific article
|
| FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)
|
scientific article
|
| Safety and immunogenicity of a nicotine conjugate vaccine in current smokers
|
scientific article
|
| The RTS,S malaria vaccine
|
scientific article
|
| Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system
|
scientific article
|
| Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
|
scientific article
|
| Immunization Safety Review: Vaccines and Autism
|
Book published by National Academies Press
|
| Molecular basis for vaccine development against anaplasmosis and babesiosis
|
scientific article
|
| Loss of vaccine-induced immunity to varicella over time
|
scientific article
|
| Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members
|
scientific article
|
| Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|
scientific article
|
| Historical review of pertussis and the classical vaccine
|
scientific article
|
| Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies
|
scientific article
|
| Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
|
scientific article
|
| A review of vaccine research and development: human enteric infections
|
scientific article
|
| Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
|
scientific article
|
| Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States
|
scientific article
|
| Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
|
scientific article
|
| How the case against the MMR vaccine was fixed
|
scientific article
|
| Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants
|
scientific article
|
| Needle-free vaccine delivery
|
scientific article
|
| Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children
|
scientific article
|
| 'Combined vaccines are like a sudden onslaught to the body's immune system': parental concerns about vaccine 'overload' and 'immune-vulnerability'
|
scientific article
|
| Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate
|
scientific article
|
| The problem with Dr Bob's alternative vaccine schedule
|
scientific article
|
| Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
|
scientific article
|
| A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication
|
scientific article
|
| Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine
|
scientific article
|
| Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B
|
scientific article
|
| Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine
|
scientific article
|
| The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism
|
scientific article
|
| The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries
|
scientific article
|
| Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine
|
scientific article
|
| Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine
|
scientific article
|
| Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development
|
scientific article
|
| Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif
|
scientific article
|
| Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials
|
scientific article
|
| The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement
|
scientific article
|
| Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates
|
scientific article
|
| A novel laser vaccine adjuvant increases the motility of antigen presenting cells
|
scientific article
|
| The key role of genomics in modern vaccine and drug design for emerging infectious diseases
|
scientific article
|
| The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America
|
scientific article
|
| Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates
|
scientific article
|
| Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy
|
scientific article
|
| Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa
|
scientific article published in 2012
|
| Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis
|
scientific article
|
| Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development
|
scientific journal article
|
| High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets
|
scientific journal article
|
| A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans
|
scientific article
|
| Risk in vaccine research and development quantified
|
scientific article
|
| Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides
|
scientific journal article
|
| Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
|
scientific article (publication date: July 2014)
|
| Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens
|
scientific journal article
|
| Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions
|
scientific article (publication date: 2010)
|
| Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model
|
scientific article (publication date: 2010)
|
| Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques
|
scientific article
|
| Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine
|
scientific article (publication date: 2013)
|
| New mouse model for dengue virus vaccine testing
|
scientific article
|
| Attenuated vesicular stomatitis viruses as vaccine vectors
|
scientific article
|
| Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
|
scientific article
|
| Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys
|
scientific article
|
| Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3
|
scientific article
|
| Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine
|
scientific article
|
| Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates
|
scientific article
|
| Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response
|
scientific article (publication date: September 2000)
|
| Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.
|
scientific article
|
| The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain.
|
scientific article
|
| Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
|
scientific article
|
| West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays
|
scientific article
|
| RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease
|
scientific article
|
| Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine
|
scientific article
|
| Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes
|
scientific article
|
| Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity
|
scientific article
|
| A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
|
scientific article
|
| A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys
|
scientific article (publication date: 2003)
|
| An antivector vaccine protects against a lethal vector-borne pathogen
|
scientific article
|
| Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle
|
scientific article (publication date: July 2006)
|
| Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques
|
scientific article
|
| Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
|
scientific article
|
| Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design
|
scientific article (publication date: May 2007)
|
| Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis
|
scientific article (publication date: 12 April 2007)
|
| DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus
|
scientific article
|
| Cancer therapy using a self-replicating RNA vaccine
|
scientific article
|
| A systematic bioinformatics approach for selection of epitope-based vaccine targets
|
scientific article (publication date: December 2006)
|
| Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice
|
scientific article
|
| Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
|
scientific article (publication date: 12 December 2007)
|
| Yellow fever 17D as a vaccine vector for microbial CTL epitopes
|
scientific article (publication date: 17 January 2005)
|
| Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
|
scientific article (publication date: 6 February 2008)
|
| Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections
|
scientific article
|
| Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development
|
scientific article (publication date: November 2003)
|
| E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence
|
scientific article (publication date: June 2008)
|
| Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine
|
scientific article
|
| A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
|
scientific article
|
| The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus
|
scientific article (publication date: 7 April 2008)
|
| Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers
|
scientific article
|
| Chimeric alphavirus vaccine candidates for chikungunya
|
scientific article
|
| Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
|
scientific article (publication date: 2008)
|
| Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
|
scientific article
|
| Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2
|
scientific article
|
| Understanding dengue pathogenesis: implications for vaccine design
|
scientific article (publication date: April 2005)
|
| Development of Orphan Vaccines: An Industry Perspective
|
scientific article (publication date: 1999)
|
| Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
|
scientific article (publication date: 11 September 2008)
|
| Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
|
scientific article (publication date: 18 May 2009)
|
| A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial
|
scientific article (publication date: 15 December 2007)
|
| Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
|
scientific article
|
| Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model
|
scientific article (publication date: December 2002)
|
| Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys
|
scientific article
|
| Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
|
scientific article
|
| The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate
|
scientific article
|
| Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design
|
scientific article
|
| Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1)
|
scientific article
|
| Crystal Structure of Neisserial Surface Protein A (NspA), a Conserved Outer Membrane Protein with Vaccine Potential
|
scientific article (publication date: 4 July 2003)
|
| Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design
|
scientific article
|
| Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design
|
scientific article
|
| Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications
|
scientific article
|
| Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope
|
scientific article
|
| Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections
|
scientific article
|
| Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody
|
scientific article
|
| Ultrahigh Resolution and Full-length Pilin Structures with Insights for Filament Assembly, Pathogenic Functions, and Vaccine Potential
|
scientific article
|
| Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
|
scientific article
|
| Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen
|
scientific article
|
| Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|
scientific article
|
| Proof of principle for epitope-focused vaccine design
|
scientific article
|
| Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign
|
scientific article
|
| Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation: Letter Report #4
|
Book published by National Academies Press
|
| Progress in HIV-1 vaccine development.
|
scientific article
|
| Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel
|
scientific article
|
| Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development
|
scientific article (publication date: 2015)
|
| Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
|
scientific article
|
| Schistosomiasis vaccines: where do we stand?
|
scientific article
|
| New concepts in HIV-1 vaccine development
|
scientific article
|
| Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
|
scientific article
|
| The Nation's Medical Countermeasure Stockpile: Opportunities to Improve the Efficiency, Effectiveness, and Sustainability of the CDC Strategic National Stockpile: Workshop Summary
|
Book published by National Academies Press
|
| The Ebola Epidemic in West Africa: Proceedings of a Workshop
|
Book published by National Academies Press
|
| Primary vaccine failure to routine vaccines: Why and what to do?
|
scientific article
|
| Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
|
scientific article
|
| Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods
|
scientific article
|
| Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment: Proceedings of a Workshop
|
Book published by National Academies Press
|
| EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
|
scientific article
|
| Global Health Impacts of Vector-Borne Diseases: Workshop Summary
|
Book published by National Academies Press
|
| Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis
|
scientific article
|
| Global Health Risk Framework: Research and Development of Medical Products: Workshop Summary
|
Book published by National Academies Press
|
| Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary
|
Book published by National Academies Press
|
| MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
|
scientific article
|
| Dendritic cell-based vaccine efficacy: aiming for hot spots
|
scientific article
|
| Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
|
scientific article
|
| Recent advances of vaccine adjuvants for infectious diseases
|
scientific article
|
| Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
|
scientific article
|
| Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
|
scientific article
|
| Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases
|
scientific article
|
| Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
|
scientific article (publication date: November 2007)
|
| A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction
|
scientific article
|
| Postlicensure safety surveillance for varicella vaccine
|
scientific article (publication date: 13 September 2000)
|
| Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
|
scientific article
|
| Prospects for vaccine prevention of meningococcal infection
|
scientific article
|
| An improved reverse genetics system for influenza A virus generation and its implications for vaccine production
|
scientific article
|
| Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans
|
scientific article
|
| Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers
|
scientific article
|
| A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth
|
scientific article
|
| Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer
|
scientific article
|
| A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis
|
scientific article
|
| Field Evaluation of a Human Anthrax Vaccine
|
scientific article
|
| Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
|
scientific article
|
| A vaccine that prevents pregnancy in women
|
scientific article
|
| Bacterial outer membrane vesicles and vaccine applications
|
scientific article
|
| Viral vectors as vaccine platforms: from immunogenicity to impact
|
scientific article
|
| In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG
|
scientific article
|
| Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus
|
scientific article
|
| Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients
|
scientific article
|
| Recombinant Newcastle disease virus as a vaccine vector for cancer therapy
|
scientific article
|
| Novel vaccine development strategies for inducing mucosal immunity
|
scientific article
|
| Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling
|
scientific article
|
| Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma
|
scientific article
|
| Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
|
scientific article
|
| Genome-wide association study of antibody response to smallpox vaccine
|
scientific article
|
| Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
|
scientific article
|
| Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma
|
scientific article
|
| A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge
|
scientific article
|
| Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
|
scientific article
|
| Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox
|
scientific article
|
| Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer
|
scientific article
|
| The yellow fever vaccine: a history
|
scientific article
|
| Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection
|
scientific article
|
| Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants
|
scientific article
|
| The role of HPV in head and neck cancer and review of the HPV vaccine
|
scientific article
|
| Multivalent fusion protein vaccine for lymphatic filariasis
|
scientific article
|
| Rotavirus diversity and evolution in the post-vaccine world
|
scientific article
|
| Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability
|
scientific article
|
| The Development of a Stable Smallpox Vaccine
|
scientific article
|
| Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands
|
scientific article
|
| Vaccine prevention of maternal cytomegalovirus infection
|
scientific article
|
| Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
|
scientific article
|
| Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate
|
scientific article
|
| Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics
|
scientific article
|
| VIOLIN: vaccine investigation and online information network
|
scientific article
|
| Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
|
scientific article
|
| Vaccine protection against Staphylococcus aureus pneumonia
|
scientific article
|
| Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza
|
scientific article
|
| The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
|
scientific article
|
| Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
|
scientific article
|
| Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant
|
scientific article
|
| Circulating vaccine-derived polioviruses: current state of knowledge
|
scientific article
|
| Estimating influenza vaccine efficacy from challenge and community-based study data
|
scientific article
|
| Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis
|
scientific article
|
| Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis
|
scientific article published on 24 February 2001
|
| Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age
|
scientific article
|
| Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine
|
scientific article
|
| Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
|
scientific article
|
| Genome plasticity of BCG and impact on vaccine efficacy
|
scientific article
|
| NadA, a novel vaccine candidate of Neisseria meningitidis
|
scientific article
|
| Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch
|
scientific article
|
| Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting
|
scientific article
|
| Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design
|
scientific article published on May 1, 2003
|
| MMR vaccine and idiopathic thrombocytopaenic purpura
|
scientific article
|
| Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis
|
scientific article
|
| Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
|
scientific article published in August 2003
|
| A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
|
scientific article
|
| Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain
|
scientific article
|
| From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
|
scientific article
|
| Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin
|
scientific article
|
| Vaccines against sexually transmitted diseases
|
scientific article
|
| Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer
|
scientific article
|
| Rates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and Aging
|
scientific article
|
| A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults
|
scientific article
|
| Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2
|
scientific article
|
| Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed
|
scientific article
|
| Vaccine policy in India
|
scientific article
|
| PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands
|
scientific article
|
| Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors
|
scientific article
|
| A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum
|
scientific article
|
| Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
|
journal article published in 2010
|
| Vaccine protection against Zika virus from Brazil
|
scientific article
|
| Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge
|
scientific article
|
| Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
|
scientific article
|
| The dengue vaccine pipeline: Implications for the future of dengue control
|
scientific article
|
| A full-length infectious cDNA clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development
|
scientific article
|
| Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review
|
scientific article
|
| Plant-based oral vaccines against zoonotic and non-zoonotic diseases
|
scientific article
|
| Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review
|
scientific article
|
| Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control
|
scientific article
|
| Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials
|
scientific article
|
| Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
|
scientific article
|
| Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
|
scientific article
|
| Toll-like receptors: the swiss army knife of immunity and vaccine development
|
scientific article
|
| Use of VacA as a Vaccine Antigen
|
scientific article
|
| Dismantling the Taboo against Vaccines in Pregnancy
|
scientific article
|
| TB vaccine development and the End TB Strategy: importance and current status.
|
scientific article
|
| Recent Advances in Subunit Vaccine Carriers
|
scientific article
|
| HIV-Host Interactions: Implications for Vaccine Design
|
scientific article
|
| Outer membrane vesicles as platform vaccine technology
|
scientific article
|
| Microneedles: A New Frontier in Nanomedicine Delivery
|
scientific article
|
| The 5As: A practical taxonomy for the determinants of vaccine uptake
|
scientific article
|
| Enter B and W: two new meningococcal vaccine programmes launched
|
scientific article
|
| Development of a cytomegalovirus vaccine: lessons from recent clinical trials
|
scientific article published in May 2001
|
| Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information
|
scientific article
|
| Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
|
scientific article
|
| Worsening disparities in HPV vaccine utilization among 19-26 year old women
|
scientific article
|
| Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors
|
scientific article
|
| Vaccines and autism
|
scientific article
|
| Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201
|
scientific article
|
| Critical issues in mucosal immunity for HIV-1 vaccine development
|
scientific article
|
| Vaccine prevention of meningococcal disease, coming soon?
|
scientific article
|
| Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
|
scientific article
|
| Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic
|
scientific article
|
| Plasmodium vivax malaria vaccine development
|
scientific article
|
| Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified 987 or K99 pili: protection correlates with pilus homology of vaccine and challenge
|
scientific article published on December 1, 1978
|
| A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years
|
scientific article
|
| Long-term efficacy of a hepatitis E vaccine.
|
scientific article
|
| The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
|
scientific article
|
| Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates
|
scientific article
|
| The E. coli alpha-hemolysin secretion system and its use in vaccine development
|
scientific article
|
| Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?
|
scientific article
|
| Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
|
scientific article
|
| All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction
|
scientific article
|
| Human cytomegalovirus vaccine: time to look for alternative options.
|
scientific article
|
| Remembering mumps
|
scientific article
|
| Replication-defective viruses as vaccines and vaccine vectors
|
scientific article published in January 2006
|
| Evidence of bias in estimates of influenza vaccine effectiveness in seniors
|
scientific article
|
| A pilot clinical trial of a recombinant ricin vaccine in normal humans.
|
scholarly article
|
| Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes
|
scholarly article
|
| Safe administration of influenza vaccine to patients with egg allergy.
|
scientific article
|
| Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development
|
scientific article
|
| The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.
|
scientific article
|
| Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens
|
scientific article
|
| Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy
|
scientific article
|
| Norovirus P particle, a novel platform for vaccine development and antibody production
|
scientific article
|
| Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
|
scientific article
|
| A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
|
scientific article
|
| Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development
|
scientific article
|
| Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine
|
scientific article
|
| Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
|
scientific article
|
| EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
|
scientific article
|
| Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
|
scientific article
|
| A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
|
scientific article
|
| Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection
|
scientific article
|
| A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model
|
scientific article
|
| Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels
|
scientific article
|
| Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
|
scientific article
|
| A cholesterol-lowering VLP vaccine that targets PCSK9
|
scientific article
|
| Designing a VAR2CSA-based vaccine to prevent placental malaria
|
scientific article
|
| Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults
|
scientific article
|
| Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
|
scientific article
|
| Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria
|
scientific article
|
| Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
|
scientific article
|
| Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers
|
scientific article
|
| Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area
|
scientific article
|
| Intussusception among infants given an oral rotavirus vaccine
|
scientific article
|
| Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen
|
scholarly article
|
| Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases
|
scientific article
|
| Limited efficacy of an inactivated feline immunodeficiency virus vaccine
|
scientific article
|
| Status of vaccine research and development for Shigella
|
scientific article
|
| Status of vaccine research and development for enterotoxigenic Escherichia coli
|
scientific article
|
| Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.
|
scientific article
|
| Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis
|
scientific article
|
| Immunity following use of Australian tick fever vaccine: a review of the evidence
|
scientific article
|
| A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection
|
scientific article
|
| FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review
|
scientific article
|
| Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase
|
scientific article
|
| Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand
|
scientific article
|
| Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design
|
scientific article
|
| The scientific and public-health imperative for a vaccine against dental caries
|
scientific article
|
| Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study
|
scientific article
|
| Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates
|
scientific article
|
| Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
|
scientific article
|
| Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine
|
scientific article
|
| Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production
|
scientific article published on January 1, 1975
|
| Towards a recombinant antigen vaccine against Onchocerca volvulus
|
scientific article
|
| Leishmaniasis vaccine candidates for development: a global overview
|
scientific article
|
| EV71 vaccine, an invaluable gift for children
|
scientific article
|
| Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy
|
scientific article
|
| Novel vaccine vectors for HIV-1.
|
scientific article
|
| MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC.
|
scientific article
|
| Rapid development of a DNA vaccine for Zika virus
|
scientific article
|
| Prospects for vaccine protection against HIV-1 infection and AIDS.
|
scientific article
|
| Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells
|
scientific article
|
| Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella‐Zoster Virus, in an Immunosuppressed Child
|
scientific article published on September 26, 2003
|
| Journalists and jabs: media coverage of the MMR vaccine
|
scientific article
|
| Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
|
scientific article
|
| Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine
|
scientific article
|
| Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels
|
scientific article
|
| Clinical cancer vaccine trials
|
scientific article
|
| Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
|
scientific article
|
| Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
|
scientific article
|
| Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine
|
scientific article
|
| Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response
|
scientific article
|
| Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis
|
scientific article
|
| Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events
|
scientific article
|
| Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine
|
scientific article
|
| Vaccine criticism on the World Wide Web.
|
scientific article
|
| Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine
|
scientific article
|
| Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial
|
scientific article
|
| Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans
|
scientific article
|
| Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
|
scientific article
|
| Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation
|
scientific article
|
| Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage
|
scientific article
|
| A brief history of vaccines & vaccination in India
|
scientific article
|
| "Vaccine diplomacy": historical perspectives and future directions
|
scientific article (publication date: June 2014)
|
| Vaccine hesitancy: an overview
|
scientific article (publication date: August 2013)
|
| High-resolution antibody dynamics of vaccine-induced immune responses
|
scientific article (publication date: April 2014)
|
| A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure
|
scientific article (publication date: October 2012)
|
| The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity
|
scientific article (publication date: 2012)
|
| Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis
|
scientific article (publication date: 2012)
|
| Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
|
scientific article (publication date: 17 August 2012)
|
| Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia
|
scientific article (publication date: 2012)
|
| Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine
|
scientific article (publication date: 2012)
|
| Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine
|
scientific article (publication date: 2012)
|
| Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes
|
scientific article (publication date: 2012)
|
| Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice
|
scientific article (publication date: 2012)
|
| DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)
|
scientific article (publication date: 2012)
|
| Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis
|
scientific article (publication date: 16 April 2012)
|
| AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland
|
scientific article (publication date: 2012)
|
| Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors
|
scientific article (publication date: 2012)
|
| Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin
|
scientific article (publication date: 2012)
|
| Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine
|
scientific article (publication date: 2012)
|
| Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults
|
scientific article (publication date: 2012)
|
| A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2
|
scientific article (publication date: 2011)
|
| A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
|
scientific article (publication date: 2011)
|
| Genomic analysis of the vaccinia virus strain variants found in Dryvax vaccine
|
scientific article (publication date: December 2011)
|
| Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine
|
scientific article (publication date: July 2011)
|
| Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells
|
scientific article (publication date: 2011)
|
| I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe
|
scientific article (publication date: 2011)
|
| Improved NYVAC-based vaccine vectors
|
scientific article (publication date: 2011)
|
| Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles
|
scientific article (publication date: 2011)
|
| Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial
|
scientific article (publication date: 2011)
|
| Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study
|
scientific article (publication date: 2011)
|
| Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in mice
|
scientific article (publication date: 2011)
|
| Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin
|
scientific article (publication date: 28 December 2010)
|
| In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers
|
scientific article (publication date: 2011)
|
| A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720
|
scientific article (publication date: 2011)
|
| Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials
|
scientific article (publication date: 29 October 2010)
|
| Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice
|
scientific article (publication date: 11 February 2010)
|
| Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults
|
scientific article (publication date: 22 January 2010)
|
| Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa
|
scientific article (publication date: 21 September 2010)
|
| Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine
|
scientific article (publication date: 13 August 2010)
|
| Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
|
scientific article (publication date: 20 July 2010)
|
| Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine
|
scientific article (publication date: 16 July 2010)
|
| Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
|
scientific article (publication date: 27 May 2010)
|
| Optimal pandemic influenza vaccine allocation strategies for the Canadian population
|
scientific article (publication date: 6 May 2010)
|
| Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
|
scientific article (publication date: December 2006)
|
| Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
|
scientific article (publication date: 5 October 2016)
|
| Reaching everyone, everywhere with life-saving vaccines
|
scientific article
|
| Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients
|
scientific journal article
|
| Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
|
scientific article (publication date: 13 November 2008)
|
| Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis
|
scientific article (publication date: August 2000)
|
| A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance
|
scientific article (publication date: 21 January 2011)
|
| A Retrospective Cohort Study of the Association of Varicella Vaccine Failure With Asthma, Steroid Use, Age at Vaccination, and Measles-Mumps-Rubella Vaccination
|
scientific article (publication date: August 2003)
|
| Vaccines for Epidemic Infections and the Role of CEPI
|
scientific article (publication date: 4 April 2017)
|
| Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005 – 2016
|
scientific article (publication date: 26 January 2017)
|
| A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
|
scientific article (publication date: 10 April 2017)
|
| Protective efficacy of Zika vaccine in AG129 mouse model
|
scientific article (publication date: 12 April 2017)
|
| A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin
|
scientific article (publication date: 15 March 2004)
|
| Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
|
scientific article (publication date: 9 October 2009)
|
| Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
|
scientific article (publication date: 2009)
|
| Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
|
scientific article (publication date: 3 November 2012)
|
| Immune-correlates analysis of an HIV-1 vaccine efficacy trial
|
scientific article (publication date: 5 April 2012)
|
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
|
scientific article (publication date: August 2005)
|
| Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|
scientific article (publication date: July 2007)
|
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes
|
scientific article (publication date: May 1998)
|
| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
|
scientific article (publication date: 23 March 2013)
|
| T-cell quality in memory and protection: implications for vaccine design
|
scientific article (publication date: April 2008)
|
| Status of vaccine research and development of vaccines for GBS
|
scientific article (publication date: June 2016)
|
| A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
|
scientific article (publication date: 19 February 2015)
|
| Zika virus-like particle (VLP) based vaccine
|
scientific article
|
| Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein
|
scientific article
|
| Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans
|
scientific article
|
| Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?
|
scientific article
|
| Toward a universal influenza virus vaccine: prospects and challenges
|
scientific article
|
| Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
|
scientific article
|
| Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies
|
scientific article
|
| Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies
|
scientific article
|
| Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
|
scientific article
|
| Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing
|
scientific article
|
| A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic
|
scientific article
|
| M2e-based universal influenza A vaccine
|
scientific article
|
| Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza
|
scientific article
|
| A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine
|
scientific article
|
| Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands
|
scientific article
|
| A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses
|
scientific article
|
| Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine
|
scientific article
|
| Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
|
scientific article
|
| Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza
|
scientific article
|
| Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.
|
scientific article
|
| Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001.
|
scientific article
|
| Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation
|
scientific article
|
| Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials
|
scientific article
|
| Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function
|
scientific article
|
| Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.
|
scientific article
|
| Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team
|
scientific article
|
| Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team
|
scientific article
|
| Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City
|
scientific article
|
| Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team
|
scientific article
|
| Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States
|
scientific article
|
| Frequently asked questions on seven rare adverse events following immunization
|
scientific article
|
| The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate
|
scientific article
|
| A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles
|
scientific article
|
| Comparison of social distribution of immunisation with measles, mumps, and rubella vaccine, England, 1991-2001
|
scientific article published on April 19, 2003
|
| Impact of distinct chemical structures for the development of a methamphetamine vaccine
|
scientific article
|
| Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses
|
scientific article published on 3 March 2011
|
| Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy
|
scientific article
|
| Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae
|
scientific article
|
| Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine
|
scientific article
|
| Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain
|
scientific article
|
| Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis
|
scientific article
|
| The new pneumococcal vaccine
|
scientific article
|
| Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease
|
scientific article
|
| Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells
|
scientific article
|
| Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
|
scientific article
|
| A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys
|
scientific article
|
| Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases
|
scientific article
|
| The challenge of developing a vaccine against hepatitis C virus
|
scientific article
|
| Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
|
scientific article
|
| Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua
|
scientific article
|
| Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
|
scientific article
|
| Structure-based vaccine design in HIV: blind men and the elephant?
|
scientific article
|
| Targeting nicotine addiction: the possibility of a therapeutic vaccine.
|
scientific article
|
| Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations
|
scientific article
|
| Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.
|
scientific article
|
| Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection
|
scientific article
|
| The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes
|
scientific article
|
| Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.
|
scientific article
|
| Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
|
scientific article
|
| Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites
|
scientific article
|
| Lactobacilli as live vaccine delivery vectors: progress and prospects
|
scientific article
|
| Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine
|
scientific article
|
| Progress towards a dengue vaccine
|
scientific article
|
| Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
|
scientific article
|
| Intussusception, rotavirus, and oral vaccines: summary of a workshop
|
scientific article
|
| Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States
|
scientific article
|
| Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.
|
scientific article
|
| Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine
|
scientific article
|
| Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications
|
scientific article
|
| Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine
|
scientific article
|
| Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine
|
scientific article
|
| In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses
|
scientific article
|
| Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza
|
scientific article
|
| First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
|
scientific article
|
| CpG DNA as a vaccine adjuvant.
|
scientific article
|
| A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis
|
scientific article
|
| Role of humoral versus cellular responses induced by a protective dengue vaccine candidate
|
scientific article
|
| Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody
|
scientific article
|
| Pediatricians' experience with and response to parental vaccine safety concerns and vaccine refusals: a survey of Connecticut pediatricians
|
scientific article
|
| Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model
|
scientific article
|
| Prospects for a mucosally-administered vaccine against Helicobacter pylori
|
scientific article
|
| A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine
|
scientific article
|
| Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants
|
scientific article
|
| Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.
|
scientific article
|
| Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men
|
scientific article
|
| Hepatitis B vaccine -- do we need boosters?
|
scientific article
|
| Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence
|
scientific article
|
| Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya
|
scientific article
|
| Emerging respiratory viruses: challenges and vaccine strategies
|
scientific article
|
| A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.
|
scientific article
|
| High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action
|
scientific article
|
| Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant
|
scholarly article
|
| Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.
|
scientific article
|
| Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults
|
scientific article
|
| VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone
|
scientific article
|
| Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain
|
scientific article
|
| Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
|
research work
|
| H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.
|
scientific article
|
| Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls
|
scientific article
|
| Emerging vaccine informatics
|
scientific article
|
| Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet
|
scientific article
|
| Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
|
scientific article
|
| End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
|
scientific article
|
| Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
|
scientific article
|
| Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
|
scientific article
|
| Effectiveness of pneumococcal polysaccharide vaccine in older adults
|
scientific article
|
| Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes
|
scientific article
|
| Development of a vaccine for toxoplasmosis: current status
|
scientific article published on April 1, 2003
|
| HPV vaccine and adolescent males
|
scientific article
|
| Vaccine assembly from surface proteins of Staphylococcus aureus.
|
scholarly article
|
| Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses
|
scientific article
|
| Nonsegmented negative-strand viruses as vaccine vectors
|
scientific article
|
| Innate endogenous adjuvants prime to desirable immune responses via mucosal routes
|
scientific article
|
| Recent advances in veterinary vaccine adjuvants
|
scientific article
|
| Vaccine research efforts for filoviruses
|
scientific article
|
| Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine
|
scientific article
|
| Measuring vaccine confidence: introducing a global vaccine confidence index
|
scientific article
|
| Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety
|
scientific article
|
| Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.
|
scientific article
|
| Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants
|
scientific article
|
| Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?
|
scientific article
|
| Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine
|
scientific article
|
| Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice
|
scientific article
|
| Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial
|
scientific article
|
| Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant
|
scientific article
|
| Microparticles as vaccine adjuvants and delivery systems
|
scientific article
|
| Epitope-based vaccines: an update on epitope identification, vaccine design and delivery
|
scientific article
|
| Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination
|
scientific article
|
| Fasciola hepatica vaccine: we may not be there yet but we're on the right road
|
scientific article
|
| Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old U.S. adolescent children
|
scientific article
|
| Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
|
scientific article
|
| Hepatitis E vaccine
|
scientific article published on 10 April 2008
|
| Nanoparticle-based vaccine delivery for cancer immunotherapy
|
scientific article published on 26 October 2013
|
| Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity
|
scientific article published on April 2008
|
| A self-adjuvanting supramolecular vaccine carrying a folded protein antigen
|
scientific article published on 25 February 2013
|
| Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.
|
scientific article published on 19 March 2005
|
| Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects
|
scientific article published on September 2012
|
| Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin
|
scientific article published on August 2009
|
| Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond
|
scientific article published on 07 October 2008
|
| Epaxal: a virosomal vaccine to prevent hepatitis A infection
|
scientific article published on October 2008
|
| Heat-shock proteins as powerful weapons in vaccine development
|
scientific article published on October 2008
|
| Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia
|
scientific article published on August 2008
|
| Advances in antiviral vaccine development
|
scientific article published on September 2013
|
| Deceptive imprinting and immune refocusing in vaccine design
|
scientific article published on 11 October 2008
|
| HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
scientific article published on 07 September 2016
|
| A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals
|
scientific article published on 15 May 2009
|
| Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells
|
scientific article published on 20 July 2009
|
| Vaccine chronicle in Japan
|
scientific article published on 09 July 2013
|
| CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development
|
scientific article published on 19 June 2009
|
| Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans
|
scientific article published on 28 June 2009
|
| Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean
|
scientific article published on August 2008
|
| Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
|
scientific article published on March 2008
|
| Inactivated rotavirus vaccines: a priority for accelerated vaccine development
|
scientific article published on 23 October 2008
|
| Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections
|
scientific article published on May 2008
|
| Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine
|
scientific article published on 02 October 2015
|
| Influenza vaccination and mortality: differentiating vaccine effects from bias
|
scientific article published on 22 July 2009
|
| Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.
|
scientific article published on September 2009
|
| Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults
|
scientific article published on 03 July 2009
|
| Mechanisms of immunity in hydatid disease: implications for vaccine development
|
scientific article
|
| Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women
|
scientific article published on August 1, 1979
|
| Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults
|
scientific article published on October 2008
|
| Direct and indirect effects in vaccine efficacy and effectiveness
|
scientific article published on February 1991
|
| The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers
|
scientific article published on 19 August 2013
|
| Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model.
|
scientific article published on 18 September 2013
|
| Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer
|
scientific article published on 27 July 2009
|
| Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.
|
scientific article published on 17 July 2009
|
| Vaccine-induced enhancement of viral infections.
|
scientific article
|
| Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma
|
scientific article published on 21 October 2013
|
| T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces
|
scientific article published on 13 May 2009
|
| A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae
|
scientific article published on 30 May 2011
|
| Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine
|
scientific article published on 10 June 2009
|
| Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay
|
scientific article published on 16 September 2013
|
| A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates
|
scientific article published on 09 October 2013
|
| Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines
|
scientific article
|
| The architecture of provider-parent vaccine discussions at health supervision visits
|
scientific article
|
| Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.
|
scientific article published on January 2009
|
| New horizons in adjuvants for vaccine development
|
scientific article published on 06 December 2008
|
| Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
|
scientific article published on 25 June 2009
|
| Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
|
scientific article published on 26 March 2009
|
| Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine
|
scientific article published on February 2009
|
| Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus
|
scientific article published on 30 August 2007
|
| Nanocarriers for systemic and mucosal vaccine delivery.
|
scientific article published on January 2007
|
| Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.
|
scientific article published on March 2009
|
| Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses
|
scientific article published on September 2004
|
| Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells
|
scientific article published on 08 July 2009
|
| Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
|
scientific article published on 09 February 2016
|
| Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery
|
scientific article published on 19 July 2009
|
| Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
|
scientific article published on January 2009
|
| Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location
|
scientific article published on January 2009
|
| Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa
|
scientific article published on 16 December 2008
|
| Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys
|
scientific article published on 24 October 2013
|
| Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.
|
scientific article published on September 2016
|
| Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge
|
scholarly article
|
| Estradiol improves genital herpes vaccine efficacy in mice
|
scientific article published on 04 August 2009
|
| Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
|
scientific article published on 30 July 2009
|
| Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine
|
scientific article
|
| Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine
|
scientific article published on January 1991
|
| Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
|
scientific article published on 25 September 2009
|
| Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates
|
scientific article published on 29 July 2009
|
| Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors
|
scientific article published on 12 May 2009
|
| Recombinant vaccines and the development of new vaccine strategies.
|
scientific article published on 06 September 2012
|
| Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.
|
scientific article published on 26 April 2012
|
| Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization
|
scientific article published on October 2009
|
| Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
|
scientific article published on 20 July 2009
|
| Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine
|
scientific article published on January 2009
|
| Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination
|
scientific article published on 26 December 2007
|
| Sepsis, parenteral vaccination and skin disinfection
|
scientific article published on 13 June 2016
|
| Can vaccine legacy explain the British pertussis resurgence?
|
scientific article published on 16 October 2013
|
| Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
|
scientific article published on October 2013
|
| Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.
|
scientific article published on February 2009
|
| How might infant and paediatric immune responses influence malaria vaccine efficacy?
|
scientific article published on September 2009
|
| Does the relative importance of MMR vaccine concerns differ by degree of parental vaccine hesitancy?: An exploratory study
|
scientific article published on 02 October 2012
|
| A pilot study on the effects of individually tailored education for MMR vaccine-hesitant parents on MMR vaccination intention
|
scientific article published on 04 January 2013
|
| New concepts in herpes simplex virus vaccine development: notes from the battlefield
|
scientific article published on August 2009
|
| Biomaterials as vaccine adjuvants
|
scientific article published on July 2008
|
| Literature review of human papillomavirus vaccine acceptability among women over 26 years.
|
scientific article published on 03 February 2009
|
| Protection of Monkeys Against Experimental Shigellosis with a Living Attenuated Oral Polyvalent Dysentery Vaccine
|
scientific article published on July 1966
|
| Willingness of Chinese injection drug users to participate in HIV vaccine trials.
|
scientific article published on 26 December 2007
|
| Mixture models for single-cell assays with applications to vaccine studies
|
scientific article published on 24 July 2013
|
| Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality
|
scientific article published on January 2009
|
| Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine
|
scientific article published on August 1986
|
| The green vaccine: A global strategy to combat infectious and autoimmune diseases
|
scientific article published on 23 July 2009
|
| Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses
|
scientific article published on September 2008
|
| Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production
|
scientific article published on 20 February 2009
|
| Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
|
scientific article published on 24 June 2009
|
| Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system
|
scientific article published on 24 June 2009
|
| Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response
|
scientific article published on 25 January 2010
|
| Vaccine adjuvants: scientific challenges and strategic initiatives
|
scientific article published on March 2009
|
| Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement
|
scientific article published on March 2009
|
| Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults
|
scientific article published on 11 August 2009
|
| Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine
|
scientific article published on 02 December 2013
|
| Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine
|
scientific article
|
| Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age
|
scientific article
|
| Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults
|
scientific article
|
| Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
|
scientific article
|
| VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells
|
scientific article
|
| Microneedles for drug and vaccine delivery
|
scientific article
|
| Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea
|
scientific article
|
| Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen
|
scientific article
|
| Vaccine adjuvants: putting innate immunity to work
|
scientific article
|
| Parental intention to have daughters receive the human papillomavirus vaccine
|
scientific article
|
| Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010-2012.
|
scientific article
|
| Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
|
scientific article
|
| Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
|
scientific article
|
| The success and failure of BCG - implications for a novel tuberculosis vaccine
|
scientific article
|
| Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series
|
scientific article
|
| Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract
|
scientific article
|
| Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.
|
scientific article
|
| Priorities for CMV vaccine development
|
scientific article
|
| Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs
|
scientific article
|
| Do correlates of HPV vaccine initiation differ between adolescent boys and girls?
|
scientific article
|
| Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine
|
scientific article
|
| Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces
|
scientific article
|
| A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses
|
scientific article
|
| The immune response to hepatitis B vaccine in humans: inheritance patterns in families
|
scientific article
|
| Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development
|
scientific article
|
| The Impact of the Gut Microbiota on Humoral Immunity to Pathogens and Vaccination in Early Infancy.
|
scientific article
|
| Prospects for a vaccine against the hepatitis C virus
|
scientific article
|
| Yellow fever vaccine
|
scientific article
|
| Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study
|
scientific article
|
| Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease
|
scientific article
|
| Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)
|
scientific article
|
| Immunity induced by the radiation-attenuated schistosome vaccine
|
scientific article
|
| Quality of physician communication about human papillomavirus vaccine: findings from a national survey
|
scientific article
|
| FluBlok, a recombinant hemagglutinin influenza vaccine
|
scientific article
|
| Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b
|
scientific article
|
| Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
|
scientific article
|
| Opportunities for vaccine research in Europe
|
scientific article
|
| Studies with inactivated equine influenza vaccine: 1. Serological responses of ponies to graded doses of vaccine
|
scientific article published on June 1, 1983
|
| A review of clinical trials of human papillomavirus prophylactic vaccines
|
scientific article
|
| Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
|
scientific article
|
| Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset
|
scientific article
|
| Recombinant poxviruses as mucosal vaccine vectors
|
scientific article
|
| Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
|
scientific article
|
| Parents' source of vaccine information and impact on vaccine attitudes, beliefs, and nonmedical exemptions
|
scientific article
|
| Development of nonhuman adenoviruses as vaccine vectors
|
scientific article
|
| Improving adolescent health: focus on HPV vaccine acceptance
|
scientific article
|
| HIV vaccine design: insights from live attenuated SIV vaccines
|
scientific article
|
| Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus
|
scientific article
|
| A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
|
scientific article
|
| Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine
|
scientific article
|
| Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine
|
scientific article
|
| Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
|
scientific article
|
| Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine
|
scientific article
|
| Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein
|
scientific article
|
| Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy
|
scientific article
|
| Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts
|
scientific article
|
| Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
|
scientific article
|
| The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis
|
scientific article
|
| Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans
|
scientific article
|
| Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)
|
scientific article
|
| Poultry coccidiosis: recent advancements in control measures and vaccine development.
|
scientific article
|
| IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
|
scientific article
|
| Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
|
scientific article
|
| Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy
|
scientific article
|
| Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century
|
scientific article
|
| Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.
|
scientific article
|
| A recombinant subunit vaccine approach to HCMV vaccine development
|
scientific article published on June 1, 1991
|
| Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses
|
scientific article
|
| Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial
|
scientific article
|
| A novel glyco-conjugate vaccine against fungal pathogens
|
scientific article
|
| A vaccine strategy that protects against genital herpes by establishing local memory T cells
|
scientific article
|
| Translating innate immunity into immunological memory: implications for vaccine development
|
scientific article
|
| Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
|
scientific article
|
| Epstein-Barr virus: an important vaccine target for cancer prevention
|
scientific article
|
| Disparities in human papillomavirus vaccine completion among vaccine initiators
|
scientific article
|
| The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission
|
scientific article
|
| Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
|
scientific article
|
| Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation
|
scientific article
|
| Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax
|
scientific article
|
| Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation
|
scientific article
|
| Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
|
scientific article
|
| Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain
|
scientific article
|
| The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy
|
scientific article
|
| Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates
|
scientific article
|
| Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review
|
scientific article
|
| Ethical analysis of HPV vaccine policy options
|
scientific article
|
| An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
|
scientific article
|
| The potential economic value of a human norovirus vaccine for the United States
|
scientific article
|
| A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease
|
scientific article
|
| Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity
|
scientific article
|
| Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system
|
scientific article
|
| Replicating and non-replicating viral vectors for vaccine development
|
scientific article
|
| The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance
|
scientific article
|
| Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015
|
scientific article
|
| Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
|
scientific article published on October 1, 2003
|
| Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review
|
scientific article
|
| Generation and characterization of a preventive and therapeutic HPV DNA vaccine
|
scientific article
|
| Advances in tuberculosis vaccine strategies
|
scientific article
|
| Subunit vaccine against the seven serotypes of botulism
|
scientific article
|
| Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children
|
scientific article
|
| Prospects for a Zika Virus Vaccine
|
scientific article
|
| Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh
|
scientific article
|
| Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.
|
scientific article
|
| Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.
|
scientific article
|
| Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection
|
scientific article
|
| Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
|
scientific article
|
| Plasmid-only rescue of influenza A virus vaccine candidates.
|
scientific article
|
| The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.
|
scientific article
|
| DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.
|
scientific article
|
| Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.
|
scientific article
|
| Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.
|
scientific article
|
| Pandemic influenza and the global vaccine supply.
|
scientific article
|
| Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.
|
scientific article
|
| Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials
|
scientific article published on September 1, 2003
|
| Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine.
|
scientific article
|
| Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
|
scientific article
|
| Prospects for an AIDS vaccine: three big questions, no easy answers.
|
scientific article
|
| Confronting the avian influenza threat: vaccine development for a potential pandemic.
|
scientific article
|
| From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
|
scientific article
|
| Strategy for distribution of influenza vaccine to high-risk groups and children.
|
scientific article
|
| Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.
|
scientific article
|
| Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.
|
scientific article
|
| A review of vaccine research and development: human acute respiratory infections.
|
scientific article
|
| Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.
|
scientific article
|
| HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics
|
scientific article
|
| Associations between health communication behaviors, neighborhood social capital, vaccine knowledge, and parents' H1N1 vaccination of their children.
|
scientific article
|
| Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.
|
scientific article
|
| A review of vaccine research and development: the human immunodeficiency virus (HIV).
|
scientific article
|
| Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects.
|
scientific article
|
| Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
|
scientific article
|
| Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.
|
scientific article
|
| Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.
|
scientific article
|
| Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.
|
scientific article
|
| Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
|
scientific article
|
| Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
|
scientific article
|
| Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
|
scientific article
|
| Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
|
scientific article
|
| Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004
|
scientific article
|
| Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.
|
scientific article
|
| Plant virus expression vector development: new perspectives.
|
scientific article published on 13 March 2014
|
| Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.
|
scientific article
|
| Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.
|
scientific article
|
| The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children.
|
scientific article published on 28 May 2014
|
| Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.
|
scientific article
|
| Influenza vaccine: the challenge of antigenic drift.
|
scientific article published on 3 August 2007
|
| Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.
|
scientific article
|
| A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.
|
scientific article
|
| Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
|
scientific article
|
| MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
|
scientific article
|
| Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
|
scientific article
|
| The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.
|
scientific article published on 6 August 2014
|
| Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets
|
scientific article
|
| Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.
|
scientific article
|
| Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
|
scientific article
|
| A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
|
scientific article
|
| CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
|
scientific article
|
| Development of stable influenza vaccine powder formulations: challenges and possibilities
|
scientific article
|
| Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
|
scientific article
|
| Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.
|
scientific article
|
| Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.
|
scientific article
|
| Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
|
scientific article
|
| The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.
|
scientific article
|
| Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
|
scientific article
|
| Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
|
scientific article
|
| A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.
|
scientific article
|
| A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
|
scientific article
|
| Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
|
scientific article
|
| Molecular and cellular signatures of human vaccine adjuvants.
|
scientific article
|
| Animal models in influenza vaccine testing.
|
scientific article
|
| H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
|
scientific article
|
| Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.
|
scientific article
|
| Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
|
scientific article
|
| Toward a broadly protective influenza vaccine
|
scientific article
|
| Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.
|
scientific article
|
| MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults
|
scientific article
|
| Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.
|
scientific article
|
| Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
|
scientific article
|
| Current status and progress of prepandemic and pandemic influenza vaccine development.
|
scientific article
|
| Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
|
scientific article
|
| Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets
|
scientific article
|
| Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
|
scientific article
|
| Assessing vaccine effects in repeated low-dose challenge experiments.
|
scientific article
|
| Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
|
scientific article
|
| Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.
|
scientific article
|
| MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
|
scientific article
|
| A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
|
scientific article
|
| Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.
|
scientific article
|
| Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.
|
scientific article
|
| Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.
|
scientific article
|
| A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
|
scientific article
|
| Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.
|
scientific article
|
| Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.
|
scientific article
|
| Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
|
scientific article
|
| Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.
|
scientific article
|
| Response to a monovalent 2009 influenza A (H1N1) vaccine.
|
scientific article
|
| The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey
|
scientific article
|
| Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice.
|
scientific article
|
| Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City
|
scientific article
|
| Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
|
scientific article
|
| Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.
|
scientific article
|
| Antibody assays suitable for assessing immune responses to live varicella vaccine
|
scientific article published on February 1, 1991
|
| Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro
|
scientific article
|
| Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine
|
scientific article
|
| Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses
|
scientific article
|
| Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
|
scientific article
|
| An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China.
|
scientific article
|
| A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
|
scientific article
|
| Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection
|
scientific article
|
| Towards a blood-stage vaccine for malaria: are we following all the leads?
|
scientific article
|
| Evolving public perceptions and stability in vaccine uptake
|
scientific article
|
| The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014
|
scientific article
|
| Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
|
scientific article
|
| Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients
|
scientific article published on November 1, 1991
|
| Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
|
scientific article
|
| Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent
|
scientific article
|
| Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
|
scientific article
|
| Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques
|
scientific article
|
| Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
|
scientific article
|
| Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome.
|
scientific article
|
| Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.
|
scientific article
|
| Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, suppo
|
scientific article
|
| Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.
|
scientific article
|
| An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
|
scientific article
|
| Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization
|
scientific article
|
| A clinical development paradigm for cancer vaccines and related biologics
|
scientific article
|
| Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States
|
scientific article
|
| The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
|
scientific article
|
| Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice
|
scientific article
|
| Serologic vaccination response after solid organ transplantation: a systematic review
|
scientific article
|
| Recombination in vaccine and circulating strains of porcine reproductive and respiratory syndrome viruses
|
scientific article
|
| Vaccine therapy in patients with renal cell carcinoma
|
scientific article
|
| Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.
|
scientific article
|
| Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review
|
scientific article
|
| Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
|
scientific article
|
| Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus
|
scientific article
|
| Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development
|
scientific article
|
| Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
|
scientific article
|
| DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer
|
scientific article
|
| HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
|
scientific article
|
| Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season
|
scientific article
|
| The immune response during acute HIV-1 infection: clues for vaccine development
|
scientific article
|
| Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults
|
scientific article
|
| Towards a Brucella vaccine for humans
|
scientific article
|
| A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma
|
scientific article
|
| Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba
|
scientific article
|
| Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype.
|
scientific article
|
| HIV vaccine strategies
|
scientific article
|
| Development of a DNA-MVA/HIVA vaccine for Kenya
|
scientific article
|
| HPV vaccine hesitancy: findings from a statewide survey of health care providers
|
scientific article
|
| Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease
|
scholarly article
|
| Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006.
|
scientific article
|
| Emerging and continuing trends in vaccine opposition website content
|
scientific article
|
| Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
|
scientific article
|
| An HIV vaccine--evolving concepts
|
scientific article
|
| Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review
|
scientific article
|
| Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge
|
scientific article
|
| Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella
|
scientific article
|
| Effective chikungunya virus-like particle vaccine produced in insect cells
|
scientific article
|
| Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach
|
scientific article
|
| New hope for an AIDS vaccine
|
scientific article
|
| Effector and memory T-cell differentiation: implications for vaccine development
|
scientific article
|
| Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.
|
scientific article
|
| The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
|
scientific article
|
| Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk
|
scientific article
|
| Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years
|
scientific article
|
| The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review
|
scientific article
|
| Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults
|
scientific article
|
| Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose
|
scientific article
|
| Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine
|
scientific article
|
| Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
|
scientific article
|
| Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study
|
scientific article
|
| PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors
|
scientific article
|
| Blueprint for schistosomiasis vaccine development
|
scientific article
|
| A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication
|
scientific article published in January 2013
|
| LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox
|
scientific article
|
| The UK Hib vaccine experience
|
scientific article
|
| Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults
|
scientific article
|
| Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine
|
scientific article
|
| Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene
|
scientific article
|
| Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
|
scientific article
|
| Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States
|
scientific article
|
| Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review
|
scientific article
|
| Challenges in the development of an HIV-1 vaccine
|
scientific article
|
| Gaps in vaccine financing for underinsured children in the United States
|
scientific article
|
| Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
|
scientific article
|
| Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
|
scientific article
|
| Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study
|
scientific article
|
| Assessment of vaccine candidates for persons aged 50 and older: a review
|
scientific article
|
| Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
|
scientific article
|
| Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
|
scientific article
|
| Vaccine resource tracking systems
|
scientific article
|
| Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes
|
scientific article
|
| IL-28B is a key regulator of B- and T-cell vaccine responses against influenza
|
scientific article
|
| The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection
|
scientific article
|
| Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety
|
scholarly article
|
| Immuno-informatics: Mining genomes for vaccine components
|
scientific article
|
| Respiratory syncytial virus: reverse genetics and vaccine strategies
|
scientific article
|
| Exploiting dendritic cells to improve vaccine efficacy
|
scientific article
|
| Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
|
scientific article
|
| Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity
|
scientific article
|
| Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development
|
scientific article
|
| A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine
|
scientific article
|
| Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
|
scientific article
|
| Recent advances in the discovery and delivery of vaccine adjuvants
|
scientific article
|
| DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency
|
scientific article
|
| Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
|
scientific article
|
| Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study
|
scientific article published on 29 January 2015
|
| New challenges in modern vaccinology
|
scientific article
|
| Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial
|
scientific article
|
| The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies
|
scientific article
|
| Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response?
|
scientific article
|
| HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable
|
scientific article
|
| Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses
|
scientific article
|
| Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine
|
scientific article
|
| Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine.
|
scientific article
|
| The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids
|
scientific article
|
| A candidate dual vaccine against influenza and noroviruses
|
scientific article
|
| Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides
|
scientific article published on August 1, 1992
|
| A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection
|
scientific article
|
| New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
|
scientific article
|
| Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors
|
scientific article
|
| A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.
|
scientific article
|
| A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates
|
scientific article
|
| Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
|
scientific article published on October 25, 1984
|
| Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine
|
scientific article
|
| Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains
|
scientific article
|
| Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli
|
scientific article
|
| Serum vaccine antibody concentrations in children exposed to perfluorinated compounds
|
scientific article
|
| Inflammatory responses to trivalent influenza virus vaccine among pregnant women
|
scientific article
|
| A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge
|
scientific article
|
| Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation
|
scientific article
|
| Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era.
|
scientific article published on 7 September 2011
|
| A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge
|
scientific article published on 21 September 2011
|
| Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type
|
scientific article published on 18 November 2014
|
| Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries
|
scientific article published on September 2011
|
| Prime-boost strategies for malaria vaccine development
|
scientific article published on November 2003
|
| DNA vaccine strategies: candidates for immune modulation and immunization regimens.
|
scientific article published on November 2003
|
| Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines
|
scientific article published on June 1997
|
| Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity
|
scientific article published on October 15, 2003
|
| Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion
|
scientific article published on 25 February 2015
|
| Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer
|
scientific article published on 14 May 2011
|
| Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy
|
scientific article published on 8 August 2011
|
| Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne Diseases
|
scientific article published on 12 December 2014
|
| Immunology of tuberculosis and implications in vaccine development
|
scientific article published on January 2004
|
| A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011
|
scientific article published on January 2012
|
| Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A
|
scientific article published on December 1, 1992
|
| Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant
|
scientific article published on December 1, 1992
|
| Contributions of humoral and cellular immunity to vaccine-induced protection in humans.
|
scientific article published on 8 January 2011
|
| A field trial to assess a blood-stage malaria vaccine
|
scientific article published on September 2011
|
| Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
|
scientific article published on 23 August 2011
|
| Malaria vaccine developments
|
scientific article published on January 2004
|
| Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine
|
scientific article published on 26 November 2011
|
| The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
|
scientific article published on December 2011
|
| Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
|
scientific article published on 27 December 2011
|
| Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens
|
scientific article published on February 2004
|
| How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?
|
scientific article published on 20 May 2011
|
| Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
|
scientific article published on 14 December 2011
|
| Immunogenicity of infectious pathogens and vaccine antigens
|
scientific article published on 29 May 2015
|
| Vaccinations in paediatric rheumatology: an update on current developments
|
scientific article published on July 2015
|
| Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
|
scientific article published on 23 November 2011
|
| Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
|
scientific article published on 7 November 2011
|
| Shigella flexneri infection: pathogenesis and vaccine development.
|
scientific article published on February 2004
|
| Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.
|
scientific article published on 6 November 2006
|
| Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine
|
scientific article published on 6 April 2011
|
| Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus
|
scientific article published on August 2004
|
| Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide
|
scientific article published on February 2004
|
| Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials
|
scientific article published on February 2004
|
| Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility
|
scientific article published on 21 November 2014
|
| High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs.
|
scientific article published on 14 December 2011
|
| Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.
|
scientific article published on 6 December 2006
|
| Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.
|
scientific article published on 3 November 2006
|
| Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
|
scientific article published on 4 January 2012
|
| Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector
|
scientific article published on 24 January 2012
|
| SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
|
scientific article published on 15 December 2011
|
| Quantifying influenza vaccine efficacy and antigenic distance.
|
scientific article published on 19 January 2006
|
| Control without separate controls: evaluation of vaccine safety using case-only methods
|
scientific article published on May 2004
|
| Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen
|
scientific article published on 18 November 2008
|
| Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques
|
scientific article published on 14 April 2008
|
| Efficacy results of a trial of a herpes simplex vaccine
|
scientific article published on January 2012
|
| The importance of adjuvant formulation in the development of a tuberculosis vaccine
|
scientific article published on 30 January 2012
|
| Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
|
scientific article published on 12 February 2007
|
| Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone
|
scientific article published on 16 February 2007
|
| Current status of live attenuated influenza virus vaccine in the US.
|
scientific article published on July 2004
|
| Systems vaccinology: learning to compute the behavior of vaccine induced immunity
|
scientific article published on 19 October 2011
|
| Consistency of HLA associations between two independent measles vaccine cohorts: a replication study
|
scientific article published on 25 January 2012
|
| Epitope analysis for influenza vaccine design.
|
scientific article published on January 2005
|
| Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
|
scientific article published on 24 September 2015
|
| A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction
|
scientific article published on 6 December 2011
|
| The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.
|
scientific article published on January 2004
|
| European union regulatory developments for new vaccine adjuvants and delivery systems
|
scientific article published on June 2004
|
| Broadly protective Shigella vaccine based on type III secretion apparatus proteins
|
scientific article published on 27 December 2011
|
| Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers
|
scientific article published on February 2012
|
| Modulating vaccine responses with dendritic cells and Toll-like receptors
|
scientific article published in June 2004
|
| Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
|
scientific article published in January 1995
|
| Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens
|
scholarly article
|
| Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.
|
scientific article published on 4 May 2015
|
| Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents
|
scientific article published in July 2004
|
| Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
|
scientific article published in August 1995
|
| Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa
|
scientific article published on 22 December 2005
|
| Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors
|
scientific article published in August 2004
|
| A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees
|
scientific article published on December 1986
|
| The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam
|
scientific article published on December 2016
|
| Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
|
scientific article published on 09 August 2013
|
| HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
|
scientific article
|
| IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity
|
scientific article published on June 2009
|
| The role of IFN-gamma Elispot assay in HIV vaccine research
|
scientific article published on January 2009
|
| Animal models of tuberculosis for vaccine development.
|
scientific article published on January 2009
|
| Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
|
scientific article published on August 2009
|
| Toll gates to periodontal host modulation and vaccine therapy
|
scientific article published on January 2009
|
| FluBlok, a next generation influenza vaccine manufactured in insect cells
|
scientific article published on 17 March 2009
|
| Virulence, immunity, and vaccine related to Streptococcus pneumoniae
|
scientific article published on January 1991
|
| Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine
|
scientific article published on March 1991
|
| Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.
|
scientific article published on May 2004
|
| Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans
|
scientific article published on 14 July 2009
|
| Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines
|
scientific article published on April 2009
|
| Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
|
scientific article published on April 2009
|
| Serum proinflammatory cytokine responses to influenza virus vaccine among women during pregnancy versus non-pregnancy
|
scientific article published on April 2013
|
| A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.
|
scientific article published on 03 January 2014
|
| Continued impact of pneumococcal conjugate vaccine on carriage in young children.
|
scientific article published on July 2009
|
| Plants as bioreactors for the production of vaccine antigens.
|
scientific article published on 06 April 2009
|
| Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations
|
scientific article published on 15 September 2009
|
| Optimized subunit vaccine protects against experimental leishmaniasis
|
scientific article published on 26 September 2009
|
| Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
|
scientific article published on 15 September 2009
|
| Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis
|
scientific article published on 26 September 2009
|
| A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults
|
research work
|
| Vaccine-induced CD8+ T cells control AIDS virus replication
|
scientific article published on 30 September 2012
|
| Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing
|
scientific article published on 17 October 2013
|
| Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni
|
scientific article published on March 2009
|
| Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra
|
scientific article published on 07 October 2009
|
| Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen
|
scientific article published on 05 October 2009
|
| Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development
|
scientific article published on December 2009
|
| Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus.
|
scientific article published on 23 September 2009
|
| Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.
|
scientific article published on 17 September 2010
|
| Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development
|
scientific article published on 12 October 2009
|
| Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals
|
scientific article published on January 2014
|
| Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens
|
scientific article published on 11 September 2009
|
| The smallpox vaccine induces an early neutralizing IgM response
|
scientific article published on 12 October 2009
|
| A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity
|
scientific article published on 14 October 2009
|
| Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
|
scientific article published on 20 October 2009
|
| Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates
|
scientific article published on 13 October 2009
|
| Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
|
scientific article published on May 2009
|
| Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development
|
scientific article published on May 2009
|
| Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination
|
scientific article published on 03 July 2013
|
| A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program
|
scientific article published on January 2014
|
| Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation
|
scientific article published on 05 October 2009
|
| The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
|
scientific article published on August 2009
|
| Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication
|
scientific article published on 03 March 2009
|
| Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.
|
scientific article published on 16 October 2009
|
| Developmental biology of the innate immune response: implications for neonatal and infant vaccine development
|
scientific article published on May 2009
|
| Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors
|
scholarly article
|
| Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine
|
scientific article published on 29 May 2009
|
| Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
|
scientific article published on 28 March 2009
|
| Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine
|
scientific article published on September 2004
|
| Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.
|
scientific article published on January 2014
|
| DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines
|
scientific article published on July 1996
|
| Meningococcal C conjugate vaccine: the experience in England and Wales
|
scientific article published on 23 May 2009
|
| Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
|
scientific article published on June 2009
|
| Strategies to overcome host immunity to adenovirus vectors in vaccine development
|
scientific article published on June 2009
|
| Current status of toxoplasmosis vaccine development.
|
scientific article published on June 2009
|
| Estimation of vaccine efficacy against acquisition of pneumococcal carriage
|
scientific article published on 23 April 2009
|
| Immunology of TLR-independent vaccine adjuvants
|
scientific article published on June 2009
|
| Immune evasion by malaria parasites: a challenge for vaccine development
|
scientific article published on June 2009
|
| Neospora caninum--how close are we to development of an efficacious vaccine that prevents abortion in cattle?
|
scientific article published on 02 June 2009
|
| Tuberculosis vaccine research: the impact of immunology
|
scientific article published on 07 June 2009
|
| The path to a successful vaccine adjuvant--'the long and winding road'.
|
scientific article published on 05 March 2009
|
| Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children
|
scientific article published on February 2014
|
| New insights on adenovirus as vaccine vectors
|
scientific article published on 09 June 2009
|
| Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
|
scientific article published on August 2009
|
| IC51 Japanese encephalitis vaccine
|
scientific article published on July 2009
|
| Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components
|
scientific article published on September 2004
|
| Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.
|
scientific article published on October 2004
|
| Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators
|
scientific article published on July 2009
|
| Chitosan-based systems for the delivery of vaccine antigens
|
scientific article published on July 2009
|
| Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice
|
scientific article published on March 2014
|
| The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity
|
scientific article published on 15 September 2010
|
| Story and science: how providers and parents can utilize storytelling to combat anti-vaccine misinformation
|
scientific article published on 28 June 2013
|
| Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development
|
scientific article published on July 2009
|
| Identification and Prioritization of the Economic Impacts of Vaccines
|
scientific article published on 12 December 2016
|
| Challenges in developing a pediatric RSV vaccine
|
scientific article published on 28 September 2009
|
| Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development
|
scientific article published on June 2009
|
| Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.
|
scientific article published on 25 October 2013
|
| A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores
|
scholarly article
|
| A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.
|
scholarly article
|
| Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
|
scholarly article
|
| Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development
|
scientific article published on 27 September 2016
|
| Immunosenescence and vaccine failure in the elderly
|
scientific article published on June 2009
|
| Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.
|
scientific article published on 16 September 2008
|
| Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.
|
scientific article published on 20 October 2016
|
| C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America
|
scientific article published on 03 January 2014
|
| Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain
|
scientific article published on 11 December 2013
|
| Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.
|
scientific article published on 31 October 2013
|
| The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
|
scientific article published on 03 February 2014
|
| Predictive value of seizure ICD-9 codes for vaccine safety research
|
scientific article published on 17 July 2009
|
| Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
|
scientific article published on 18 July 2009
|
| Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
|
scientific article published on August 2009
|
| Maraba virus as a potent oncolytic vaccine vector
|
scientific article published on 25 October 2013
|
| Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus
|
scientific article published on October 2004
|
| Strategic priorities for respiratory syncytial virus (RSV) vaccine development
|
scientific article published on April 2013
|
| Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?
|
scientific article published on December 2013
|
| Developing novel immunogens for a safe and effective Alzheimer's disease vaccine
|
scientific article published on January 2009
|
| Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis.
|
scientific article
|
| Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.
|
scientific article
|
| Delivering influenza vaccine to pregnant women
|
scientific article
|
| Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine
|
scientific article
|
| The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
|
scholarly article
|
| The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design
|
scientific article
|
| Psoriasis - a possible candidate for vaccination
|
scientific article published on June 2006
|
| Biodegradable particles as vaccine delivery systems: size matters
|
scientific article published on 10 October 2012
|
| Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs
|
scientific article published on April 1990
|
| Progress in tuberculosis vaccine development
|
scientific article published on 13 June 2006
|
| MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study
|
scientific article published on 17 December 2012
|
| Animal models for vaccine studies for visceral leishmaniasis
|
scientific article published on March 2006
|
| Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications
|
scientific article published on 29 November 2012
|
| IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection
|
scientific article published on 10 March 2008
|
| Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates
|
scientific article published on March 2004
|
| A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection
|
scientific article published on 3 May 2009
|
| Self-disseminating vaccines for emerging infectious diseases
|
scientific article published on 2 November 2015
|
| Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
|
scientific article published on 31 July 2012
|
| An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector
|
scientific article published on October 2003
|
| Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?
|
scientific article published on April 2006
|
| Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
|
scientific article published on 10 January 2008
|
| Th1 memory: implications for vaccine development
|
scientific article published on June 2006
|
| HIV vaccines: new frontiers in vaccine development
|
scientific article published on 6 July 2006
|
| Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results
|
scientific article published on 4 February 2008
|
| Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates
|
scientific article published on 11 February 2008
|
| A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice
|
scientific article published on November 2003
|
| Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.
|
scholarly article
|
| The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
|
scientific article published on August 2006
|
| Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases
|
scientific article published on 5 September 2014
|
| Tools and approaches to ensure quality of vaccines throughout the cold chain
|
scientific article published on 28 May 2014
|
| Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies
|
scientific article published on January 2006
|
| Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
|
scientific article published on 29 December 2012
|
| Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine
|
scientific article published on 31 December 2012
|
| Viral vectors for malaria vaccine development
|
scientific article published on August 2006
|
| Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis
|
scientific article published on March 2004
|
| Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection
|
scientific article published on 25 August 2006
|
| Marker vaccine strategies and candidate CSFV marker vaccines
|
scientific article published on 7 August 2006
|
| Chikungunya virus and prospects for a vaccine
|
scientific article published on September 2012
|
| Chapter 13: Current findings from prophylactic HPV vaccine trials
|
scientific article published on 23 June 2006
|
| Chapter 14: HPV vaccine introduction in industrialized countries
|
scientific article published on August 2006
|
| Chapter 15: HPV vaccine use in the developing world
|
scientific article published on August 2006
|
| Chapter 24: Psychosocial aspects of vaccine acceptability.
|
scientific article published on August 2006
|
| Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer
|
scientific article published on September 2006
|
| Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.
|
scientific article published on August 2006
|
| The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches
|
scientific article published on January 2013
|
| Mimicking live flavivirus immunization with a noninfectious RNA vaccine
|
scholarly article
|
| Role of T lymphocyte replicative senescence in vaccine efficacy
|
scientific article published on 7 September 2006
|
| High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
|
scientific article published on 21 November 2006
|
| Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
|
scientific article published on 17 October 2015
|
| Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial
|
scientific article published on February 2007
|
| A review of human vaccine research and development: malaria
|
scientific article published on 5 October 2006
|
| Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
|
scientific article published on 18 September 2006
|
| LC16m8: an attenuated smallpox vaccine
|
scientific article published on 21 April 2006
|
| Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice
|
scientific article published on November 2007
|
| Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
|
scientific article published on 27 June 2011
|
| Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.
|
scientific article published on October 2006
|
| Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.
|
scientific article published on November 1993
|
| A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge
|
scientific article published on January 1993
|
| Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells
|
scientific article published on 23 October 2012
|
| Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study
|
scientific article published on 24 April 2008
|
| Group B Streptococcus: global incidence and vaccine development
|
scientific article published on 6 November 2006
|
| Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France
|
scientific article published on January 2016
|
| Immune epitope mapping in the post-genomic era: lessons for vaccine development
|
scientific article published on 17 November 2006
|
| Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
|
scientific article published on 20 November 2006
|
| Progress and obstacles in the development of an AIDS vaccine
|
scientific article published on December 2006
|
| Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety
|
scientific article published on January 1990
|
| The impact of making vaccines thermostable in Niger's vaccine supply chain
|
scientific article published on 10 July 2012
|
| Identification of two determinants that attenuate vaccine-related type 2 poliovirus
|
scientific article published on March 1, 1991
|
| Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.
|
scientific article published on August 2004
|
| Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction
|
scientific article published on January 2007
|
| Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates
|
scientific article published on February 1, 1992
|
| Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara
|
scientific article published on November 2008
|
| T-cell epitope vaccine design by immunoinformatics
|
scientific article published on 8 January 2013
|
| Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells
|
scientific article published on 7 April 2008
|
| A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing
|
scientific article published on 7 January 2013
|
| American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
|
scientific article published on January 2007
|
| Vaccine delivery using nanoparticles.
|
scientific article published on 25 March 2013
|
| Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
|
scientific article published on May 2012
|
| An update on the search for a Plasmodium vivax vaccine
|
scientific article published on 29 January 2007
|
| Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
|
scientific article published on 8 November 2006
|
| Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
|
scientific article published on 8 November 2006
|
| Vaccine delivery methods using viral vectors
|
scientific article published on January 2007
|
| An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.
|
scientific article published on 5 February 2008
|
| Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial
|
scientific article published on 16 June 2008
|
| Developing an HPV vaccine to prevent cervical cancer and genital warts
|
scientific article published on 18 January 2007
|
| West Nile virus: recent trends in diagnosis and vaccine development
|
scientific article published on 22 December 2006
|
| Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
|
scientific article published on 13 March 2013
|
| Vaccine adjuvants revisited
|
scientific article published on 16 February 2007
|
| Mucosal vaccine adjuvants update
|
scientific article published on 31 July 2012
|
| An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs
|
scientific article published on 30 January 2013
|
| Toll or toll-free adjuvant path toward the optimal vaccine development
|
scientific article published on 17 March 2007
|
| Harnessing CD4⁺ T cell responses in HIV vaccine development
|
scientific article published on 6 February 2013
|
| Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species
|
scientific article published on January 2012
|
| Freezing temperatures in the vaccine cold chain: a systematic literature review
|
scientific article published on 7 March 2007
|
| Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy
|
scientific article published on January 1992
|
| The threat of peste des petits ruminants: progress in vaccine development for disease control
|
scientific article published on 26 February 2007
|
| New hepatitis B vaccine formulated with an improved adjuvant system
|
scientific article published on April 2007
|
| Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells
|
scientific article published on April 2007
|
| Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses
|
scientific article published on May 2016
|
| Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
|
scientific article published on March 1989
|
| PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.
|
scientific article
|
| A novel influenza A (H1N1) vaccine in various age groups.
|
scientific article
|
| Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
|
scientific article
|
| Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.
|
scientific article published on 4 December 2009
|
| Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
|
scientific article
|
| Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
|
scientific article
|
| Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.
|
scientific article
|
| Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
|
scientific article
|
| Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive c
|
scientific article
|
| Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design
|
scientific article published on March 2010
|
| Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada
|
scientific article
|
| Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
|
scientific article
|
| Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine
|
scientific article
|
| Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus
|
scientific article
|
| Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets
|
scientific article
|
| Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?
|
scientific article
|
| Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.
|
scientific article
|
| Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.
|
scientific article
|
| AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
|
scientific article
|
| The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns
|
scientific article
|
| How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?
|
scientific article
|
| Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study
|
scientific article
|
| Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign
|
scientific article
|
| Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults
|
scientific article
|
| An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to [...]
|
scientific article
|
| Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus
|
scientific article
|
| An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
|
scientific article
|
| Plant-made vaccines in support of the Millennium Development Goals
|
scientific article
|
| A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains
|
scientific article
|
| Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England
|
scientific article
|
| Safety and effectiveness of a 2009 H1N1 vaccine in Beijing
|
scientific article
|
| Influenza vaccine immunology
|
scientific article
|
| Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents
|
scientific article
|
| Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine
|
scientific article
|
| Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain
|
scientific article
|
| A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates
|
scientific article
|
| Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age.
|
scientific article
|
| Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients
|
scientific article
|
| Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
|
scientific article
|
| Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus
|
scientific article
|
| A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
|
scientific article
|
| Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic
|
scientific article
|
| Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study.
|
scientific article
|
| Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study
|
scientific article
|
| Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice
|
scientific article
|
| Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States
|
scientific article
|
| A pandemic influenza vaccine in India: from strain to sale within 12 months
|
scientific article
|
| WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer
|
scientific article
|
| Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine
|
scientific article
|
| Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review
|
scientific article
|
| Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
|
scientific article
|
| H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
|
scientific article published in August 2011
|
| Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies
|
scientific article
|
| Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
|
scientific article
|
| H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans
|
scientific article
|
| Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series
|
scientific article
|
| Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden
|
scientific article
|
| Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study.
|
scientific article
|
| Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
|
scientific article
|
| Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial
|
scientific article
|
| Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
|
scientific article
|
| Vaccine design for CD8 T lymphocyte responses
|
scientific article published in September 2011
|
| Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine
|
scientific article
|
| Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment
|
scientific article
|
| Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study
|
scientific article
|
| Strategies to achieve the healthy people 2020 annual influenza vaccine coverage goal for health-care personnel: recommendations from the national vaccine advisory committee
|
scientific article
|
| Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
|
scientific article
|
| Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
|
scientific article
|
| Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy
|
scientific article published in July 2012
|
| Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype
|
scientific article
|
| Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
|
scientific article published on 16 July 2012
|
| Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies
|
scientific article
|
| Global production capacity of seasonal influenza vaccine in 2011.
|
scientific article
|
| A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.
|
scientific article
|
| A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine
|
scientific article
|
| High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season
|
scientific article
|
| History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system
|
scientific article
|
| Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
|
scientific article
|
| Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.
|
scientific article
|
| Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial
|
scientific article
|
| IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
|
scientific article
|
| Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
|
scientific article
|
| A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost
|
scientific article
|
| Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations
|
scientific article
|
| Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge
|
scientific article
|
| Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior
|
scientific article
|
| NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
|
scientific article
|
| Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine
|
scientific article
|
| Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).
|
scientific article
|
| Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
|
scientific article
|
| Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
|
scientific article
|
| Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine
|
scientific article
|
| Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation
|
scientific article
|
| Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines
|
scientific article
|
| Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System
|
scientific article
|
| Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans
|
scientific article
|
| Novel vaccine strategies to T-independent antigens
|
scientific article
|
| Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme
|
scientific article
|
| European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.
|
scientific article
|
| Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough
|
scientific article
|
| Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.
|
scientific article
|
| Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
|
scientific article
|
| Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
|
scientific article
|
| An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers
|
scientific article
|
| Puf mediates translation repression of transmission-blocking vaccine candidates in malaria parasites
|
scientific article
|
| Resiquimod and other immune response modifiers as vaccine adjuvants
|
scientific article
|
| Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine
|
scientific article
|
| Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways
|
scientific article
|
| A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis
|
scientific article
|
| Japanese encephalitis vaccine for travelers: exploring the limits of risk.
|
scientific article
|
| Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine
|
scientific article
|
| Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A
|
scientific article
|
| Non-human primate models for AIDS vaccine research
|
scientific article
|
| Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications
|
scientific article
|
| Identification of tumour-associated T-cell epitopes for vaccine development
|
scientific article
|
| Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen
|
scientific article
|
| Comparison of vaccine strategies against congenital CMV infection in the guinea pig model
|
scientific article
|
| Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
|
scientific article
|
| Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease
|
scientific article published on December 1, 1991
|
| Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
|
scientific article
|
| Mother-daughter communication about HPV vaccine
|
scientific article
|
| Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate
|
scientific article
|
| Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine
|
scientific article
|
| Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine
|
scientific article
|
| Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningoc
|
scientific article
|
| Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.
|
scientific article
|
| Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach
|
scientific article
|
| A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers
|
scientific article
|
| Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials
|
scientific article
|
| Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population
|
scientific article
|
| Development of an improved vaccine for anthrax
|
scientific article
|
| Fundamentals of vaccine immunology
|
scientific article
|
| Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
|
scientific article
|
| Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures
|
scientific article
|
| Recent advances in vaccine adjuvants
|
scientific article
|
| Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study
|
scientific article
|
| Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer.
|
scientific article
|
| Vaccine beliefs of parents who oppose compulsory vaccination
|
scientific article
|
| Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine
|
scientific article
|
| Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer
|
scientific article
|
| Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine
|
scientific article
|
| Effectiveness of 2 doses of varicella vaccine in children
|
scientific article
|
| Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial
|
scientific article
|
| A therapeutic dendritic cell-based vaccine for HIV-1 infection
|
scientific article published on 13 January 2011
|
| Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults
|
scientific article
|
| Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States
|
scientific article
|
| Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.
|
scientific article
|
| Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults
|
scientific article
|
| The HIV-1 vaccine race
|
scientific article
|
| Mast cell activators: a new class of highly effective vaccine adjuvants
|
scientific article
|
| Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory
|
scientific article
|
| Bacillus anthracis virulence in Guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality
|
scientific article
|
| Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
|
scientific article
|
| A live attenuated strain of Yersinia pestis KIM as a vaccine against plague
|
scientific article
|
| Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
|
scientific article
|
| Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.
|
scientific article
|
| Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink
|
scientific article
|
| Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
|
scientific article
|
| Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets
|
scientific article
|
| Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry
|
scientific article
|
| Text message reminders for second dose of influenza vaccine: a randomized controlled trial
|
scientific article
|
| Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy
|
scientific article
|
| Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine
|
scientific article
|
| Bacterial infectious disease control by vaccine development
|
scientific article
|
| Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
|
scientific article
|
| Design and selection of vaccine adjuvants: animal models and human trials
|
scientific article
|
| Overview of vaccine adjuvants: present and future
|
scientific article
|
| Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins
|
scientific article
|
| Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
|
scientific article
|
| Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
|
scientific article
|
| Animal models for influenza viruses: implications for universal vaccine development
|
scientific article
|
| Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques
|
scientific article
|
| Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia
|
scientific article
|
| Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge
|
scientific article
|
| Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach
|
scientific article
|
| A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial
|
scientific article
|
| DNA vaccine protects ornamental koi (Cyprinus carpio koi) against North American spring viremia of carp virus
|
scientific article
|
| Immunity to asexual blood stage malaria and vaccine approaches
|
scientific article
|
| The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine
|
scientific article
|
| Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
|
scientific article
|
| Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.
|
scientific article
|
| Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity
|
scholarly article
|
| HPV vaccine acceptability in heterosexual, gay, and bisexual men.
|
scientific article
|
| Economic value of dengue vaccine in Thailand
|
scientific article
|
| Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression
|
scientific article
|
| Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.
|
scientific article
|
| Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate
|
scientific article
|
| Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand
|
scientific article
|
| Rotarix: a rotavirus vaccine for the world
|
scientific article
|
| A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation
|
scientific article
|
| Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice
|
scientific article
|
| IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine
|
scientific article published in January 2009
|
| Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge
|
scientific article
|
| Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
|
scientific article
|
| The use of genomics in microbial vaccine development
|
scientific article
|
| Impact of meningococcal C conjugate vaccine in the UK.
|
scientific article
|
| Bacterial spores as vaccine vehicles
|
scientific article
|
| Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine
|
scientific article
|
| A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery
|
scientific article
|
| The cancer vaccine roller coaster
|
scientific article
|
| HIV and SIV CTL escape: implications for vaccine design
|
scientific article published in August 2004
|
| Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
|
scientific article published on 11 April 2007
|
| Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
|
scientific article published on 28 February 2007
|
| Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine
|
scientific article published in March 1996
|
| Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
|
scientific article published on 28 February 2007
|
| The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda
|
scientific article published on 31 January 2012
|
| Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
|
scientific article published in June 1996
|
| Simian immunodeficiency virus DNA vaccine trial in macaques.
|
scientific article published in June 1996
|
| Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains
|
scientific article published in July 1996
|
| Progress on new vaccine strategies against chronic viral infections
|
scientific article published in August 2004
|
| A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
|
scholarly article
|
| Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination
|
scholarly article
|
| Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials
|
scientific article published on 28 February 2007
|
| Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design
|
scientific article published in February 2012
|
| IL-4 in tuberculosis: implications for vaccine design
|
scientific article published in September 2004
|
| The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.
|
scientific article published in October 2004
|
| Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
|
scientific article published in February 1998
|
| Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial
|
scientific article published in January 2014
|
| Enteric pathogens as vaccine vectors for foreign antigen delivery
|
scientific article published in October 2004
|
| Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
|
scientific article published in December 2004
|
| The mucosal immune system: from fundamental concepts to vaccine development
|
scientific article published on January 1, 1992
|
| Toxoplasmosis: the first commercial vaccine
|
scientific article published in September 1993
|
| Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis
|
scientific article published on 26 February 2007
|
| Vaccine policy changes and epidemiology of poliomyelitis in the United States
|
scientific article published in October 2004
|
| Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years
|
scientific article published in December 2011
|
| Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
|
scientific article published in December 2011
|
| Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study
|
scientific article published in December 2011
|
| Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England
|
scientific article published in September 2003
|
| Novel approaches to vaccine delivery
|
scientific article published in September 2004
|
| Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates
|
scientific article published on 13 March 2007
|
| A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria
|
scientific article published on 13 November 2009
|
| Structural basis of antigenic escape of a malaria vaccine candidate
|
scholarly article
|
| Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial
|
scientific article
|
| Parents' Internet use for information about HPV vaccine
|
scientific article
|
| In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies
|
scientific article
|
| Bacteria as DNA vaccine carriers for genetic immunization
|
scientific article
|
| Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells
|
scientific article
|
| Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages
|
scientific article
|
| Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
|
scientific article
|
| The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
|
scientific article
|
| Increasing vaccine potency through exosome antigen targeting
|
scientific article
|
| Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease
|
scientific article
|
| Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica
|
scientific article
|
| A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy
|
scientific article
|
| A dually active anthrax vaccine that confers protection against both bacilli and toxins
|
scientific article
|
| Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations
|
scientific article
|
| Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
|
scientific article
|
| Development of a survey to identify vaccine-hesitant parents: the parent attitudes about childhood vaccines survey
|
journal article published in 2011
|
| Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
|
scientific article
|
| The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens
|
scientific article
|
| An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.
|
scientific article
|
| Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine
|
scientific article
|
| Clinical practice: prevention of hepatitis B with the hepatitis B vaccine
|
scientific article
|
| Efficacy and other milestones for human papillomavirus vaccine introduction
|
scientific article
|
| Vaccine-induced immunity to malaria parasites and the need for novel strategies
|
scientific article
|
| Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors
|
scientific article
|
| Hepatitis B virus, the vaccine, and the control of primary cancer of the liver
|
scientific article
|
| New paradigms for HIV/AIDS vaccine development
|
scientific article
|
| A microneedle patch containing measles vaccine is immunogenic in non-human primates
|
scientific article
|
| Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
|
scientific article
|
| Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?
|
scientific article
|
| Progress toward an HIV vaccine
|
scientific article
|
| Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans
|
scientific article
|
| Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials
|
scientific article
|
| Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine
|
scientific article
|
| An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010
|
scientific article
|
| The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response
|
scientific article
|
| Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
|
scientific article
|
| A vaccine for HIV type 1: the antibody perspective
|
scientific article
|
| HIV with multiple gene deletions as a live attenuated vaccine for AIDS.
|
scientific article
|
| Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates
|
scientific article
|
| Chloroplast-derived vaccine antigens and other therapeutic proteins
|
scientific article
|
| Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?
|
scientific article
|
| Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant
|
scientific article
|
| The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
|
scientific article
|
| Current progress in tuberculosis vaccine development
|
scientific article
|
| Bacterial otitis media: a vaccine preventable disease?
|
scientific article
|
| The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines
|
scientific article
|
| Development and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review
|
scientific article
|
| Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research
|
scientific article
|
| Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design
|
scientific article
|
| High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine
|
scientific article
|
| Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
|
scientific article
|
| Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
|
scientific article
|
| Systems vaccinology: Enabling rational vaccine design with systems biological approaches
|
scientific article
|
| Targeting the innate immune response with improved vaccine adjuvants
|
scientific article
|
| Immunologic uniqueness of the genital tract: challenge for vaccine development
|
scientific article
|
| Progress in filovirus vaccine development: evaluating the potential for clinical use.
|
scientific article
|
| A universal vaccine for serogroup B meningococcus
|
scholarly article
|
| Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand
|
scientific article
|
| Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
|
scientific article
|
| Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.
|
scientific article
|
| A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
|
scientific article
|
| Mucosal immunity: implications for vaccine development
|
scientific article
|
| Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
|
scientific article
|
| New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development
|
scientific article
|
| Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction
|
scientific article
|
| A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania
|
scientific article
|
| A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes
|
scientific article
|
| Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine
|
scientific article
|
| A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile.
|
scientific article published on 07 August 2009
|
| Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.
|
scientific article published on 12 August 2012
|
| Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences
|
scientific article published on August 1991
|
| Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature
|
scientific article published on August 2009
|
| Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals
|
scientific article published on 18 December 2013
|
| Different spectra of therapeutic vaccine development against HPV infections
|
scientific article published on 28 October 2009
|
| Mucosal Vaccine Development Based on Liposome Technology
|
scientific article published on 29 December 2016
|
| Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review.
|
scientific article published on January 2009
|
| The development of the RTS,S malaria vaccine candidate: challenges and lessons
|
scientific article published on September 2009
|
| Viral vectors in malaria vaccine development
|
scientific article published on September 2009
|
| Do we still need a malaria vaccine?
|
scientific article published on September 2009
|
| The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs
|
scientific article
|
| The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity
|
scientific article published on 19 March 2011
|
| Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
|
scientific article published on 22 August 2009
|
| Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine
|
scientific article published on February 2012
|
| Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer
|
scientific article published on January 2014
|
| A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|
scholarly article
|
| Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada
|
scientific article published on September 2009
|
| Vaccine wastage in Bangladesh
|
scientific article published on 27 August 2009
|
| DNA vaccine manufacture: scale and quality
|
scientific article published on September 2009
|
| Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).
|
scientific article published on January 2009
|
| Approaches to the treatment of disease induced by chikungunya virus
|
scientific article
|
| Novel adjuvants & delivery vehicles for vaccines development: a road ahead
|
scientific article
|
| Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
|
scientific article published on December 2004
|
| Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate
|
scientific article published on December 2004
|
| CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1.
|
scientific article published on December 2004
|
| Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production
|
scientific article
|
| Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
|
scientific article
|
| Recommendations for the administration of influenza vaccine in children allergic to egg.
|
scientific article published on 15 September 2009
|
| Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.
|
scientific article published on June 2010
|
| Immunosenescence and influenza vaccine efficacy
|
scientific article published on January 2009
|
| Global emm type distribution of group A streptococci: systematic review and implications for vaccine development
|
scientific article published on October 2009
|
| Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons
|
scientific article published on 04 January 2014
|
| Cell-penetrating peptides: application in vaccine delivery
|
scientific article published on 25 September 2009
|
| Squalene emulsions for parenteral vaccine and drug delivery
|
scientific article published on September 2009
|
| A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.
|
scientific article
|
| Landscape analysis of interactions between nutrition and vaccine responses in children.
|
scientific article published on 30 September 2009
|
| Dengue vaccine candidates in development
|
scientific article published on January 2010
|
| Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe
|
scientific article published on October 2009
|
| From the circumsporozoite protein to the RTS, S/AS candidate vaccine
|
scientific article published on 30 January 2010
|
| Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
|
scientific article published on 04 October 2009
|
| HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine
|
scientific article published on 24 January 2014
|
| Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12.
|
scientific article published on June 2008
|
| The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development.
|
scientific article published on 23 January 2010
|
| Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers
|
scientific article published on January 2014
|
| Toward an antibody-based HIV-1 vaccine
|
scientific article published on January 2010
|
| Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage
|
scientific article published on January 2014
|
| Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization
|
scientific article published on January 2014
|
| Vaccine protocols optimization: in silico experiences
|
scientific article published on January 2010
|
| Plant-made vaccine antigens and biopharmaceuticals
|
scientific article published on 14 October 2009
|
| Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
|
scientific article published on 20 September 2011
|
| Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.
|
scientific article published on 04 March 2014
|
| The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.
|
scientific article published on January 2014
|
| Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children
|
scientific article published on January 2014
|
| Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice
|
scientific article published on 18 February 2014
|
| 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.
|
scientific article
|
| Protective immunity against Eimeria acervulina following in ovo immunization with a recombinant subunit vaccine and cytokine genes
|
scientific article published on December 2004
|
| Factors associated With Medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls
|
scientific article published on 21 September 2013
|
| Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.
|
scientific article
|
| Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
|
scientific article
|
| Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.
|
scientific article published on January 2010
|
| A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer
|
scientific article published on December 2009
|
| Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein
|
scientific article published on 16 September 2013
|
| Update on Rotarix: an oral human rotavirus vaccine
|
scientific article published on December 2009
|
| A biologist's perspective on malaria vaccine development
|
scientific article published on 24 January 2010
|
| Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine
|
scientific article published on February 2010
|
| Oral vaccine delivery by recombinant spore probiotics
|
scientific article published on January 2009
|
| The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
|
scientific article published on December 2009
|
| A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
|
scientific article published on 08 January 2014
|
| Viruses as vaccine vectors for infectious diseases and cancer
|
scientific article published on January 2010
|
| Ethnic differences in human papillomavirus awareness and vaccine acceptability.
|
scientific article published on 17 September 2009
|
| Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq
|
scientific article published on December 2009
|
| PATH Malaria Vaccine Initiative (MVI): perspectives on the status of malaria vaccine development
|
scientific article published on 29 January 2010
|
| Current status of Plasmodium vivax vaccine.
|
scientific article published on 26 January 2010
|
| Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
|
scientific article published on February 2017
|
| Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
|
scientific article published on 24 August 2016
|
| Challenges for structure-based HIV vaccine design
|
scientific article published on September 2009
|
| Working together: interactions between vaccine antigens and adjuvants
|
scientific article published on May 2013
|
| Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine
|
scientific article published on 26 January 2014
|
| Recommended vaccinations for asplenic and hyposplenic adult patients
|
scientific article published on 08 December 2016
|
| Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities
|
scientific article published on 15 January 2014
|
| New technologies in using recombinant attenuated Salmonella vaccine vectors
|
scientific article published on January 2010
|
| Polymeric particles in vaccine delivery
|
scientific article published on 14 January 2010
|
| Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response
|
scientific article
|
| Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines
|
scientific article
|
| Domain III of the envelope protein as a dengue vaccine target
|
scientific article published on February 2010
|
| Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial
|
scientific article published on 09 April 2013
|
| Acceptability of human papillomavirus vaccine for males: a review of the literature
|
scientific article published on February 2010
|
| Chronic stress alters the immune response to influenza virus vaccine in older adults.
|
scientific article published on April 1996
|
| HPV vaccine: Cervarix
|
scientific article published on March 2010
|
| Recent progress in dengue vaccine research and development
|
scientific article published on February 2010
|
| Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
|
scientific article published on 08 July 2013
|
| A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease
|
scientific article published on January 1991
|
| CD4+ T cell epitope discovery and rational vaccine design
|
scientific article published on 14 February 2010
|
| Salmonella as live trojan horse for vaccine development and cancer gene therapy
|
scientific article published on February 2010
|
| Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures
|
scientific article published on 30 January 2014
|
| Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine
|
scientific article published on 28 June 2013
|
| Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial
|
scientific article published on April 2012
|
| Post-licensure monitoring of HPV vaccine in the United States
|
scientific article published on 25 February 2010
|
| The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant
|
scientific article published on March 2010
|
| The need and challenges for development of an Epstein-Barr virus vaccine
|
scientific article published on April 2013
|
| Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs
|
scientific article published on 19 May 2008
|
| Exploiting the defensive sugars of HIV-1 for drug and vaccine design
|
scientific article published on April 2007
|
| Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses
|
scientific article published on 20 December 2012
|
| Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice
|
scientific article published on 12 May 2008
|
| Recombinant virus vaccine for bluetongue disease in sheep
|
scientific article published on May 1990
|
| More than one reason to rethink the use of peptides in vaccine design
|
scientific article published on May 2007
|
| Genetically engineered, attenuated whole-cell vaccine approaches for malaria
|
scientific article published on 29 January 2010
|
| Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil
|
scientific article published on April 2013
|
| Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
|
scientific article published on October 1989
|
| Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids
|
scientific article published on 26 June 2008
|
| Virus-like particles: flexible platforms for vaccine development
|
scientific article published on June 2007
|
| Lessons learned from HIV-1 vaccine trials: new priorities and directions
|
scientific article published on 18 April 2012
|
| Pathogenic epitopes, heterologous immunity and vaccine design
|
scientific article published on July 2007
|
| The challenges of vaccine responses in early life: selected examples
|
scientific article published on 7 June 2007
|
| A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years
|
scientific article published on 7 March 2013
|
| Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
|
scientific article published on 25 July 2012
|
| Apoptosis and other immune biomarkers predict influenza vaccine responsiveness
|
scientific article published on 16 April 2013
|
| The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
|
scientific article published on 29 February 2016
|
| Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.
|
scientific article published on July 2007
|
| Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
|
scientific article published on 16 April 2013
|
| Augmented designs to assess immune response in vaccine trials
|
scientific article published on December 2006
|
| A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
|
scientific article published on August 1988
|
| Predictors of HPV vaccine acceptability: a theory-informed, systematic review
|
scientific article published on 2 June 2007
|
| Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
|
scientific article published on 29 June 2007
|
| Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies
|
scientific article published on July 2007
|
| Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt
|
scientific article published on 6 May 2013
|
| Vaccine therapy for melanoma: current status and future directions
|
scientific article published on 5 July 2007
|
| Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study
|
scientific article published on February 1988
|
| Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.
|
scientific article published on 9 May 2013
|
| The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus
|
scientific article published on 21 July 2008
|
| Reassortant rotaviruses as potential live rotavirus vaccine candidates
|
scientific article published on March 1985
|
| L-BLP25: a peptide vaccine strategy in non small cell lung cancer
|
scientific article published on August 2007
|
| Quadrivalent human papillomavirus vaccine
|
scientific article published on 25 July 2007
|
| A ten-year review of commercial vaccine performance for control of tick infestations on cattle
|
scientific article published on June 2007
|
| Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies
|
scientific article published on 10 April 2013
|
| Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes
|
scientific article published on March 1984
|
| Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
|
scientific article published on January 2000
|
| Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
|
scientific article published on 03 February 2015
|
| Reconsideration of the use of meningococcal polysaccharide vaccine
|
scientific article published on August 2007
|
| The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
|
scientific article published on 30 July 2008
|
| Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
|
scientific article published on 30 April 2013
|
| The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers
|
scientific article published on 25 June 2008
|
| Needle-free vaccine delivery
|
scientific article published on September 2007
|
| Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein
|
scientific article published on August 1, 1992
|
| Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b tri
|
scientific article published on 16 September 2015
|
| Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting
|
scientific article published on March 2004
|
| Influenza vaccine effectiveness in the community and the household
|
scientific article published on 14 February 2013
|
| Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).
|
scientific article published on September 2007
|
| Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.
|
scientific article published on January 2007
|
| Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
|
scientific article published on 20 September 2007
|
| Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons
|
scientific article published on November 2008
|
| The economic value of a quadrivalent versus trivalent influenza vaccine
|
scientific article published on 19 October 2012
|
| Live vaccine strain of Francisella tularensis: infection and immunity in mice
|
scientific article published on September 1991
|
| Nanoparticles and microparticles as vaccine-delivery systems
|
scientific article published on October 2007
|
| Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
|
scientific article published on 08 August 2008
|
| Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
|
scientific article published on June 2008
|
| Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
|
scientific article published on July 2008
|
| Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41
|
scientific article published on 28 November 2006
|
| Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination
|
scientific article published on January 2014
|
| Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics
|
scientific article published on 31 October 2007
|
| Nicotine vaccines to assist with smoking cessation: current status of research
|
scientific article published on March 2012
|
| Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
|
scientific article published on June 2016
|
| Tick vaccines and the control of tick-borne pathogens
|
scientific article published on 09 July 2013
|
| Mucin-type O-glycosylation and its potential use in drug and vaccine development
|
scientific article published on 25 September 2007
|
| Attenuated measles virus as a vaccine vector
|
scientific article published on 02 February 2007
|
| Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease
|
scientific article
|
| CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses
|
scientific article published on 10 September 2008
|
| A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
|
scientific article published on 17 September 2011
|
| Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model
|
scientific article published on May 1988
|
| Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment
|
scientific article published on October 1, 1981
|
| Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B.
|
scientific article published on August 1998
|
| A game dynamic model for vaccine skeptics and vaccine believers: measles as an example
|
scientific article
|
| Arenavirus reverse genetics for vaccine development
|
scientific article published on 30 January 2013
|
| A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors
|
scientific article published on September 2011
|
| Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection
|
scientific article published on April 2004
|
| BCG vaccine in Korea
|
scientific article published on 03 July 2013
|
| The old and the new: vaccine hesitancy in the era of the Web 2.0. Challenges and opportunities
|
scientific article published on January 2016
|
| Epitope-based vaccine against influenza
|
scientific article published on December 2007
|
| ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODEL.
|
scientific article published on March 2008
|
| Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine
|
scientific article published on January 2008
|
| Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010.
|
scientific article published on 20 September 2012
|
| Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs
|
scientific article published on February 1987
|
| Causal Vaccine Effects on Binary Postinfection Outcomes
|
scientific article published on March 2006
|
| The 1961 Middletown Oral Poliovirus Vaccine Program. IX. Isolation of enteroviruses from sewage before and after vaccine administration
|
scientific article published on April 1962
|
| Prospects of HIV Env modification as an approach to HIV vaccine design
|
scientific article
|
| Roles of HIV-1 Env variable regions in viral neutralization and vaccine development
|
scientific article
|
| HIV-1 neutralization: mechanisms and relevance to vaccine design
|
scientific article
|
| Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin
|
scientific article published on May 1987
|
| Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
|
scientific article published on 02 June 2008
|
| Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates
|
scientific article published on July 1987
|
| A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes
|
scientific article published on May 1992
|
| The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG.
|
scientific article published on August 1987
|
| Assessment of methodological quality and sources of variation in the magnitude of vaccine efficacy: a systematic review of studies from 1960 to 2005 reporting immunization with Moraxella bovis vaccines in young cattle
|
scientific article published on 26 October 2007
|
| Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development
|
scientific article published on August 1986
|
| Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015
|
scientific article published on 22 March 2016
|
| Bridging the knowledge gaps in vaccine design
|
scientific article published on December 2007
|
| Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.
|
scientific article published on March 1986
|
| An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
|
scientific article published on 09 July 2013
|
| Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig
|
scientific article published on May 1986
|
| Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
|
scientific article
|
| Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?
|
scientific article
|
| Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example
|
scientific article
|
| Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine
|
scientific article
|
| Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials
|
scientific article
|
| Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children
|
scientific article published on September 19, 1992
|
| Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
|
scientific article
|
| Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine
|
scientific article published on December 12, 2003
|
| Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics
|
scientific article
|
| On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data
|
scientific article
|
| Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005.
|
scientific article
|
| Use of live bacterial vaccine vectors for antigen delivery: potential and limitations
|
scientific article
|
| Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
|
scientific article
|
| Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis
|
scientific article
|
| Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines.
|
scientific article
|
| Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.
|
scientific article
|
| Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine
|
scientific article
|
| Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
|
scientific article published on December 18, 1992
|
| Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
|
scientific article
|
| Pluronic F127-based systemic vaccine delivery systems
|
scientific article
|
| Coccidioidomycosis: host response and vaccine development
|
scientific article
|
| Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial
|
scientific article
|
| A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses
|
scientific article
|
| Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine
|
scientific article
|
| A vaccine against the salmonid pathogen Piscirickettsia salmonis based on recombinant proteins
|
scientific article
|
| Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine
|
scientific article published on October 26, 1991
|
| Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine
|
scientific article
|
| Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion
|
scientific article
|
| Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children
|
scientific article
|
| Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations
|
scientific article
|
| Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells
|
scientific article
|
| Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali
|
scientific article
|
| Coping with viral diversity in HIV vaccine design
|
scientific article
|
| Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge
|
scientific article
|
| Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults
|
scientific article
|
| Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada
|
scientific article
|
| Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
|
scientific article
|
| HIV-1 group M conserved elements vaccine
|
scientific article
|
| Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies
|
scientific article
|
| Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial
|
scientific article
|
| Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis
|
scientific article
|
| Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae
|
scientific article
|
| Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
|
scientific article
|
| Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research
|
scientific article
|
| Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy
|
scientific article
|
| Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree
|
scientific article
|
| Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes
|
scientific article
|
| The postmarketing safety profile of varicella vaccine
|
scientific article
|
| Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination
|
scientific article
|
| Idiopathic thrombocytopenic purpura and MMR vaccine
|
scientific article
|
| Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine
|
scientific article
|
| A vaccine against nicotine for smoking cessation: a randomized controlled trial
|
scientific article
|
| Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
|
scientific article
|
| Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research
|
scientific article
|
| Bovine Neonatal Pancytopenia: is this alloimmune syndrome caused by vaccine-induced alloreactive antibodies?
|
scientific article
|
| Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets
|
scientific article
|
| Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya
|
scientific article
|
| Transdermal influenza immunization with vaccine-coated microneedle arrays
|
scientific article
|
| Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.
|
scientific article
|
| MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques
|
scientific article
|
| Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis
|
scientific article
|
| A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli
|
scientific article
|
| Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001.
|
scientific article
|
| MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team
|
scientific article
|
| Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
scientific article
|
| Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin
|
scientific article
|
| Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
|
scientific article published on 5 October 2009
|
| Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection
|
scientific article
|
| Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum
|
scientific article
|
| African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults
|
scientific article
|
| Schistosomiasis vaccine discovery using immunomics
|
scientific article published on 28 January 2010
|
| Mumps and mumps vaccine: a global review
|
scientific article
|
| Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development
|
scientific article
|
| Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
|
scientific article
|
| Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
|
scientific article
|
| Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
|
scientific article
|
| Human T-cell recognition of the circumsporozoite protein of plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule
|
research work
|
| Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
|
scientific article
|
| Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles
|
scientific article
|
| Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial
|
scientific article
|
| Enterovirus 71 vaccine: close but still far.
|
scientific article
|
| Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states
|
scientific article
|
| T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis
|
scientific article
|
| Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains
|
scientific article
|
| A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
|
scientific article
|
| Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-gamma
|
scientific article
|
| A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt
|
scientific article
|
| Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine
|
scientific article
|
| Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody
|
scientific article
|
| Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine
|
scientific article
|
| Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine
|
scientific article
|
| Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant
|
scientific article
|
| Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species
|
scientific article
|
| Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study
|
scientific article
|
| Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model
|
scientific article
|
| Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery
|
scientific article
|
| The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis
|
scientific article
|
| Acceptability of HPV vaccine among a national sample of gay and bisexual men.
|
scientific article
|
| Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions
|
scientific article
|
| Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice
|
scientific article
|
| Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
|
scientific article published on November 2012
|
| Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males
|
scientific article published on 2 July 2013
|
| Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
|
scientific article published on 16 November 2012
|
| Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization
|
scientific article published on May 2009
|
| Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
|
scientific article published on July 2008
|
| Recombinant vaccine-derived poliovirus in Madagascar
|
scientific article published on July 2003
|
| The epitope regions of H1-subtype influenza A, with application to vaccine efficacy
|
scientific article published on 3 July 2009
|
| How to communicate with vaccine-hesitant parents
|
scientific article published on 18 April 2011
|
| Improved influenza vaccination in the skin using vaccine coated microneedles
|
scientific article published on 15 September 2009
|
| MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives
|
scientific article published on 4 December 2008
|
| Examination of the selective pressures on a live PRRS vaccine virus
|
scientific article published on January 1999
|
| Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group
|
scientific article published on November 2000
|
| The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.
|
scientific article published on May 1989
|
| Developing an epitope-driven tuberculosis (TB) vaccine
|
scientific article
|
| Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations
|
scientific article
|
| Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy
|
scientific article published on May 2005
|
| Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan
|
scientific article published on 17 August 2010
|
| Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
|
scientific article published on March 1998
|
| A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
|
scientific article published on 27 March 2013
|
| Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A
|
scientific article published on 19 May 2010
|
| Antibody-based HIV-1 vaccines: recent developments and future directions
|
scientific article published on December 2007
|
| THE EFFECT OF EXTRACTS OF CERTAIN ORGANS FROM NORMAL AND IMMUNIZED ANIMALS ON THE INFECTING POWER OF VACCINE VIRUS.
|
scientific article published on August 1929
|
| Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain
|
scientific article published on 22 November 2010
|
| Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion
|
scientific article published on October 2002
|
| Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.
|
scientific article
|
| Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins
|
scientific article published on July 1956
|
| PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
|
scientific article published on June 2011
|
| A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
|
scientific article published on 23 October 2010
|
| Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study
|
scientific article published on June 1996
|
| Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
|
scientific article published on 4 March 2008
|
| Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.
|
scientific article published on 17 June 2008
|
| Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection
|
scientific article published on February 2004
|
| Side-effects with Japanese encephalitis vaccine
|
scientific article published on April 1991
|
| Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
|
scientific article published on 7 December 2015
|
| Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine
|
scientific article published on September 2004
|
| Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2.
|
scientific article published on August 1990
|
| Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology
|
scientific article published on 18 September 2009
|
| Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.
|
scientific article published in December 1988
|
| Anaphylaxis from yellow fever vaccine
|
scientific article published in April 1999
|
| A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
|
scientific article published on 5 February 2006
|
| Surface-displayed viral antigens on Salmonella carrier vaccine.
|
scientific article published in June 2000
|
| Hepatitis and death following vaccination with 17D-204 yellow fever vaccine
|
scientific article published in July 2001
|
| Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers
|
scientific article published on 30 June 2011
|
| An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses
|
scientific article published on 31 August 2007
|
| Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
|
scientific article published on 16 September 2010
|
| Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009.
|
scientific article published on 3 August 2010
|
| Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence
|
scientific article published on 13 April 2010
|
| Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
|
scientific article published on 3 December 2008
|
| Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus
|
scientific article published on 18 March 2008
|
| Influenza vaccine coverage rates and perceptions on vaccination in South Korea
|
scientific article published on 28 June 2007
|
| Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
|
scientific article published on 4 August 2006
|
| Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
|
scientific article published in February 2005
|
| Update: influenza activity--United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine
|
scientific article published in July 2004
|
| Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine
|
scientific article published in March 2010
|
| Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism
|
scientific article published in September 2008
|
| A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique
|
scientific article published on 25 December 2009
|
| Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
|
scientific article published on 9 November 2008
|
| A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran
|
scientific article published in February 1999
|
| A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).
|
scientific article published in December 2000
|
| Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait
|
scientific article published on 12 September 2005
|
| The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine
|
scientific article published on 15 December 2005
|
| Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques
|
scientific article published on 5 November 2009
|
| MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination
|
scientific article published in October 2009
|
| Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies
|
scientific article published on 13 August 2009
|
| Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care
|
scientific article published in December 2006
|
| Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly
|
scientific article published on August 1, 1992
|
| Waning protection after fifth dose of acellular pertussis vaccine in children
|
scientific article published in September 2012
|
| Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.
|
scientific article published on 15 June 2010
|
| Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection.
|
scientific article published on 17 May 2011
|
| Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
|
scientific article
|
| Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
|
scientific article published in December 2009
|
| Pseudomonas aeruginosa vaccine in cancer patients
|
scientific article published in October 1973
|
| Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
|
scientific article published in July 1986
|
| Real-time monitoring of the influenza vaccine field effectiveness
|
scientific article published on 9 June 2006
|
| The HPV vaccine: are dosing recommendations being followed?
|
scientific article published on 5 February 2011
|
| Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule
|
scientific article published in January 2011
|
| Dendritic cells internalize vaccine adjuvant after intramuscular injection
|
scientific article published in May 1998
|
| Immunoprotective analysis of VhhP2, a Vibrio harveyi vaccine candidate
|
scientific article published on 25 March 2009
|
| Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus
|
scientific article published on 27 February 2009
|
| The safety of inactivated influenza vaccine in adults and children with asthma
|
scientific article
|
| A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains
|
research work
|
| Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines
|
scientific article published in November 1988
|
| Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella typhimurium elicits a protective immune response against Trichinella spiralis larval challenge
|
scientific article published on 25 January 2010
|
| The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
|
scientific article published in March 2001
|
| Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin
|
scientific article published in April 2001
|
| Live attenuated mumps virus vaccine. 1. Vaccine development
|
scientific article published in December 1966
|
| Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States
|
scientific article
|
| Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine
|
scientific article
|
| A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques
|
scientific article
|
| Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
|
scientific article
|
| A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
|
scientific article
|
| Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
|
scientific article
|
| Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
|
scientific article
|
| Comparative efficacy of an indigenous 'inactivated vaccine' using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis 'Bison type' with a commercial vaccine for the control of Capri-paratuberculosis in India
|
scientific article
|
| Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults
|
scientific article
|
| Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine
|
scientific article published in January 2005
|
| A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
|
scientific article published in June 2001
|
| A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
|
scientific article published on 27 April 2006
|
| Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection
|
scientific article published on January 1, 1976
|
| Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine
|
scientific article published on 2 August 2006
|
| Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection
|
article
|
| The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years
|
|
| Nationwide measles epidemic in Ukraine: The effect of low vaccine effectiveness
|
article
|
| A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
|
article by Jaya Chakravarty et al published April 2011 in Vaccine
|
| Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
|
|
| Vaccines and Autism
|
retracted scientific article from 2002
|
| Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus
|
|
| Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy
|
article
|
| Systems vaccinology and big data in the vaccine development chain
|
article
|
| Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness
|
scientific article published on 12 October 2018
|
| Reactions to small pox vaccine in naïve and previously-vaccinated individuals
|
article by Cressida Auckland et al published July 2005 in Vaccine
|
| From genome to vaccines for leishmaniasis: Screening 100 novel vaccine candidates against murine Leishmania major infection
|
article
|
| Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
|
article
|
| Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil
|
article
|
| Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study
|
scientific article published in October 2009
|
| Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls
|
scientific article published in June 2009
|
| The Pneumococcal Vaccine After 15 Years of Use
|
article
|
| Influenza vaccine in healthy children: a meta-analysis
|
article
|
| Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆
|
article
|
| A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial
|
scientific article published on 05 August 2012
|
| Pentavalent Rotavirus Vaccine and Prevention of Gastroenteritis Hospitalizations in Australia
|
article
|
| Antigenic competition in a multivalent foot rot vaccine
|
article
|
| The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales
|
article
|
| Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology
|
scientific article published on 27 November 2008
|
| Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the “Protection against Podal Generalisation” test
|
scientific article published on 05 May 2008
|
| Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
|
article
|
| Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada
|
article
|
| Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design
|
article by J Suker et al published January 1996 in Microbiology
|
| Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
|
scientific article published in The Journal of the American Medical Association
|
| Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
|
article
|
| A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine
|
article
|
| Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine
|
article
|
| Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults
|
article
|
| Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity
|
scientific article published on 01 July 1994
|
| Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four
|
scientific article published on 01 May 1994
|
| Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration
|
|
| Predictors of Influenza Vaccine Acceptance among Healthy Adults
|
scientific article published on 01 October 1999
|
| Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults
|
article
|
| Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women
|
article
|
| Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
|
article by Scott A Halperin et al published January 2007 in Vaccine
|
| Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults
|
scientific article published on 14 October 2005
|
| Crude saponins improve the immune response to an oral plant-made measles vaccine
|
article
|
| Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
|
article
|
| Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine
|
article
|
| Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998–2003
|
article
|
| Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastoris
|
|
| Pertussis vaccine pleurisy: A model of delayed hypersensitivity
|
article
|
| Development of a live, oral, attenuated vaccine against El Tor cholera
|
article
|
| Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge
|
article by C. O. Tacket et al published 1 September 1995 in Journal of Infectious Diseases
|
| Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development
|
scientific article published in The Lancet
|
| Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial
|
scientific article published on 01 August 1988
|
| Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep
|
article
|
| ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy
|
|
| Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age
|
article
|
| Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other
|
article
|
| Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups
|
scientific article published on 10 October 2005
|
| Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children
|
scientific article published on 01 June 2000
|
| The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
|
|
| Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for Disease
|
article
|
| RANDOMIZED, CONTROLLED TRIAL EFFICACY OF PNEUMOCOCCAL CONJUGATE VACCINE AGAINST OTITIS MEDIA AMONG NAVAJO AND WHITE MOUNTAIN APACHE INFANTS
|
article
|
| Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations
|
article
|
| Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
|
article
|
| Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
|
article
|
| Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates
|
|
| Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia
|
scientific article published on 27 February 2006
|
| A live vaccine against Neospora caninum abortions in cattle
|
scientific article published on 07 February 2015
|
| Use ofLactococcus lactisExpressing Pili from Group BStreptococcusas a Broad‐Coverage Vaccine against Streptococcal Disease
|
article
|
| Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic
|
article
|
| Alloimmunization as an AIDS vaccine?
|
scientific article published in Science
|
| Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
|
|
| Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a ‘high-affinity’ FcγRIIa genotype
|
article
|
| Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12
|
article
|
| Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
|
scholarly article
|
| Pneumococcal Conjugate Vaccine, Polysaccharide Vaccine, or Both for Adults? We’re Not There Yet
|
scientific article published on 01 November 2009
|
| Anticapsular Serum Antibody Concentration and Protection against Pneumococcal Colonization among Children Vaccinated with 7-Valent Pneumococcal Conjugate Vaccine
|
scientific article published on 23 March 2007
|
| Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial
|
article
|
| Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults
|
article
|
| Effect of Community‐Wide Conjugate Pneumococcal Vaccine Use in Infancy on Nasopharyngeal Carriage through 3 Years of Age: A Cross‐Sectional Study in a High‐Risk Population
|
article by Eugene V. Millar et al published July 2006 in Clinical Infectious Diseases
|
| Safety and Immunogenicity of a Novel Quadrivalent Meningococcal CRM-conjugate Vaccine Given Concomitantly With Routine Vaccinations in Infants
|
article
|
| An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS)
|
scientific article published on 01 April 2009
|
| Age‐Dependent Differences in IgG Isotype and Avidity Induced by Measles Vaccine Received during the First Year of Life
|
article
|
| CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
|
|
| Twelve-year follow-up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children
|
scientific article published on 01 March 1999
|
| Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responses
|
article
|
| Mycobacterial 70kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis
|
|
| Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine
|
|
| Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
|
|
| Live Attenuated Varicella Vaccine: Protection in Healthy Adults Compared with Leukemic Children
|
scientific article published on 01 April 1990
|
| A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination
|
article by Juliana Cassataro et al published May 2007 in Vaccine
|
| Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence
|
article
|
| Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru
|
scientific article published on 01 August 1996
|
| Low Knowledge of the Three-Dose HPV Vaccine Series among Mothers of Rural Hispanic Adolescents
|
scientific article published on 01 May 2012
|
| An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi
|
scientific article published on 01 January 1997
|
| HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains
|
article
|
| A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand
|
article
|
| Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand
|
article
|
| Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trial
|
article
|
| Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years
|
article
|
| Modular engineering of a microbially-produced viral capsomere vaccine for influenza
|
article published in 2013
|
| Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom
|
scientific article published on 01 May 2010
|
| The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants.
|
scientific article published on March 2010
|
| The Human Hookworm Vaccine
|
scientific article published on April 2013
|
| Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study.
|
scientific article published on 17 July 2013
|
| MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
|
scientific article published on April 2010
|
| Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin
|
scientific article published on 19 February 2014
|
| Mapping vaccine hesitancy--country-specific characteristics of a global phenomenon.
|
scientific article
|
| Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives
|
scientific article published on 02 December 2013
|
| Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
|
scientific article published on 11 March 2010
|
| Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
|
scientific article published on 11 February 2014
|
| Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
|
scientific article published on 15 March 2010
|
| Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
|
scientific article published on December 2015
|
| Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens
|
scientific article published on May 2014
|
| Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research
|
scientific article published on April 2014
|
| Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS)
|
scientific article published on 08 April 2014
|
| Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy
|
scientific article published on 19 February 2014
|
| An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector
|
scientific article published on 14 October 2010
|
| EV71: an emerging infectious disease vaccine target in the Far East?
|
scientific article published on 19 March 2010
|
| Regulation of CD4 T-cell receptor diversity by vaccine adjuvants
|
scientific article published on 17 March 2010
|
| The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox
|
scientific article published on April 2010
|
| Lessons learned from HIV vaccine clinical efficacy trials
|
scientific article published on September 2013
|
| Safety of influenza vaccine administration in egg-allergic patients
|
scientific article published on 05 April 2010
|
| Suppression of vaccine responses by malaria: insignificant or overlooked?
|
scientific article published on April 2010
|
| Tuberculosis vaccine development: The development of novel (preclinical) DNA vaccine
|
scientific article published on 24 April 2010
|
| Mother-daughter communication and human papillomavirus vaccine uptake by college students.
|
scientific article published on 12 April 2010
|
| Designer vaccine nanodiscs for personalized cancer immunotherapy
|
scientific article published on 26 December 2016
|
| Baculovirus as vaccine vectors
|
scientific article published on June 2010
|
| Quantum chemical analysis of MHC-peptide interactions for vaccine design
|
scientific article published on July 2010
|
| High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site
|
scientific article published on July 2012
|
| Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development
|
scientific article published on 21 April 2010
|
| Relevance of pili in pathogenic streptococci pathogenesis and vaccine development
|
scientific article published on May 2010
|
| Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques
|
scientific article published on January 2005
|
| Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine
|
scientific article published on January 2005
|
| Current controversies in the USA regarding vaccine safety
|
scientific article published on May 2010
|
| Immune responses and vaccine-induced immunity against Porcine circovirus type 2.
|
scientific article published on 07 April 2010
|
| Vaccinia virus: a tool for research and vaccine development
|
scientific article
|
| Potential mechanisms for HPV vaccine-induced long-term protection
|
scientific article published on June 2010
|
| Molecular genesis of drug-resistant and vaccine-escape HBV mutants
|
scientific article published on January 2010
|
| Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends.
|
scientific article published on June 2010
|
| Decrease in the effectiveness of Bacille Calmette-Guérin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation
|
scientific article published on July 2010
|
| Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy
|
scientific article published on 09 June 2010
|
| Lympho-geographical concepts in vaccine delivery
|
scientific article published on 23 May 2010
|
| Acceptable levels of endotoxin in vaccine formulations during preclinical research
|
scientific article published on January 2011
|
| Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
|
scientific article published on 27 July 2010
|
| Japanese encephalitis: update on vaccines and vaccine recommendations
|
scientific article published on October 2010
|
| Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice
|
scientific article published on 29 June 2010
|
| HIV vaccine acceptability: a systematic review and meta-analysis
|
scientific article published on July 2010
|
| Glycoconjugate vaccines and immune interference: A review
|
scientific article published on 25 June 2010
|
| Developing a vaccine against aspergillosis
|
scientific article published on 07 July 2010
|
| Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review
|
scientific article published on 23 July 2010
|
| Plant glycans: friend or foe in vaccine development?
|
scientific article published on August 2010
|
| VP6: A candidate rotavirus vaccine
|
scientific article published on September 2010
|
| Cellular vaccine approaches
|
scientific article published on July 2010
|
| Prevention or treatment: the benefits of Trichomonas vaginalis vaccine
|
scientific article published on 15 May 2010
|
| Principles of vaccine design-Lessons from nature
|
scientific article published on August 2010
|
| The need for quadrivalent vaccine against seasonal influenza
|
scientific article published on September 2010
|
| Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.
|
scientific article published on September 2010
|
| Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.
|
scientific article published on September 2010
|
| Taming PRRSV: revisiting the control strategies and vaccine design
|
scientific article published on 22 September 2010
|
| Development of Sanofi Pasteur tetravalent dengue vaccine
|
scientific article published on 16 September 2010
|
| Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
|
scientific article published on 24 September 2010
|
| Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
|
scientific article published on 24 September 2010
|
| Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease
|
scientific article published on October 2011
|
| Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].
|
scientific article published on October 2010
|
| Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience
|
scientific article published on October 2010
|
| Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine
|
scientific article published on October 2010
|
| Virus-like particles in vaccine development.
|
scientific article published on October 2010
|
| Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine
|
scientific article published on October 2010
|
| Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
|
scientific article published on 15 October 2010
|
| Development and outlook for a caries vaccine
|
scientific article published on January 1990
|
| Immunologic basis of vaccine vectors
|
scientific article published on October 2010
|
| Malaria vaccine design: immunological considerations
|
scientific article published on October 2010
|
| Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach
|
scientific article published on December 2010
|
| Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative
|
scientific article published on 07 December 2010
|
| Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains
|
scientific article published on January 2011
|
| Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks
|
scientific article published on December 2010
|
| Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant
|
scientific article published on 24 December 2010
|
| Progress and novel strategies in vaccine development and treatment of anthrax
|
scientific article published on January 2011
|
| Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
|
scientific article published on February 2011
|
| The Lyme disease vaccine--a public health perspective
|
scientific article published on February 2011
|
| New developments in dry powder pulmonary vaccine delivery.
|
scientific article published on 20 January 2011
|
| Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients
|
scientific article published on February 2011
|
| Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
|
scientific article published on 07 July 2017
|
| The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.
|
scientific article published on 19 April 2016
|
| Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
|
scientific article published on March 2011
|
| Aging and impaired immunity to influenza viruses: implications for vaccine development
|
scientific article published on January 2011
|
| Current strategies for subunit and genetic viral veterinary vaccine development.
|
scientific article published on 21 February 2011
|
| Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein
|
scientific article published on 06 March 2015
|
| Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment
|
scientific article published on 04 January 2010
|
| Development status and future prospects for a vaccine against Chlamydia trachomatis infection
|
scientific article published on 22 August 2013
|
| In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system
|
scientific article published on 28 July 2012
|
| Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology
|
scientific article published on 09 January 2012
|
| Natural products and the search for novel vaccine adjuvants
|
scientific article published on 23 July 2011
|
| Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.
|
scientific article published on 05 March 2011
|
| A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans
|
scientific article published on 25 June 2010
|
| Evidence of Chlamydophila abortus vaccine strain 1B as a possible cause of ovine enzootic abortion.
|
scientific article published on August 2010
|
| Liposomal vaccine delivery systems
|
scientific article published on 18 March 2011
|
| Advances in fish vaccine delivery
|
scientific article published on 23 March 2011
|
| Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development.
|
scientific article published on 25 March 2011
|
| Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial
|
scientific article published on August 2007
|
| Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile
|
scientific article published on 04 April 2011
|
| Immunogenetics of seasonal influenza vaccine response
|
scientific article published on September 2008
|
| Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
|
scientific article published on May 2011
|
| Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis
|
scientific article
|
| Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.
|
scientific article
|
| Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques
|
scientific article published on 29 October 2008
|
| Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox
|
scientific article
|
| A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
|
scientific article published on 26 September 2008
|
| Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine
|
scientific article published on July 2013
|
| Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine
|
scientific article published on March 1985
|
| Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy
|
scientific article published on 28 May 2013
|
| Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants
|
scientific article published on 09 May 2013
|
| Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children
|
scientific article published on 11 July 2013
|
| Dracunculiasis (guinea worm disease): eradication without a drug or a vaccine
|
scientific article published on 24 June 2013
|
| Vaccine refusal and the endgame: walking the last mile first
|
scientific article published on 24 June 2013
|
| A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.
|
scientific article published on January 2008
|
| Sipuleucel-T: a vaccine for metastatic, asymptomatic, androgen-independent prostate cancer
|
scientific article published on 19 December 2007
|
| Human CMV vaccine trials: what if CMV caused a rash?
|
scientific article published on 21 December 2007
|
| Vaccine immunogenetics: bedside to bench to population
|
scientific article published on July 2008
|
| High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda
|
scientific article published on 22 July 2013
|
| TLR adaptor MyD88 is essential for pathogen control during oral toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite
|
scientific article published on September 2008
|
| Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children
|
scientific article published on 10 June 2008
|
| Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas
|
scientific article
|
| Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues
|
scientific article published on 27 October 2010
|
| Transcriptomic profiles of high and low antibody responders to smallpox vaccine
|
scientific article published on 18 April 2013
|
| B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
|
scientific article published on 17 December 2007
|
| Population genomics of post-vaccine changes in pneumococcal epidemiology.
|
scientific article published on 05 May 2013
|
| Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates
|
scientific article
|
| IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity
|
scientific article published on 11 July 2013
|
| Purification and vaccine potential of Klebsiella capsular polysaccharides
|
scientific article published on October 1985
|
| Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.
|
scientific article published on April 1986
|
| Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine
|
scientific article published on April 1986
|
| Appropriate use of cervical cancer vaccine.
|
scientific article published on January 2008
|
| Current status of group A streptococcal vaccine development.
|
scientific article published on January 2008
|
| Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting
|
scientific article published on February 1986
|
| Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes
|
scientific article published on January 2008
|
| Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond
|
scientific article published on December 2007
|
| Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
|
scientific article published on March 1993
|
| Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design.
|
scientific article published on 16 January 2008
|
| Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors
|
scientific article published on November 1, 2003
|
| Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox
|
scientific article published on 07 September 2015
|
| Vaccine approaches to prevent and treat prion infection : progress and challenges
|
scientific article published on January 2008
|
| Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.
|
scientific article published on October 2006
|
| Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine
|
scientific article published on April 1997
|
| Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
|
scientific article published on 29 May 2013
|
| Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection
|
scientific article published on October 2008
|
| Recent advances in flavivirus antiviral drug discovery and vaccine development
|
scientific article published on January 2006
|
| Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
|
scientific article published on 18 September 2008
|
| Apical membrane antigen 1: a malaria vaccine candidate in review
|
scientific article published on 15 January 2008
|
| Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery
|
scientific article published on 08 July 2013
|
| Newcastle disease virus as a vaccine vector for humans.
|
scientific article published on February 2008
|
| Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
|
scholarly article
|
| Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes
|
scientific article published on August 2008
|
| An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
|
scientific article published on August 2008
|
| Measles outbreak in a community with very low vaccine coverage, the Netherlands
|
scientific article published on January 2001
|
| The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle
|
scientific article published on December 2008
|
| Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.
|
scientific article published on February 2008
|
| Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials
|
scientific article published on 23 May 2013
|
| Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix].
|
scientific article published on January 2008
|
| Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis
|
scientific article published on January 1984
|
| Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
|
scientific article published on February 2008
|
| Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya
|
scientific article published on July 2007
|
| Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women
|
scientific article published on 10 May 2013
|
| Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.
|
scientific article published on May 2010
|
| Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs.
|
scientific article published on March 2008
|
| Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways
|
scientific article published on May 2008
|
| Ever closer to a prophylactic vaccine for HCV.
|
scientific article published on 07 May 2013
|
| Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics
|
scientific article published on January 2008
|
| Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease
|
scientific article published on April 1998
|
| The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
|
scientific article published on 06 February 2008
|
| Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol
|
scientific article published on April 2004
|
| Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
|
scientific article published on July 2008
|
| Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
|
scientific article published on 12 July 2013
|
| Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine
|
scientific article published on February 1984
|
| Vaccine adjuvants - Current status and prospects on controlled release adjuvancity
|
scientific article published on 25 June 2011
|
| Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom
|
scientific article published on 17 December 2008
|
| Veterinary vaccine development from an industrial perspective
|
scientific article published on 03 March 2008
|
| HLA typing demands for peptide-based anti-cancer vaccine
|
scientific article published on 04 March 2008
|
| Current progress of DNA vaccine studies in humans
|
scientific article published on March 2008
|
| Nanotechnology in vaccine delivery
|
scientific article published on 07 February 2008
|
| Progress and pitfalls in Shigella vaccine research
|
scientific article published on 19 February 2013
|
| Low HPV vaccine coverage among female community college students
|
scientific article published on December 2012
|
| Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
|
scholarly article
|
| Evaluating a surrogate endpoint at three levels, with application to vaccine development
|
scientific article published on October 2008
|
| Comparison of multiple vaccine vectors in a single heterologous prime-boost trial
|
scientific article published on 20 September 2008
|
| Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant
|
scientific article published on October 2008
|
| Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina
|
scientific article published on 05 January 2009
|
| The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
|
scientific article published on February 2008
|
| Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season
|
scientific article published on 20 June 2013
|
| Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
|
scholarly article
|
| Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years
|
scientific article published on 07 August 2013
|
| Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
|
scientific article
|
| Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
|
scientific article published on April 2004
|
| Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.
|
scientific article published on 14 January 2009
|
| Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis
|
scientific article published on 14 January 2009
|
| Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains
|
scientific article published on April 2004
|
| Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells
|
scientific article published on April 2004
|
| Specific immunotherapy for common grass pollen allergies: pertinence of a five grass pollen vaccine
|
scientific article published on 21 March 2008
|
| Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague.
|
scientific article published on April 2004
|
| Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
|
scientific article published on 18 July 2008
|
| An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain
|
scientific article published on 08 August 2008
|
| A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine
|
scientific article
|
| A life without worms
|
scientific article
|
| Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin
|
scientific article
|
| New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development
|
scientific article published on December 1, 1983
|
| High throughput T epitope mapping and vaccine development
|
scientific article
|
| An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.
|
scientific article
|
| Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.
|
scientific article
|
| Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system
|
scientific article published on August 1, 1988
|
| The potential for vaccine against infection of the genital tract with Chlamydia trachomatis
|
scientific article
|
| Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men
|
scientific article
|
| In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.
|
scientific article
|
| HIV-1 vaccine development after STEP.
|
scientific article
|
| Adhesins as targets for vaccine development
|
scientific article
|
| A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
|
scientific article
|
| Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development
|
scientific article
|
| Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity
|
scientific article
|
| Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale
|
scientific article
|
| Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
|
scientific article
|
| Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
|
scientific article
|
| Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries
|
scientific article
|
| EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM.
|
scientific article
|
| Gender effects on humoral immune responses to smallpox vaccine
|
scientific article
|
| Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
|
scientific article
|
| Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial
|
scientific article
|
| T lymphocyte responses in HIV-1 infection: implications for vaccine development
|
scientific article
|
| Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
|
scientific article
|
| Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus
|
scientific article
|
| Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients
|
scientific article
|
| Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains
|
scientific article
|
| Robust immune responses elicited by a fully synthetic three-component vaccine
|
scientific article
|
| Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells
|
scientific article
|
| Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)
|
scientific article
|
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies
|
scientific article
|
| Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis
|
scientific article
|
| A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
|
scientific article
|
| Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution
|
scientific article
|
| Design and interpretation of vaccine field studies.
|
scientific article
|
| Vaccine entrapment in liposomes
|
scientific article
|
| Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.
|
scientific article
|
| Advances in vaccine adjuvants
|
scientific article
|
| Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain.
|
scientific article
|
| Human tumor antigens for cancer vaccine development
|
scientific article
|
| Mucosal immunity and tolerance: relevance to vaccine development
|
scientific article
|
| Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative
|
scientific article
|
| The development of live attenuated cold-adapted influenza virus vaccine for humans
|
scientific article
|
| A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
|
scientific article
|
| Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
|
scientific article
|
| Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms
|
scientific article
|
| Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
|
scientific article
|
| Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity
|
scientific article
|
| Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
|
scientific article
|
| Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe
|
scientific article
|
| Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.
|
scientific article
|
| Protein microarray for profiling antibody responses to Yersinia pestis live vaccine
|
scientific article
|
| Human immune response to a plague vaccine comprising recombinant F1 and V antigens
|
scientific article
|
| Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria
|
scientific article
|
| Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis
|
scientific article
|
| Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
|
scientific article
|
| Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
|
scientific article
|
| Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies
|
scientific article
|
| Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics
|
scientific article
|
| Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals
|
scientific article
|
| Vaccines in historic evolution and perspective: a narrative of vaccine discoveries
|
scientific article
|
| Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant
|
scientific article published on 31 January 2011
|
| Effective vaccine for lassa fever
|
scientific article
|
| Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus
|
scientific article
|
| Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation
|
scientific article
|
| The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs
|
scientific article
|
| T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization
|
scientific article
|
| In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen
|
scientific article
|
| Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant
|
scientific article
|
| Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity
|
scientific article
|
| Recent advances with recombinant bacterial vaccine vectors.
|
scientific article
|
| Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China
|
scientific article
|
| The changing epidemiology of diphtheria in the vaccine era.
|
scientific article
|
| Development of a safe live Leishmania vaccine line by gene replacement.
|
scientific article
|
| Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development
|
scientific article
|
| Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.
|
scientific article
|
| A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.
|
scientific article
|
| Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
|
scientific article
|
| CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing
|
scientific article
|
| Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage
|
scientific article
|
| Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells
|
scientific article
|
| Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development
|
scientific article
|
| Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development
|
scientific article
|
| Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
|
scientific article
|
| Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases
|
scientific article
|
| Recombinant Newcastle disease virus as a vaccine vector
|
scientific article
|
| Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
|
scientific article
|
| Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials
|
scientific article
|
| Effectiveness of influenza vaccine in health care professionals: a randomized trial
|
scientific article
|
| Immunogenicity in humans of an edible vaccine for hepatitis B.
|
scientific article
|
| A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults
|
scientific article published in March 2010
|
| Cost-effectiveness of a potential vaccine for human papillomavirus
|
scientific article
|
| Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.
|
scientific article
|
| Dendritic cell-based human immunodeficiency virus vaccine
|
scientific article
|
| Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers
|
scientific article
|
| A universal influenza A vaccine based on the extracellular domain of the M2 protein
|
scientific article
|
| Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults
|
scientific article
|
| Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial
|
scientific article
|
| Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe
|
scientific article published in September 2003
|
| Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
|
scientific article published in April 2012
|
| A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity
|
scientific article published on 17 June 2009
|
| Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. The Kaiser-UCLA Vaccine Study Group
|
scientific article
|
| Failure of live, attenuated oral rotavirus vaccine
|
scientific article
|
| Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
|
scientific article
|
| Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
|
scientific article
|
| Inactivated Smallpox Vaccine: Immunogenicity of Inactivated Intracellular and Extracellular Vaccinia Virus
|
scientific article published on October 1, 1971
|
| Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
|
scientific article published on 18 May 2013
|
| Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance
|
scientific article published in October 2001
|
| Anthrax vaccine: short-term safety experience in humans
|
scientific article published in December 2001
|
| Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus
|
scientific article published in December 1971
|
| Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans
|
scientific article published in January 2002
|
| Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras
|
scientific article published on 9 January 2010
|
| Plant-expressed HA as a seasonal influenza vaccine candidate
|
scientific article published on 9 April 2008
|
| Efficacy trial of a parenteral gonococcal pilus vaccine in men
|
scientific article published on March 1, 1991
|
| Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note
|
scientific article published in December 1997
|
| Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine
|
scientific article published in May 2009
|
| Human therapeutic cocaine vaccine: safety and immunogenicity
|
scientific article published in January 2002
|
| Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years
|
scientific article published on 6 November 2008
|
| Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits
|
scientific article published on 6 February 2009
|
| Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
|
scientific article published on 13 March 2008
|
| Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants
|
scientific article published in April 1997
|
| Immune responses in infants whose mothers received Tdap vaccine during pregnancy.
|
scientific article published in November 2013
|
| Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine
|
scientific article published on 13 March 2012
|
| Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine
|
scientific article published on 14 July 2006
|
| Priming of memory but not effector CD8 T cells by a killed bacterial vaccine
|
scientific article published in November 2001
|
| Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
|
scientific article published on 19 October 2012
|
| Infectious bronchitis virus vaccine interferes with the replication of avian pneumovirus vaccine in domestic fowl
|
scientific article published in June 2001
|
| Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials
|
scientific article
|
| Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum
|
scientific article
|
| Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States
|
scientific article published on 25 January 2010
|
| The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety
|
scientific article published in September 2004
|
| Dose-related effects of smallpox vaccine
|
scientific article published on 28 March 2002
|
| Immunotoxicity of aflatoxin B1: impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression.
|
scientific article
|
| Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents
|
scientific article
|
| Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study
|
scientific article published in October 2008
|
| Uptake of influenza vaccine by pregnant women: a cross-sectional survey.
|
scientific article
|
| Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
|
scientific article
|
| Minimal variation in a vaccine candidate from the sexual stage of plasmodium falciparum
|
research work
|
| Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|
scientific article
|
| An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs
|
scientific article
|
| Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
|
scientific article
|
| Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages
|
scientific article
|
| Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
|
scientific article published in April 2004
|
| Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap
|
scientific article
|
| Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma
|
scientific article
|
| Mucosal immunity to infection with implications for vaccine development
|
scientific article
|
| Immunization of eyed channel catfish, Ictalurus punctatus, eggs with monovalent Flavobacterium columnare vaccine and bivalent F. columnare and Edwardsiella ictaluri vaccine
|
scientific article published on 2 October 2006
|
| Experimental vaccine protection against feline immunodeficiency virus
|
scientific article published in November 1991
|
| Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
|
scientific article published on 30 October 2017
|
| Anthrax capsule vaccine protects against experimental infection
|
scientific article published in November 2004
|
| Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification
|
scientific article published on 21 March 2014
|
| Lipid-formulated bcg as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand
|
scientific article published in July 2009
|
| Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant
|
scientific article published in September 2002
|
| Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
|
scientific article published in January 2008
|
| Pathways and strategies for developing a malaria blood-stage vaccine
|
scientific article published in January 1998
|
| Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada
|
scientific article published in November 2008
|
| Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes
|
scientific article published on 9 October 2000
|
| Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward
|
scientific article published on 29 July 2014
|
| Human T clones reactive to the sexual stages of plasmodium falciparum malaria. high frequency of gamete-reactive T cells in peripheral blood from nonexposed donors
|
research work
|
| Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|
scientific article published in July 1987
|
| The 230-kDa gamete surface protein of plasmodium falciparum is also a target for transmission-blocking antibodies
|
research work
|
| Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine
|
scientific article published in June 1987
|
| Experimental human challenge infections can accelerate clinical malaria vaccine development
|
scientific article published in January 2011
|
| Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
|
scientific article published on 5 December 2004
|
| Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria
|
scientific article published in May 2005
|
| Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine
|
scientific article published in February 2013
|
| Effect of narrative reports about vaccine adverse events and bias-awareness disclaimers on vaccine decisions: a simulation of an online patient social network
|
scientific article published on 8 August 2012
|
| Control of multiple arthropod vector infestations with subolesin/akirin vaccines.
|
scientific article published on 3 January 2013
|
| Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.
|
scientific article published on 3 July 2006
|
| A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group
|
scientific article published in January 1997
|
| Intent to receive an HPV vaccine among university men and women and implications for vaccine administration
|
scientific article published in July 2008
|
| Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine
|
scientific article published in August 2002
|
| Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system
|
scientific article published in March 2012
|
| Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial
|
scientific article published in March 1982
|
| Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses
|
scientific article published in December 2008
|
| Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
|
scientific article published on 8 October 2009
|
| Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
|
scientific article published on 11 July 2012
|
| Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors
|
scientific article published on 4 May 2006
|
| Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.
|
scientific article published on 19 October 2012
|
| An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
|
scientific article published on 19 January 2006
|
| HPV vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions
|
scientific article
|
| Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba
|
scientific article
|
| Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.
|
scientific article
|
| Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections
|
scientific article
|
| Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults
|
scientific article
|
| Therapeutic dendritic-cell vaccine for simian AIDS.
|
scientific article
|
| Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
|
scientific article
|
| Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
|
scientific article
|
| Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen
|
scientific article
|
| A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report
|
scientific article
|
| Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States
|
scientific article published on 6 May 2008
|
| Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial
|
scientific article published in June 2000
|
| Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life
|
scientific article published in January 2007
|
| Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
|
scientific article published on 8 November 2011
|
| Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population
|
scientific article published in April 2003
|
| A controlled trial of a human papillomavirus type 16 vaccine
|
scientific article published in November 2002
|
| A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis
|
scientific article published in May 2003
|
| Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
|
scientific article published on 24 October 2007
|
| Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection.
|
scientific article published on 13 December 2006
|
| Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways
|
scientific article published on 18 March 2011
|
| Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings.
|
scientific article published on January 2005
|
| Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project
|
scientific article published on 18 April 2011
|
| A novel recombinant multisubunit vaccine against Chlamydia
|
scientific article published on September 2004
|
| Influenza virosomes as a vaccine adjuvant and carrier system
|
scientific article published on April 2011
|
| Cationic liposomes as vaccine adjuvants
|
scientific article published on April 2011
|
| Trends in vaccine adjuvants.
|
scientific article published on April 2011
|
| Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children
|
scientific article published on May 2011
|
| Viral vectors as vaccine platforms: deployment in sight
|
scientific article published on 20 April 2011
|
| Current progress on development of respiratory syncytial virus vaccine.
|
scientific article published on April 2011
|
| The safety evaluation of adjuvants during vaccine development: the AS04 experience
|
scientific article published on 27 April 2011
|
| Comparative effects of carrier proteins on vaccine-induced immune response
|
scientific article published on 05 May 2011
|
| Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions.
|
scientific article published on 06 May 2011
|
| Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission
|
scientific article published on 19 April 2011
|
| Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development
|
scientific article published on April 2000
|
| Fetal immunization by a DNA vaccine delivered into the oral cavity
|
scientific article published on August 2000
|
| Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
|
scientific article published on 26 May 2011
|
| Vaccine candidates for leishmaniasis: a review
|
scientific article published on 25 May 2011
|
| New approaches to the assessment of vaccine herd protection in clinical trials
|
scientific article published on June 2011
|
| Toward the development of a hepatitis E vaccine
|
scientific article published on 18 May 2011
|
| Use of a live chlamydial vaccine to prevent ovine enzootic abortion
|
scientific article published on July 1997
|
| Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infe
|
scientific article published on August 1995
|
| Proteases in blood-feeding nematodes and their potential as vaccine candidates
|
scientific article published on January 2011
|
| Progress on plague vaccine development
|
scientific article published on 14 June 2011
|
| Avian necrotic enteritis: experimental models, host immunity, pathogenesis, risk factors, and vaccine development.
|
scientific article published on July 2011
|
| Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis
|
scientific article published on October 1993
|
| Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
|
scientific article published on 06 June 2011
|
| CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
|
scientific article published on June 2011
|
| Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selection
|
scientific article published on 27 June 2011
|
| The gold industry standard for risk and cost of drug and vaccine development revisited
|
scientific article published on 29 June 2011
|
| Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions
|
scientific article published on 21 June 2011
|
| Duration of live measles vaccine-induced immunity
|
scientific article published on February 1990
|
| Fact and fiction in tuberculosis vaccine research: 10 years later
|
scientific article published on August 2011
|
| Critical issues in dengue vaccine development
|
scientific article published on October 2011
|
| Ricin vaccine development
|
scientific article published on January 2012
|
| Current adjuvants and new perspectives in vaccine formulation.
|
scientific article published on July 2011
|
| Insect cell technology is a versatile and robust vaccine manufacturing platform
|
scientific article published on July 2011
|
| Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink
|
scientific article published on August 2011
|
| Vaccine development against Trypanosoma cruzi and Chagas disease.
|
scientific article published on January 2011
|
| Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis
|
scientific article published on 05 August 2011
|
| Cytokines: the future of intranasal vaccine adjuvants.
|
scientific article published on 31 July 2011
|
| Trachoma vaccine field trials in The Gambia
|
scientific article published on December 1969
|
| Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice
|
scientific article published on 18 August 2011
|
| Visceral leishmaniasis: immunology and prospects for a vaccine
|
scientific article published on 18 August 2011
|
| Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference
|
scientific article published on August 2011
|
| The future of cell culture-based influenza vaccine production
|
scientific article published on August 2011
|
| Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults
|
scientific article published on August 2011
|
| Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles
|
scientific article published on 23 August 2011
|
| New developments and concepts related to biomarker application to vaccines
|
scientific article published on 06 September 2011
|
| Inflammation, immunity, and vaccine development for Helicobacter pylori.
|
scientific article published on September 2011
|
| Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
|
scientific article published on 13 September 2011
|
| Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy
|
scientific article published on September 2011
|
| New developments in vaccine research--unveiling the secret of vaccine adjuvants.
|
scientific article published on September 2011
|
| Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
|
scientific article
|
| Novel strategies to improve DNA vaccine immunogenicity
|
scientific article published on December 2011
|
| When vaccines go viral: an analysis of HPV vaccine coverage on YouTube
|
scientific article published on 27 October 2011
|
| Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine
|
scientific article published on August 1990
|
| Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity
|
scientific article published on December 2011
|
| New insights in mucosal vaccine development.
|
scientific article
|
| Intradermal fractional dose inactivated polio vaccine: a review of the literature
|
scientific article
|
| HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem
|
scientific article
|
| Is there a future for a Staphylococcus aureus vaccine?
|
scientific article
|
| Prospects for an HIV vaccine: leading B cells down the right path
|
scientific article published on 05 December 2011
|
| Female genital tract immunity: distinct immunological challenges for vaccine development
|
scientific article published on 10 December 2011
|
| Effects of vaccine on rotavirus disease in the pediatric population
|
scientific article published on February 2012
|
| Salmonella enterica as a vaccine carrier.
|
scientific article published on January 2012
|
| Combat pneumococcal infections: adhesins as candidates for protein-based vaccine development
|
scientific article published on March 2012
|
| Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
|
scientific article published on 09 January 2012
|
| Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
|
scientific article published on 12 January 2012
|
| Correlates of vaccine protection from influenza and its complications
|
scientific article published on January 2012
|
| The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise
|
scientific article published on January 2012
|
| Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
|
scientific article published on February 2012
|
| The worldwide impact of the seven-valent pneumococcal conjugate vaccine
|
scientific article published on May 2012
|
| Microneedle technologies for (trans)dermal drug and vaccine delivery
|
scientific article published on 04 February 2012
|
| Bovine tuberculosis vaccine research: historical perspectives and recent advances.
|
scientific article published on 16 February 2012
|
| Challenges for a universal Staphylococcus aureus vaccine
|
scientific article published on 21 February 2012
|
| Marine polysaccharides in microencapsulation and application to aquaculture: "from sea to sea".
|
scientific article published on 08 December 2011
|
| Vaccine process technology
|
scientific article published on 30 March 2012
|
| Bexsero: a multicomponent vaccine for prevention of meningococcal disease.
|
scientific article published on February 2012
|
| Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo
|
scientific article published on 07 September 2011
|
| Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities
|
scientific article published on 29 March 2012
|
| The double-edged sword: How evolution can make or break a live-attenuated virus vaccine
|
scientific article published on December 2011
|
| Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy
|
scientific article published on 05 April 2012
|
| Factors associated with HPV vaccine uptake in teenage girls: a systematic review
|
scientific article published on 03 April 2012
|
| Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.
|
scientific article published on April 2012
|
| Current issues with the immunization program in Japan: can we fill the "vaccine gap"?
|
scientific article published on 19 April 2012
|
| Mucosal vaccine design and delivery
|
scientific article published on 18 April 2012
|
| Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults
|
scientific article published on 26 April 2012
|
| The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States
|
scientific article published on 09 May 2012
|
| Immune markers and correlates of protection for vaccine induced immune responses
|
scientific article published on 30 May 2012
|
| Flaviviruses and flavivirus vaccines
|
scientific article published on June 2012
|
| Clostridium difficile: development of a novel candidate vaccine
|
scientific article published on June 2012
|
| Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective
|
scientific article published on 03 July 2012
|
| Recent progress in mucosal vaccine development: potential and limitations
|
scientific article published on 25 July 2012
|
| Mucosal IgA responses in influenza virus infections; thoughts for vaccine design
|
scientific article published on 24 July 2012
|
| Modulation of vaccine response by concomitant probiotic administration
|
scientific article published on March 2013
|
| The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
|
scientific article published on 03 October 2012
|
| Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials
|
scientific article
|
| Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development
|
scientific article
|
| Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus
|
article
|
| The value of a database in surveillance and vaccine selection
|
scholarly article by C Macken et al published October 2001 in International Congress Series
|
| Nanoparticle Vaccines Against Infectious Diseases
|
scholarly article by Rashmirekha Pati et al published 4 October 2018 in Frontiers in Immunology
|
| Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
|
scientific article published on 19 July 2011
|
| Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine
|
scientific article published on 01 July 2006
|
| The benefits of redesigning Benin's vaccine supply chain
|
scientific article published on 09 May 2014
|
| Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants” [Vaccine 26 (2008) 2234–2241]
|
scholarly article by John C. Victor et al published January 2014 in Vaccine
|
| Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006
|
article
|
| Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine
|
article
|
| Safety and Immunogenicity of Glycoprotein D--Adjuvant Genital Herpes Vaccine
|
scientific article published on 24 March 2005
|
| Combined hepatitis A and B vaccine in elderly
|
scientific article published on 01 January 2004
|
| Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults
|
scholarly article by P. Van Damme published in January 2001
|
| Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design
|
article
|
| CD4 T Cells Following Infection and Immunization: Implications for More Effective Vaccine Design
|
scientific article published on 10 August 2018
|
| Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
|
article
|
| Quality and Vaccine Efficacy of CD4+ T Cell Responses Directed to Dominant and Subdominant Epitopes in ESAT-6 from Mycobacterium tuberculosis
|
article
|
| Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection
|
scientific article published on 01 March 2007
|
| Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
|
scientific article published on 01 April 2005
|
| Tuberculosis subunit vaccine development: on the role of interferon-γ
|
article
|
| Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi
|
|
| Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial
|
article
|
| Development of Streptococcal Pyrogenic Exotoxin C Vaccine Toxoids That Are Protective in the Rabbit Model of Toxic Shock Syndrome
|
article
|
| Liposomes as immunological adjuvants and vaccine carriers
|
scholarly article by Gregory Gregoriadis et al published August 1996 in Journal of Controlled Release
|
| Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro
|
article
|
| Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands
|
article
|
| Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001–2013
|
article
|
| Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam
|
article
|
| The India HPV-vaccine suspension
|
scientific article published in The Lancet
|
| Accelerating HIV vaccine development
|
scientific article published in Nature
|
| Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates
|
scientific article published in Nature
|
| Failure of killed Listeria monocytogenes vaccine to produce protective immunity
|
scientific article published on May 20, 1982
|
| Immunology and the elusive AIDS vaccine
|
scientific article published in Nature
|
| HIV vaccine failure prompts Merck to halt trial
|
scientific article published in Nature
|
| Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine
|
scientific article published on December 19, 1991
|
| Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults
|
scientific article published on 13 December 2005
|
| The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant
|
scientific article published on 01 January 2002
|
| Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants
|
scientific article published on 01 April 2014
|
| Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine
|
article
|
| Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments
|
scientific article published on 01 January 1999
|
| Recombinant, octavalent group A streptococcal M protein vaccine
|
scientific article published on 01 July 1996
|
| Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007
|
scientific article published on 01 January 2009
|
| Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine
|
scientific article published on 01 November 1997
|
| Live oral cholera vaccine : from principle to product
|
article by M.M. Levine & J.B. Kaper published October 1995 in Bulletin de l'Institut Pasteur
|
| Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR
|
article
|
| Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults
|
article
|
| Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55–74 years living in Alaska: No evidence of hyporesponsiveness☆☆☆
|
article
|
| Immune History and Influenza Vaccine Effectiveness
|
|
| Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
|
scientific article published on 13 June 2018
|
| Access to vaccine technologies in developing countries: Brazil and India
|
article
|
| Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
|
scientific article published on 1 October 2006
|
| Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
|
article
|
| Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons
|
scientific article published on 18 May 2014
|
| Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation
|
scientific article published on 05 January 2010
|
| Vaccine characteristics and acceptability of HIV immunization among adolescents
|
article
|
| High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects
|
article
|
| A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
|
scientific article published on 01 February 2002
|
| Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States
|
scientific article published on 28 September 2010
|
| Novel application of trimethyl chitosan as an adjuvant in vaccine delivery
|
scientific article published on 23 November 2018
|
| CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis
|
scientific article published on 01 December 2004
|
| Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)
|
article
|
| Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine
|
scientific article published on 01 June 2007
|
| Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older
|
scientific article published on 01 June 1999
|
| Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia
|
scientific article published on 01 January 2006
|
| Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years
|
scientific article published on 01 October 2008
|
| C-polysaccharide in a pneumococcal vaccine
|
scientific article published on 01 December 1984
|
| Integrating Clinical Research into Epidemic Response: The Ebola Experience
|
Book published by National Academies Press
|
| Priming after a Fractional Dose of Inactivated Poliovirus Vaccine
|
scientific article published on 01 January 2013
|
| Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
|
journal article from 'International Journal of Molecular Sciences' published in 2019
|
| Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?
|
|
| Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations
|
article
|
| Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
|
|
| Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates
|
article
|
| Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine
|
scientific article published on 01 January 2008
|
| Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?
|
scientific article published on 01 January 2018
|
| Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04
|
scientific article published on 01 December 2004
|
| Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer
|
Book published by National Academies Press
|
| Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients
|
article
|
| EstimatingHaemophilus influenzaeType b Vaccine Effectiveness in England and Wales by Use of the Screening Method
|
article
|
| Clinical and Immunological Risk Factors Associated withHaemophilus influenzaeType b Conjugate Vaccine Failure in Childhood
|
scientific article published on 25 October 2000
|
| Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group
|
scientific article published on 01 July 1996
|
| Field experiment with BCG vaccine in Malawi
|
scientific article published on 01 January 1981
|
| Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose
|
article
|
| Specific vaccine therapy in chronic hepatitis B infection
|
scientific article published on 01 July 1994
|
| Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?
|
scholarly article by Katja Fink published 13 February 2019 in Frontiers in Immunology
|
| The effectiveness of the mumps component of the MMR vaccine: a case control study
|
scientific article published on 01 July 2005
|
| Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety
|
scientific article published on 08 October 2007
|
| Mucosal vaccines and technology
|
scientific article published on 08 April 2019
|
| Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
|
research work
|
| Counterattacking the tick bite: towards a rational design of anti-tick vaccines targeting pathogen transmission
|
article
|
| HLA-E: exploiting pathogen-host interactions for vaccine development
|
article
|
| The Maintenance of Memory Plasma Cells
|
|
| Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses
|
article
|
| Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations
|
scientific article published on 06 May 2019
|
| Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006
|
scientific article published on 19 May 2008
|
| Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study
|
scientific article published on 05 November 2007
|
| Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey
|
article
|
| Detection and identification of vaccine-related polioviruses by the polymerase chain reaction
|
scientific article published on July 1, 1991
|
| Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study
|
scientific article published on 01 September 2001
|
| Exposure to heat and freezing in the vaccine cold chain in Thailand
|
scientific article published on 18 October 2006
|
| Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era
|
scientific article published on 01 April 2001
|
| Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial
|
scientific article published on 22 August 2013
|
| Paradigm shifts in cancer vaccine therapy.
|
scientific article published on 28 March 2008
|
| Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design
|
scientific article published on 10 January 2008
|
| An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody
|
scientific article published on 17 July 2013
|
| Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection.
|
scientific article published on 12 June 2013
|
| Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine
|
scientific article published on December 2007
|
| Application of carbohydrate array technology to antigen discovery and vaccine development
|
scientific article published on December 2007
|
| Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection
|
scientific article published on July 2016
|
| Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain
|
scientific article published on 17 June 2013
|
| IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model
|
scholarly article
|
| Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis
|
scientific article published on 04 January 2009
|
| Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin
|
scientific article published on July 2008
|
| Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario
|
scientific article published on 09 May 2013
|
| Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection
|
scientific article published on 07 March 2012
|
| Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.
|
scientific article published on January 2008
|
| HIV vaccine research in Thailand: lessons learned
|
scientific article published on April 2008
|
| Type I interferons as vaccine adjuvants against infectious diseases and cancer
|
scientific article published on April 2008
|
| Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children
|
scientific article published on June 2016
|
| Economic evaluation of vaccines in Canada: A systematic review
|
scientific article published on 18 February 2016
|
| Primary vaccine failure after 1 dose of varicella vaccine in healthy children
|
scientific article published on April 2008
|
| The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300
|
scientific article published on 22 December 2008
|
| Improving vaccine delivery using novel adjuvant systems
|
scientific article published on 15 February 2008
|
| Norovirus vaccine development: next steps
|
scientific article published on September 2012
|
| Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains.
|
scientific article published on February 2009
|
| Identification and characterization of gonococcal iron transport systems as potential vaccine antigens
|
scientific article published on June 2008
|
| Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production
|
scientific article published on 02 October 2015
|
| Student HPV vaccine attitudes and vaccine completion by education level
|
scientific article published on 02 February 2016
|
| Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls
|
scientific article published on 22 March 2016
|
| Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells
|
scientific article published on 03 December 2008
|
| Secreted heat shock protein gp96-Ig: an innovative vaccine approach
|
scientific article published on May 2008
|
| Antibody-mediated immunity against tuberculosis: implications for vaccine development
|
scientific article published on March 2013
|
| Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals
|
scientific article published on January 2001
|
| Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum
|
scientific article published on March 1987
|
| Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine
|
scientific article published on September 2007
|
| Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil
|
scientific article published on January 2009
|
| Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine
|
scientific article published on 25 May 2013
|
| Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine
|
scientific article published on March 2008
|
| The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine
|
scientific article published on March 2008
|
| Molecular analysis of the Oka vaccine strain of varicella-zoster virus
|
scientific article published on March 2008
|
| Vaccine Oka variants and sequence variability in vaccine-related skin lesions
|
scientific article published on March 2008
|
| Varicella vaccine effectiveness in the US vaccination program: a review
|
scientific article published on March 2008
|
| Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge
|
scientific article published on 07 January 2009
|
| Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials
|
scientific article published on June 2014
|
| Norovirus vaccine against experimental human Norwalk Virus illness
|
scientific article published on December 2011
|
| A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
|
scientific article published on 16 December 2008
|
| Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.
|
scientific article published on 09 February 2009
|
| Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies
|
scientific article published on June 2008
|
| Replication-deficient ebolavirus as a vaccine candidate
|
scientific article published on 11 February 2009
|
| A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.
|
scientific article published on 07 January 2009
|
| Removing the regional level from the Niger vaccine supply chain
|
scientific article published on 17 April 2013
|
| Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.
|
scientific article published on 29 January 2009
|
| Evaluation of the humoral immune responses in adult cattle and sheep, 4 and 2.5 years post-vaccination with a bluetongue serotype 8 inactivated vaccine
|
scientific article published on 19 June 2013
|
| Virus-like particles as a vaccine delivery system: myths and facts.
|
scientific article published on 11 January 2008
|
| Age-related decline in immunity: implications for vaccine responsiveness
|
scientific article published on May 2008
|
| Salmonella typhi: from a human pathogen to a vaccine vector
|
scientific article published on April 2008
|
| What happens to the DNA vaccine in fish? A review of current knowledge
|
scientific article published on 19 March 2008
|
| Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine
|
scientific article published on 22 April 2013
|
| Shigellosis: the current status of vaccine development
|
scientific article published on June 2008
|
| Molecular characterization of Trichinella spiralis aminopeptidase and its potential as a novel vaccine candidate antigen against trichinellosis in BALB/c mice
|
scientific article published on 23 August 2013
|
| Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.
|
scientific article published on August 1988
|
| A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries
|
scientific article published on 30 August 2013
|
| A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice
|
scientific article published on 06 February 2009
|
| Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
|
scientific article published on 11 February 2009
|
| A mixed methods study of parental vaccine decision making and parent-provider trust
|
scientific article published on September 2013
|
| A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study
|
scientific article published on September 2013
|
| Toward an AIDS vaccine
|
scientific article
|
| Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine
|
scientific article published on May 2008
|
| What are the factors that contribute to parental vaccine-hesitancy and what can we do about it?
|
scientific article
|
| A vault nanoparticle vaccine induces protective mucosal immunity
|
scientific article published on 30 April 2009
|
| Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
|
scientific article published on 22 April 2008
|
| Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.
|
scientific article published on August 2016
|
| Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
|
scientific article published on March 1989
|
| Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
|
scientific article published on 11 August 2016
|
| Oncolytic virotherapy as a personalized cancer vaccine
|
scientific article published on August 2008
|
| Engineering virus-like particles as vaccine platforms
|
scientific article published on 29 March 2016
|
| Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine
|
scientific article published on 28 April 2008
|
| Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
|
scientific article published on May 2008
|
| WT1 peptide vaccine for the treatment of cancer
|
scientific article published on April 2008
|
| The skin stage of malaria infection: biology and relevance to the malaria vaccine effort
|
scientific article published on June 2008
|
| Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
|
scientific article published on 23 January 2009
|
| Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate
|
scientific article published on 10 September 2013
|
| Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
|
scientific article published on 31 May 2016
|
| Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients
|
scientific article published on 21 July 2009
|
| Vaccine strategies to enhance immune responses in the aged
|
scientific article published on 10 June 2013
|
| DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory
|
scientific article published on March 2008
|
| Sexual dimorphism of humoral immunity with human vaccines
|
scientific article published on 09 May 2008
|
| Rabies in Estonia: situation before and after the first campaigns of oral vaccination of wildlife with SAG2 vaccine bait
|
scientific article published on 12 May 2008
|
| Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients
|
scientific article published on 29 August 2013
|
| An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes
|
scientific article published on 29 January 2008
|
| Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies
|
scientific article published on 17 February 2016
|
| CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens
|
scientific article published on 28 April 2013
|
| The E75 HER2/neu peptide vaccine
|
scientific article published on 07 June 2008
|
| In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells
|
scientific article published on December 2008
|
| Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.
|
scientific article published on March 2009
|
| Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults
|
scientific article published on August 2013
|
| Bacterial genome variability and its impact on vaccine design
|
scientific article published on June 2008
|
| A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis
|
scientific article published on August 2013
|
| Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection
|
scientific article published on 21 July 2013
|
| An HSV-1 gD mutant virus as an entry-impaired live virus vaccine
|
scientific article published on 14 January 2008
|
| TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
|
scientific article published on 03 April 2009
|
| Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.
|
scientific article
|
| The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.
|
scientific article
|
| Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.
|
scientific article
|
| Vaccines for mucosal immunity to combat emerging infectious diseases
|
scientific article
|
| A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats
|
scientific article
|
| A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.
|
scientific article
|
| ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile
|
scientific article
|
| Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
|
scientific article
|
| Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
|
scientific article
|
| Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group
|
scientific article
|
| How advances in immunology provide insight into improving vaccine efficacy.
|
scientific article
|
| Increased DNA vaccine delivery and immunogenicity by electroporation in vivo
|
scientific article
|
| HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities
|
scientific article
|
| Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity
|
scientific article
|
| Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers
|
scientific article
|
| Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
|
scientific article
|
| CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?
|
scientific article
|
| Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.
|
scientific article
|
| Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin
|
scientific article
|
| Vaccine-acquired rotavirus in infants with severe combined immunodeficiency
|
scientific article
|
| An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
|
scientific article
|
| Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
|
scientific article
|
| Leishmaniasis Vaccine: Where are We Today?
|
scientific article
|
| Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development
|
scientific article
|
| Current status and prospects for development of an HSV vaccine
|
scientific article published on 6 September 2013
|
| Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8
|
scientific article
|
| Efficacy of a pneumococcal conjugate vaccine against acute otitis media
|
scientific article
|
| Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii
|
scientific article
|
| Rational antibody-based HIV-1 vaccine design: current approaches and future directions
|
scientific article
|
| Twin studies of immunogenicity--determining the genetic contribution to vaccine failure
|
scientific article
|
| Understanding those who do not understand: a brief review of the anti-vaccine movement.
|
scientific article
|
| Reverse vaccinology, a genome-based approach to vaccine development
|
scientific article
|
| Leishmaniasis: current status of vaccine development
|
scientific article
|
| Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
|
scientific article
|
| Challenges and opportunities for development of an AIDS vaccine
|
scientific article
|
| Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.
|
scientific article
|
| The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children
|
scientific article
|
| Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research
|
scientific article
|
| LcrV plague vaccine with altered immunomodulatory properties
|
scientific article
|
| The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults
|
scientific article
|
| Improving vaccine performance with adjuvants
|
scientific article
|
| A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.
|
scientific article
|
| Comparative pathogenesis and systems biology for biodefense virus vaccine development
|
scientific article
|
| Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes
|
scientific article
|
| A new method for the evaluation of vaccine safety based on comprehensive gene expression analysis
|
scientific article
|
| A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region
|
scientific article
|
| Recent progress in herpes simplex virus immunobiology and vaccine research
|
scientific article
|
| Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques
|
scientific article
|
| Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults
|
scientific article published on October 1, 2003
|
| Efficient vaccine against the virus causing a lethal disease in cultured Cyprinus carpio
|
scientific article published on December 1, 2003
|
| Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years
|
scientific article
|
| Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
|
scientific article
|
| Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
|
scientific article
|
| Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis
|
scientific article
|
| Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study
|
scientific article
|
| Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells
|
scientific article
|
| Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates
|
scientific article
|
| Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
|
scientific article published in March 2005
|
| Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
|
scientific article
|
| Chimpanzee adenovirus vaccine protects against Zaire Ebola virus
|
scientific article
|
| Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease
|
scientific article
|
| A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus
|
scientific article
|
| Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
|
scientific article
|
| Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses
|
scientific article
|
| Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland
|
scientific article
|
| Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine
|
scientific article
|
| Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni
|
scientific article
|
| Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain
|
scientific article
|
| Safety and efficacy of a recombinant hepatitis E vaccine
|
scientific article
|
| Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum
|
scientific article
|
| Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications
|
scientific article
|
| Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers
|
scientific article
|
| Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys
|
scientific article
|
| Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine
|
scientific article
|
| Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network.
|
scientific article
|
| Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon
|
scientific article
|
| Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults
|
scientific article
|
| Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite.
|
scientific article
|
| Characterization of conserved T- and B-cell epitopes in plasmodium falciparum major merozoite surface protein 1
|
research work
|
| Human immune responses to Schistosoma mansoni vaccine candidate antigens
|
scientific article
|
| Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.
|
scientific article
|
| Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51
|
scientific article
|
| Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate
|
scientific article
|
| Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes
|
scientific article
|
| Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes
|
scientific article
|
| HPV vaccine acceptability among Kenyan women
|
scientific article
|
| HPV vaccine decision making in pediatric primary care: a semi-structured interview study
|
scientific article
|
| Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults
|
scientific article
|
| Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates
|
scientific article
|
| Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques
|
scientific article
|
| Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.
|
scientific article
|
| Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
|
scientific article
|
| Vaccine development for hepatitis C.
|
scientific article
|
| Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains
|
scientific article
|
| Boosting vaccine for tuberculosis
|
scientific article
|
| Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.
|
scientific article
|
| Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model
|
scientific article
|
| Search for correlates of protective immunity conferred by anthrax vaccine
|
scientific article
|
| Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting
|
scientific article
|
| Effectiveness of influenza vaccine in the community-dwelling elderly
|
scientific article
|
| Human papillomavirus vaccine introduction--the first five years
|
scientific article
|
| Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).
|
scientific article published on 07 March 2013
|
| Clinical development of Modified Vaccinia virus Ankara vaccines
|
scientific article published on 21 March 2013
|
| Challenges in the research and development of new human vaccines.
|
scientific article published on February 2013
|
| Desirability and feasibility of a vaccine against cytomegalovirus
|
scientific article published on April 2013
|
| Case study for a vaccine against leishmaniasis
|
scientific article published on April 2013
|
| The imperative for stronger vaccine supply and logistics systems
|
scientific article published on April 2013
|
| Global support for new vaccine implementation in middle-income countries
|
scientific article published on April 2013
|
| Emergence of serogroup X meningococcal disease in Africa: need for a vaccine
|
scientific article published on 24 April 2013
|
| Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects".
|
scientific article published on 23 April 2013
|
| Accelerating next-generation vaccine development for global disease prevention
|
scientific article published on May 2013
|
| Vaccine effects and impact of vaccination programmes in post-licensure studies
|
scientific article published on 13 July 2013
|
| A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy.
|
scientific article published on 13 July 2013
|
| The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
|
scientific article published on July 2013
|
| The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis
|
scientific article published on 23 July 2013
|
| Identifying protective dengue vaccines: guide to mastering an empirical process
|
scientific article published on 26 July 2013
|
| Effectiveness of meningococcal serogroup C vaccine programmes
|
scientific article published on 09 August 2013
|
| The role of health economic analyses in vaccine decision making
|
scientific article published on 20 August 2013
|
| Group B streptococcal epidemiology and vaccine needs in developed countries.
|
scientific article published on August 2013
|
| Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants
|
scientific article published on August 2013
|
| Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
|
scientific article published on 03 October 2013
|
| Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program
|
scientific article published on 02 December 2013
|
| Nanoparticle vaccines
|
scientific article published on 02 December 2013
|
| Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials
|
scientific article published on 13 December 2013
|
| Immunomodulatory properties of the vaccine adjuvant alum
|
scientific article published on 23 January 2014
|
| Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.
|
scientific article published on 02 March 2014
|
| Targeting TLR2 for vaccine development
|
scientific article
|
| Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology
|
scientific article published on 05 August 2014
|
| The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment
|
scientific article published on 24 October 2013
|
| Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations
|
scientific article published on September 1989
|
| Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.
|
scientific article published on 23 December 2014
|
| Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
|
scientific article
|
| The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.
|
scientific article
|
| Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older
|
scientific article published on July 2009
|
| Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents
|
scientific article published on July 2009
|
| Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial
|
scientific article published on October 2008
|
| Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial
|
scientific article published on October 2014
|
| The test-negative design for estimating influenza vaccine effectiveness
|
scientific article published on 13 March 2013
|
| How to deal with vaccine hesitancy?
|
scientific article published on 18 April 2015
|
| Measuring vaccine hesitancy: The development of a survey tool
|
scientific article published on 17 April 2015
|
| Strategies intended to address vaccine hesitancy: Review of published reviews
|
scientific article published on 18 April 2015
|
| Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices
|
scientific article published on 18 April 2015
|
| Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.
|
scientific article published on 05 March 2014
|
| Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial
|
scientific article published on 15 March 2012
|
| Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
|
scientific article published on February 2012
|
| Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
|
scientific article published on 13 October 2015
|
| Polyethylenimine-based micro/nanoparticles as vaccine adjuvants
|
scientific article published on 31 July 2017
|
| Recombinant subunit vaccines for soil-transmitted helminths
|
scientific article
|
| Vaccine hesitancy: Causes, consequences, and a call to action
|
scientific article
|
| Development of vaccines against Crimean-Congo haemorrhagic fever virus
|
scientific article
|
| An immunogenic personal neoantigen vaccine for patients with melanoma
|
scientific article
|
| Protective and immunological behavior of chimeric yellow fever dengue vaccine
|
scientific article published on 09 February 2016
|
| Participant-centred active surveillance of adverse events following immunisation: a narrative review
|
scientific article published on May 2017
|
| Advances in RSV vaccine research and development - A global agenda
|
scientific article published on 19 April 2016
|
| Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design.
|
scientific article published on 7 April 2017
|
| Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network
|
scientific article
|
| Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines
|
scientific article
|
| Zika Virus: Immunity and Vaccine Development
|
scientific article
|
| Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study
|
scientific article
|
| Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate
|
scientific article published on 13 September 2009
|
| Vaccine hesitancy and healthcare providers.
|
scientific article published on 31 October 2016
|
| Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
|
scientific article published on 18 July 2014
|
| Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
|
scientific article published on 27 October 2016
|
| Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
|
scientific article published on 18 March 2008
|
| Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia
|
scientific article published on 13 January 2009
|
| Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
|
scientific article published on 15 January 2011
|
| Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
|
scientific article published on 28 May 2014
|
| Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants
|
scientific article published on June 1987
|
| First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
|
scientific article published on August 2014
|
| Measles mortality and vaccine efficacy in rural West Africa
|
scientific article published on April 1983
|
| Complex immune correlates of protection in HIV-1 vaccine efficacy trials
|
scientific article published on January 2017
|
| Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis
|
scientific article published on April 1991
|
| Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
|
scientific article published on May 2004
|
| Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70
|
scientific article published on January 1, 1971
|
| Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo
|
scientific article published on 16 May 2013
|
| Influence of protein fold stability on immunogenicity and its implications for vaccine design
|
scientific article published on 14 March 2017
|
| Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial
|
scientific article published on June 2009
|
| Household survey of hepatitis B vaccine coverage among Brazilian children
|
scientific article published on 17 July 2009
|
| Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease
|
scientific article published on August 31, 1978
|
| Validation of influenza and pneumococcal vaccine status in adults based on self-report
|
scientific article published on 2 June 2006
|
| A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database
|
scientific article published on 26 May 2004
|
| Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
|
scientific article published on October 1992
|
| Effective messages in vaccine promotion: a randomized trial
|
scientific article published on 3 March 2014
|
| Impact of Haemophilus influenzae Type b Polysaccharide-Tetanus Protein Conjugate Vaccine on Responses to Concurrently Administered Diphtheria-Tetanus-Pertussis Vaccine
|
scientific article published on February 5, 1992
|
| Advancing a vaccine to prevent human schistosomiasis
|
scientific article
|
| RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol
|
scientific article
|
| Modes of Action for Mucosal Vaccine Adjuvants
|
scientific article
|
| Pneumococcal Vaccine: Dose, Revaccination, and Coadministration with Influenza Vaccine
|
scientific article published on September 1, 1979
|
| Recombinant allergy vaccines based on allergen-derived B cell epitopes.
|
scientific article published on May 2017
|
| Barriers to influenza vaccine acceptance. A survey of physicians and nurses
|
scientific article published on August 1989
|
| Use of pertussis vaccine in an epidemic involving hospital staff
|
scientific article published on September 20, 1975
|
| Effect of group-A meningococcal vaccine in army recruits in Finland
|
scientific article published on November 8, 1975
|
| Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
|
scientific article published on 3 November 2006
|
| An updated methodology to review developing-country vaccine manufacturer viability
|
scientific article
|
| Pertussis vaccine: present status and future prospects
|
scientific article
|
| Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals
|
scientific article
|
| Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
|
scientific article
|
| Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
|
scientific article
|
| Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine
|
scientific article
|
| Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
|
scientific article
|
| A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.
|
scientific article published on 18 April 2006
|
| Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults
|
scientific article published in September 2011
|
| A conserved 37 kDa outer membrane protein of Edwardsiella tarda is an effective vaccine candidate
|
scientific article published in September 2004
|
| Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
|
scientific article published on 18 May 2013
|
| Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema
|
scientific article
|
| Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies
|
scientific article
|
| Assessing the potential impact of Salmonella vaccines in an endemically infected dairy herd
|
scientific article
|
| Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals
|
scientific article
|
| Onset and duration of fecal shedding, cell-mediated and humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated vaccine strain of Lawsonia intracellularis.
|
scientific article
|
| Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee
|
scientific article published in April 1986
|
| Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease
|
scientific article published on 15 August 2012
|
| Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component
|
scientific article
|
| Development of an attenuated strain of chikungunya virus for use in vaccine production
|
scientific article published in September 1986
|
| CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
|
scientific article published in March 2000
|
| Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis
|
scientific article published in August 2003
|
| Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy
|
scientific article published in September 2003
|
| Influenza activity--United States, 2012-13 season and composition of the 2013-14 influenza vaccine
|
scientific article published in June 2013
|
| First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response
|
scientific article published in July 1998
|
| Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
|
scientific article published in September 2003
|
| Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease
|
scientific article published on 27 April 2006
|
| Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis
|
scientific article published on May 1, 1975
|
| Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile
|
scientific article published in April 2011
|
| Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults
|
scientific article published in March 2000
|
| Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine
|
scientific article published on 5 October 2011
|
| Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
|
scientific article published in May 2007
|
| Immunogenicity of combined hepatitis A and B vaccine in elderly persons
|
scientific article published in September 2003
|
| Enhancement of immune responses to an HBV DNA vaccine by electroporation
|
scientific article published on 19 August 2005
|
| Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study
|
scientific article published in November 1986
|
| Long-term persistence of antibodies after one or two doses of MMR-vaccine.
|
scientific article published on 26 July 2007
|
| Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes
|
scientific article published in January 2006
|
| Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009.
|
scientific article published on 20 October 2010
|
| Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine
|
scientific article
|
| Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis
|
scientific article
|
| Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant
|
scientific article published on 3 April 2011
|
| Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected childre
|
scientific article published on 25 October 2007
|
| Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine
|
scientific article published on 22 December 2003
|
| Comparative varicella vaccine effectiveness during outbreaks in day-care centres
|
scientific article
|
| Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine
|
scientific article
|
| Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV).
|
scientific article
|
| Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
|
scientific article
|
| Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months
|
scientific article published on 27 August 2009
|
| Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group
|
scientific article published in February 1997
|
| Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity
|
scientific article published on 27 November 2006
|
| Ten year follow-up of healthy children who received one or two injections of varicella vaccine
|
scientific article published in February 2004
|
| Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group
|
scientific article published in May 1997
|
| Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus
|
scientific article published on 12 June 2005
|
| Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
|
scientific article published in May 2004
|
| Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii
|
scientific article published on 20 May 2008
|
| The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring
|
scientific article published in November 2005
|
| Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand
|
scientific article published in January 2004
|
| Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
|
scientific article published on 8 December 2012
|
| Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine
|
scientific article published on 4 June 2007
|
| Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus
|
scientific article published in September 1997
|
| Vaccine manufacturing: challenges and solutions
|
scientific article published in November 2006
|
| Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study
|
scientific article
|
| A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs
|
scientific article
|
| Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.
|
scientific article
|
| Vaccine strategies against latent tuberculosis infection
|
scientific article
|
| Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine
|
scientific article
|
| Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System
|
scientific article
|
| Rotavirus vaccine introduction in the Americas: progress and lessons learned
|
scientific article
|
| HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
|
scientific article
|
| A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children
|
scientific article
|
| Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine
|
scientific article
|
| Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle
|
scientific article
|
| A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
|
scientific article
|
| Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine
|
scientific article
|
| Parent and adolescent perspectives about adolescent vaccine delivery: practical considerations for vaccine communication.
|
scientific article
|
| Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers
|
scientific article
|
| Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
|
scientific article
|
| Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine
|
scientific article
|
| Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children
|
scientific article
|
| Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system
|
scientific article
|
| Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development
|
scientific article published in September 2004
|
| Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development
|
scientific article published in March 1994
|
| Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine
|
scientific article published in April 2004
|
| Priming with whole-cell versus acellular pertussis vaccine
|
scientific article published in February 2013
|
| Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide
|
scientific article published on 20 February 2008
|
| Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients
|
scientific article published in June 2005
|
| Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis
|
scientific article published in October 2004
|
| Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy
|
scientific article published in September 1987
|
| Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
|
scientific article published in December 2004
|
| Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.
|
scientific article published in December 2004
|
| Progress in the development of an HIV-1 vaccine
|
scientific article published in June 1998
|
| Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
|
scientific article published on 28 November 2004
|
| Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes
|
scientific article published in March 2010
|
| Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
|
scientific article published on 20 August 2010
|
| Self-replicating Semliki Forest virus RNA as recombinant vaccine
|
scientific article published in December 1994
|
| Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure
|
scientific article published in November 1977
|
| Can a 'flawless' live vector vaccine strain be engineered?
|
scientific article published in August 2001
|
| Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes
|
scientific article
|
| High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins.
|
scientific article published in February 2005
|
| Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
|
scientific article published in March 2012
|
| A serine protease inhibitor (serpin) from Haemaphysalis longicornis as an anti-tick vaccine
|
scientific article published in January 2005
|
| Immunization of healthy adults with live attenuated varicella vaccine
|
scientific article published in July 1988
|
| Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
|
scientific article published on 16 October 2006
|
| CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance
|
scientific article published in February 1993
|
| An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink
|
scientific article
|
| NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.
|
scientific article published in January 2001
|
| Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
|
scientific article published on 12 April 2013
|
| A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice
|
scientific article published on 05 April 2009
|
| Genetic engineering of a modified herpes simplex virus 1 vaccine vector.
|
scientific article published on 13 March 2009
|
| A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model
|
scientific article published on 28 January 2009
|
| Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed
|
scientific article published on 17 February 2009
|
| A baculovirus dual expression system-based malaria vaccine induces strong protection against Plasmodium berghei sporozoite challenge in mice
|
scientific article published on 17 February 2009
|
| Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens
|
scientific article published on 30 April 2008
|
| Influenza A virus lacking M2 protein as a live attenuated vaccine
|
scientific article published on 25 March 2009
|
| Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.
|
scientific article published on 11 March 2009
|
| Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?
|
scientific article published on 12 June 2008
|
| Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast
|
scientific article published on 24 March 2008
|
| Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
|
scientific article published on July 2016
|
| Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy
|
scientific article published on July 2008
|
| Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement
|
scientific article published on June 2008
|
| Vaccines: correlates of vaccine-induced immunity
|
scientific article published on August 2008
|
| Influenza vaccine: a travelers' vaccine?
|
scientific article published on July 2008
|
| A systematic review of ethical issues in vaccine studies involving pregnant women
|
scientific article published on 31 May 2016
|
| Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy.
|
scientific article published on 17 July 2013
|
| Confounding in evaluating the effectiveness of influenza vaccine.
|
scientific article published on 23 June 2008
|
| Development of a DNA vaccine targeting Merkel cell polyomavirus
|
scientific article published on 29 December 2011
|
| Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
|
scientific article published on January 1986
|
| Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine
|
scientific article published on January 1986
|
| Haemophilus influenzae type b conjugate vaccine use and effectiveness
|
scientific article published on July 2008
|
| A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants
|
scientific article published on 09 August 2013
|
| Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider
|
scientific article published on July 2008
|
| Identification of migR, a regulatory element of the Francisella tularensis live vaccine strain iglABCD virulence operon required for normal replication and trafficking in macrophages.
|
scientific article published on 06 April 2009
|
| Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
|
scientific article published on August 1986
|
| Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis
|
scientific article published on April 2008
|
| Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states
|
scientific article published on 07 April 2009
|
| Variability in the immune system: of vaccine responses and immune states
|
scientific article published on 13 August 2013
|
| Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients
|
scientific article published on 04 June 2013
|
| Mandates for adolescent immunizations: recommendations from the National Vaccine Advisory Committee
|
scientific article published on August 2008
|
| Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection
|
scientific article published on 09 May 2009
|
| Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine
|
scientific article published on 12 February 2008
|
| Efficacy and bait acceptance of vaccinia vectored rabies glycoprotein vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris).
|
scientific article published on 11 July 2008
|
| Tuberculosis vaccine development: goals, immunological design, and evaluation
|
scientific article published on July 2008
|
| Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues.
|
scientific article published on 22 April 2009
|
| Appalachian and non-Appalachian pediatricians' encouragement of the human papillomavirus vaccine: implications for health disparities.
|
scientific article published on 09 September 2011
|
| Pneumococcal Vaccine Trials in Papua New Guinea: Relationships Between Epidemiology of Pneumococcal Infection and Efficacy of Vaccine
|
scientific article published on May 1, 1991
|
| Application of genomics in bacterial vaccine discovery: a decade in review
|
scientific article published on 24 July 2008
|
| Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine
|
scientific article published on June 2009
|
| Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine
|
scientific article published on August 1987
|
| Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model
|
scientific article published on 10 March 2009
|
| Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial
|
scientific article
|
| Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008.
|
scientific article published on October 2010
|
| Immunization of elderly people with two doses of influenza vaccine
|
scientific article published on September 1987
|
| HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine
|
scientific article published on 05 February 2009
|
| What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?
|
scientific article published on 25 May 2009
|
| Bounding the infectiousness effect in vaccine trials
|
scientific article published on September 2011
|
| Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles
|
scientific article published on 18 August 2009
|
| Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys
|
scientific article published on 21 July 2008
|
| Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.
|
scientific article published on 04 June 2007
|
| Use of oral cholera vaccine in Haiti: a rural demonstration project
|
scientific article published on October 2013
|
| A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention
|
scientific article published on 23 July 2008
|
| Virus-sized vaccine delivery systems
|
scientific article published on 07 August 2008
|
| Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants
|
scientific article published on March 1990
|
| Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.
|
scientific article published on 17 January 2007
|
| Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
|
scientific article published on 23 September 2013
|
| Oral vaccine delivery: can it protect against non-mucosal pathogens?
|
scientific article published on August 2008
|
| Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis
|
scientific article published on August 2008
|
| Staphylococcus aureus antigens and challenges in vaccine development
|
scientific article published on August 2008
|
| FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
|
scientific article published on August 2008
|
| Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine
|
scientific article published on 15 October 2013
|
| Coccidia: a review of recent advances on immunity and vaccine development
|
scientific article published on March 1993
|
| Systems biological approaches to measure and understand vaccine immunity in humans
|
scientific article published on 21 June 2013
|
| Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge
|
scientific article published on 29 April 2009
|
| Distinguishing vaccine efficacy and effectiveness
|
scientific article published on 31 August 2012
|
| World wide experience with inactivated poliovirus vaccine
|
scientific article published on 03 August 2008
|
| Vaccine adjuvants: the dream becomes real
|
scientific article published on 16 September 2008
|
| Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia
|
scientific article published on 03 May 2009
|
| A review of vaccine approaches for West Nile virus
|
scientific article published on 10 September 2013
|
| Vaccine adjuvants: current challenges and future approaches.
|
scientific article published on April 2009
|
| Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design
|
scientific article published on 19 August 2008
|
| Immune response to influenza vaccine in children with inflammatory bowel disease
|
scientific article published on 27 January 2009
|
| Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
|
scientific article published on 22 August 2008
|
| Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus
|
scientific article published on 09 August 2013
|
| Characterization and optimization of the glucan particle-based vaccine platform
|
scientific article published on 14 August 2013
|
| Development and preclinical evaluation of an alphavirus replicon vaccine for influenza
|
scientific article published on 05 October 2007
|
| Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
|
scientific article published on 31 July 2013
|
| A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes
|
scientific article published on 04 October 2012
|
| Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.
|
scientific article published on 03 May 2009
|
| Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.
|
scientific article published on 27 August 2013
|
| Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine
|
scientific article published on April 1, 1973
|
| Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.
|
scientific article published on 28 April 2009
|
| A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.
|
scientific article published on 09 April 2009
|
| Cell fusion: from hybridoma to dendritic cell-based vaccine.
|
scientific article published on September 2008
|
| Marek's disease vaccines: a solution for today but a worry for tomorrow?
|
scientific article published on July 2008
|
| Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
|
scientific article published on 07 June 2016
|
| Issues in pediatric vaccine-preventable diseases in low- to middle-income countries
|
scientific article published on 20 June 2016
|
| Are good intentions putting the vaccination ecosystem at risk?
|
scientific article published on 06 June 2016
|
| Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age
|
scientific article published on 29 October 2013
|
| HPV vaccine acceptability among men: a systematic review and meta-analysis.
|
scientific article published on 04 July 2013
|
| A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes
|
scientific article published on 03 March 2008
|
| A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
|
scientific article published on 25 March 2009
|
| Vaccine injection technique and reactogenicity--evidence for practice
|
scientific article published on 17 September 2008
|
| Vaccines for the future: learning from human immunology
|
scientific article published on 31 August 2011
|
| Reintroduction of two deleted virulence loci restores full virulence to the live vaccine strain of Francisella tularensis
|
scientific article published on 08 June 2009
|
| A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis
|
scientific article published on June 2009
|
| What can HIV vaccine trials teach us about future HIV vaccine dissemination?
|
scientific article published on 28 March 2008
|
| Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes
|
scientific article published on 03 March 2009
|
| Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.
|
scientific article published on 4 November 2013
|
| Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage
|
article
|
| Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2)
|
article by Nancy Cox et al published December 1988 in Virology
|
| Parents concerned about vaccine safety: Differences in race/ethnicity and attitudes
|
scientific article published on 13 July 2006
|
| Varicella mortality: trends before vaccine licensure in the United States, 1970-1994
|
scientific article published on 12 July 2000
|
| Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
|
scientific article published on 01 April 2006
|
| Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors
|
scientific article published on 09 December 2008
|
| Underimmunization among children: effects of vaccine safety concerns on immunization status
|
scientific article published on 01 July 2004
|
| Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study
|
article by R B Wainwright et al published March 1997 in Journal of Infectious Diseases
|
| Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population
|
article
|
| Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine
|
article
|
| Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis
|
scientific article published on 01 February 1995
|
| The Vaccine Adverse Event Reporting System (VAERS)
|
scientific article published on 01 May 1994
|
| Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity
|
article
|
| Strategies to increase adoption of animal vaccines by smallholder farmers with focus on neglected diseases and marginalized populations
|
|
| Interventions to increase the distribution of vaccines in Sub-Saharan Africa: a scoping review
|
scientific article published on 09 January 2019
|
| One step forward, two steps back--will there ever be an AIDS vaccine?
|
article
|
| Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
|
scientific article published on 01 February 2006
|
| A recombinant human adenovirus vaccine against rabies
|
|
| Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251
|
scientific article published on 01 February 2005
|
| Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans
|
article by F H Top et al published August 1971 in Journal of Infectious Diseases
|
| The Threat of Pandemic Influenza: Are We Ready? Workshop Summary
|
Book published by National Academies Press
|
| Adjuvant influenza adenovirus vaccine
|
scientific article published on 01 February 1962
|
| Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions
|
scientific article published on 01 September 2004
|
| Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels
|
scientific article published on 26 January 2011
|
| IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content
|
article
|
| Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains
|
article
|
| Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group
|
scientific article published on 01 October 1998
|
| Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine
|
scientific article published on 01 January 1996
|
| Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine
|
scientific article published in 1993
|
| Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens
|
scientific article published on 01 January 1991
|
| OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.
|
scientific article
|
| Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
|
scientific article
|
| Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality.
|
scientific article
|
| Clinical experience with inactivated, virosomal influenza vaccine.
|
scientific article
|
| The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration.
|
scientific article published on 31 May 2019
|
| The impact of dosing schedules on the success of vaccination programmes in elderly populations: A summary of current evidence.
|
scientific article published on 31 May 2018
|
| Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.
|
scientific article published on 29 May 2019
|
| Pneumococcal Infection and Pneumococcal Vaccine
|
scientific article published on October 27, 1977
|
| Evolution of poliovirus since introduction of attenuated vaccine
|
scientific article published on 01 June 1977
|
| Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964
|
scientific article published on 01 April 1978
|
| Thymus Dependence of Rabies Vaccine
|
scientific article published on 01 December 1976
|
| Methods of Immunoprophylaxis Against Bovine Anaplasmosis with Emphasis on use of the Attenuated Anaplasma Marginale Vaccine
|
scientific article published on 01 January 1977
|
| Efficacy of Mycobacterial Cell Walls as a Vaccine against Airborne Tuberculosis in the Rhesus Monkey
|
scientific article published on 01 May 1971
|
| Group A Meningococcal Polysaccharide Vaccine and Course of the Group A Meningococcal Epidemic in Finland
|
scientific article published on 01 January 1978
|
| Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test
|
scientific article published on 01 April 1978
|
| Antibody response of infants in tropics to five doses of oral polio vaccine
|
scientific article published on 01 April 1976
|
| Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains
|
scientific article published on 01 February 1992
|
| Immune response of elderly individuals to a live attenuated varicella vaccine
|
scientific article published on 01 August 1992
|
| Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age
|
scientific article published on February 29, 1992
|
| Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly
|
scientific article published on January 22, 1977
|
| Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia
|
scientific article published on 01 January 1977
|
| Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity
|
scientific article published on April 14, 1977
|
| Rubella vaccination of schoolgirls: factors affecting vaccine uptake
|
scientific article published on March 19, 1977
|
| Controlled release microparticles for vaccine development
|
scientific article published on 01 October 1991
|
| Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP)
|
scientific article published on 01 August 1991
|
| The measles epidemic. The problems, barriers, and recommendations. The National Vaccine Advisory Committee
|
scientific article published on 01 September 1991
|
| The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex
|
scientific article published on 01 June 1991
|
| Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine
|
scientific article published on 01 November 1991
|
| Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C
|
scientific article published on 01 January 1992
|
| Pneumococcal vaccine--past, present, and future
|
scientific article published on 01 November 1991
|
| Impaired response to recombinant hepatitis B vaccine in HIV-infected persons
|
scientific article published on 01 January 1992
|
| Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine
|
scientific article published on 01 February 1992
|
| Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group
|
scientific article published on March 18, 1992
|
| Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit
|
scientific article published on 01 January 1992
|
| Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism
|
scientific article published on March 15, 1992
|
| Stress-induced modulation of the immune response to recombinant hepatitis B vaccine
|
scientific article published on 01 January 1992
|
| Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine
|
scientific article published on 01 August 1990
|
| Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection
|
scientific article published on 01 June 1992
|
| Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture
|
scientific article published on 01 August 1992
|
| The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group
|
scientific article published on 01 November 1991
|
| Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies
|
scientific article published on 01 September 1991
|
| Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases
|
scientific article published on 01 December 1991
|
| The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
|
scientific article published on 01 May 1988
|
| Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
|
scientific article published on 01 November 1991
|
| Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine
|
scientific article published on 01 November 1991
|
| Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis
|
scientific article published on November 16, 1991
|
| Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine
|
scientific article published on 01 November 1990
|
| Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies
|
scientific article published on 01 June 1988
|
| Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development
|
scientific article published on 01 April 1990
|
| Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants
|
scientific article published on 01 November 1990
|
| Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine
|
scientific article published on 01 June 1990
|
| Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial
|
scientific article published on 01 September 1990
|
| Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group
|
scientific article published on 01 November 1990
|
| Natural history of pertussis antibody in the infant and effect on vaccine response
|
scientific article published on 01 March 1990
|
| Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide
|
scientific article published on 01 April 1990
|
| Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b
|
scientific article published on 01 April 1990
|
| Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial
|
scientific article published on 01 January 1986
|
| Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine
|
scientific article published on 01 August 1986
|
| Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid
|
scientific article published on 01 January 1987
|
| Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine
|
scientific article published on 01 November 1987
|
| Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination
|
scientific article published on 01 June 1990
|
| Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms
|
scientific article published on 01 January 1987
|
| Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection
|
scientific article published on 01 January 1972
|
| Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay
|
scientific article published on 01 August 1989
|
| Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine
|
scientific article published on 01 April 1989
|
| Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers
|
scientific article published on 01 May 1989
|
| Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine
|
scientific article published on 01 January 1973
|
| Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide
|
scientific article published on 01 May 1986
|
| Maternally derived measles immunity in era of vaccine-protected mothers
|
scientific article published on 01 May 1986
|
| Natural and vaccine-related immunity to Streptococcus pneumoniae
|
scientific article published on 01 August 1986
|
| Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection
|
scientific article
|
| Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults
|
scientific article
|
| Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis
|
scientific article
|
| Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
|
scientific article
|
| Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
|
scientific article
|
| Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
|
scientific article
|
| Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
|
scientific article
|
| Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes
|
scientific article
|
| Hepatitis C vaccine: supply and demand
|
scientific article
|
| Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
|
scientific article
|
| The potential value of Clostridium difficile vaccine: an economic computer simulation model
|
scientific article
|
| An HIV vaccine--challenges and prospects
|
scientific article
|
| The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development
|
scientific article
|
| Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
|
scientific article
|
| Effect of pneumococcal conjugate vaccine on pneumococcal meningitis
|
scientific article
|
| Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency
|
scientific article
|
| The spike protein of SARS-CoV--a target for vaccine and therapeutic development
|
scientific article
|
| Application of DNA vaccine technology to aquaculture
|
scientific article
|
| The effectiveness of varicella vaccine in China
|
scientific article
|
| Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
|
scientific article
|
| Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial
|
scientific article
|
| A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use.
|
scientific article
|
| Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy
|
scientific article
|
| Aluminum vaccine adjuvants: are they safe?
|
scientific article
|
| A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge.
|
scientific article
|
| Anti-vaccine activists, Web 2.0, and the postmodern paradigm--an overview of tactics and tropes used online by the anti-vaccination movement
|
scientific article
|
| Influenza virus vaccine based on the conserved hemagglutinin stalk domain
|
scientific article
|
| Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis
|
scientific article
|
| A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response
|
scientific article
|
| Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
|
scientific article
|
| Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development
|
scientific article
|
| Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B
|
scientific article
|
| Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.
|
scientific article
|
| The chimpanzee and other non-human-primate models in HIV-1 vaccine research
|
scientific article
|
| Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems
|
scientific article
|
| Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
|
scientific article
|
| Strategies for cancer vaccine development
|
scientific article
|
| Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development
|
scientific article
|
| Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine
|
scientific article
|
| A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
|
scientific article
|
| Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years
|
scientific article
|
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
|
scientific article
|
| A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice
|
scientific article
|
| Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient
|
scientific article
|
| AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein
|
scientific article
|
| Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.
|
scientific article
|
| Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature
|
scientific article
|
| Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development
|
scientific article
|
| Issues in tick vaccine development: identification and characterization of potential candidate vaccine antigens
|
scientific article
|
| A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses
|
scientific article
|
| Single versus multi-dose vaccine vials: an economic computational model
|
scientific article
|
| An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans
|
scientific article
|
| Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?
|
scientific article
|
| Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine
|
scientific article
|
| Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model
|
scientific article
|
| Memories that last forever: strategies for optimizing vaccine T-cell memory
|
scientific article
|
| Hepatitis B vaccine responsiveness in Connecticut public safety personnel
|
scientific article
|
| Vaccine-associated immune-mediated hemolytic anemia in the dog.
|
scientific article
|
| Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial
|
scientific article
|
| Impact of anti-vaccine movements on pertussis control: the untold story
|
scientific article
|
| Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus
|
scientific article
|
| Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene
|
scientific article
|
| Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses
|
scientific article
|
| Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children
|
scientific article
|
| Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse
|
scientific article
|
| Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development
|
scientific article
|
| Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.
|
scientific article
|
| Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus
|
scientific article
|
| Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine
|
scientific article
|
| Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine
|
scientific article
|
| Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.
|
scientific article
|
| Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium
|
scientific article published on February 1, 1978
|
| Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.
|
scientific article
|
| Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
|
scientific article
|
| How parents hear about human papillomavirus vaccine: implications for uptake
|
scientific article
|
| Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins
|
scientific article
|
| Design of a group-randomized Streptococcus pneumoniae vaccine trial
|
scientific article
|
| Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
|
scientific article
|
| Immunoglobulin GM and KM allotypes and vaccine immunity
|
scientific article
|
| The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine
|
scientific article
|
| Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil.
|
scientific article
|
| Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico
|
scientific article
|
| A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector
|
scientific article
|
| Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity
|
scientific article
|
| Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice
|
scientific article
|
| HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure
|
scientific article
|
| Vaccine demand driven by vaccine side effects: dynamic implications for SIR diseases.
|
scientific article
|
| Enhanced vaccine control of epidemics in adaptive networks
|
scientific article
|
| A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults
|
scientific article
|
| Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
|
scientific article
|
| Chlamydia trachomatis control requires a vaccine
|
scientific article
|
| Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice
|
scientific article
|
| Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory
|
scientific article
|
| Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
|
scientific article
|
| Emergence and reemergence of smallpox: the need for development of a new generation smallpox vaccine.
|
scientific article
|
| Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children
|
scientific article
|
| The Vaccine Safety Datalink project
|
scientific article
|
| Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum
|
scientific article
|
| Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration
|
scientific article
|
| DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis
|
scientific article
|
| The complexity and cost of vaccine manufacturing - An overview
|
scientific article
|
| Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey.
|
scientific article published on 15 June 2013
|
| Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly
|
scientific article published on August 2004
|
| Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world
|
scientific article published on March 1985
|
| Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.
|
scientific article
|
| Field trial of a locally produced, killed, oral cholera vaccine in Vietnam
|
scientific article
|
| Dissolving Microneedle Patches for Dermal Vaccination
|
scientific article
|
| Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
|
scientific article published on 13 February 2013
|
| Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine
|
scientific article published on February 2005
|
| Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial
|
scientific article
|
| Immunization policies and vaccine coverage among adults. The risk for missed opportunities
|
scientific article
|
| Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
scientific article
|
| Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England.
|
scientific article
|
| Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.
|
scientific article
|
| The effect of falsely balanced reporting of the autism-vaccine controversy on vaccine safety perceptions and behavioral intentions
|
scientific article published on 27 November 2012
|
| Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
|
scientific article published on December 2007
|
| Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.
|
scientific article published on December 1999
|
| Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine
|
scientific article published on December 2000
|
| Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity
|
scientific article published on January 2001
|
| A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages
|
research work
|
| Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital
|
scientific article published on January 6, 1979
|
| Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized
|
scientific article published on July 2000
|
| Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach.
|
scientific article published on 28 May 2012
|
| Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum
|
scientific article published on 29 October 2013
|
| Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease.
|
scientific article published on 12 October 2015
|
| Assessing vaccine efficacy in the field. Further observations
|
scientific article published on January 1988
|
| Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers
|
scientific article published on January 2005
|
| A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results
|
scientific article published on March 1982
|
| Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.
|
scientific article published on January 2005
|
| Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine
|
scientific article published on November 1995
|
| Controlled trials of a polyvalent pseudomonas vaccine in burns
|
scientific article published on November 10, 1979
|
| Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine
|
scientific article published on 14 December 2001
|
| Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine
|
scientific article published on January 2000
|
| The public health value of vaccines beyond efficacy: methods, measures and outcomes
|
scientific article published on 26 July 2017
|
| Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development
|
scientific article published on May 2010
|
| Commercialisation of a recombinant vaccine against Boophilus microplus
|
scientific article published on January 1995
|
| Recent advances in the development of an improved, human anthrax vaccine.
|
scientific article published on March 1988
|
| Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
|
scientific article published on September 2000
|
| Analysis of porcine circovirus type 1 detected in Rotarix vaccine
|
scientific article published on 18 November 2010
|
| Auxotrophic Salmonella typhi as live vaccine
|
scientific article published on April 1988
|
| A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users
|
scientific article published on August 2003
|
| Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield
|
scientific article published on 24 August 2010
|
| Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs
|
scientific article published on 12 August 2010
|
| Correlation between healthcare workers' knowledge of influenza vaccine and vaccine receipt
|
scientific article published on November 2003
|
| Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests
|
scientific article published on 17 July 2010
|
| Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission
|
scientific article published on 14 July 2010
|
| Immunity to schistosomes: progress toward vaccine
|
scientific article published on November 1987
|
| Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract.
|
scientific article published on 25 June 2010
|
| Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus
|
scientific article published on November 2002
|
| Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates
|
scientific article
|
| Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network
|
scientific article
|
| Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
|
scientific article
|
| Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets
|
scientific article
|
| Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain
|
scientific article published on 14 April 2010
|
| Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing
|
scientific article published on 26 March 2010
|
| Predictors of STI vaccine acceptability among parents and their adolescent children
|
scientific article published on September 2005
|
| Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1.
|
scientific article published on March 2003
|
| Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity
|
scientific article
|
| Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
|
scientific article
|
| HPV vaccine acceptability in Ghana, West Africa
|
scientific article
|
| Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate
|
scientific article published on 27 October 2009
|
| Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.
|
scientific article published on January 2011
|
| Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity
|
scientific article published on 11 September 2009
|
| Widening inequalities in MMR vaccine uptake rates among ethnic groups in an urban area of the UK during a period of vaccine controversy (1994-2000).
|
scientific article
|
| Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
|
scientific article
|
| The demand for a dengue vaccine: a contingent valuation survey in Metro Manila
|
scientific article
|
| Use of MDCK cells for production of live attenuated influenza vaccine
|
scientific article
|
| Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium
|
scientific article published on 17 September 2010
|
| Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.
|
scientific article
|
| Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling
|
scientific article
|
| Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.
|
scientific article published on 14 May 2009
|
| A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability
|
scientific article published on 13 March 2009
|
| Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding
|
scientific article published on 13 January 2009
|
| Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.
|
scientific article published on June 1996
|
| Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector
|
scientific article
|
| A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
|
scientific article
|
| Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination
|
scientific article
|
| Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization
|
scientific article
|
| Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States
|
scientific article
|
| Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.
|
scientific article published on 22 October 2009
|
| Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy
|
scientific article published on October 2009
|
| Parental response to human papillomavirus vaccine availability: uptake and intentions.
|
scientific article published on 30 May 2009
|
| Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial
|
scientific article
|
| Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials
|
scientific article
|
| Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults
|
scientific article
|
| A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
|
scientific article
|
| A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
|
scientific article
|
| Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine
|
scientific article
|
| Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential
|
scientific article
|
| Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
|
scientific article
|
| A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine
|
scientific article
|
| MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages
|
scientific article
|
| Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany
|
scientific article
|
| A universal epitope-based influenza vaccine and its efficacy against H5N1.
|
scientific article
|
| Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.
|
scientific article
|
| A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health
|
scientific article
|
| The HPV vaccine: a content analysis of online news stories
|
scientific article
|
| From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein
|
scientific article published on 3 August 2016
|
| Plant-made vaccines and reagents for the One Health initiative
|
scientific article
|
| Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
|
scientific article published on 4 October 2007
|
| Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage
|
scientific article published on 11 July 2002
|
| Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.
|
scientific article published on 15 January 2006
|
| Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly
|
scientific article published on 4 September 2007
|
| Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide
|
scientific article published in February 2005
|
| Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
|
scientific article published on March 9, 1991
|
| Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations
|
scientific article
|
| Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
|
scientific article published on 18 May 2013
|
| WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
|
scientific article published on 19 June 2015
|
| A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice
|
scientific article published on 7 January 2013
|
| A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge
|
scientific article published on 7 September 2012
|
| Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
|
scientific article published on 10 February 2012
|
| Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine
|
scientific article published on 10 August 2011
|
| Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
|
scientific article published on 23 May 2010
|
| Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
|
scientific article published on 24 September 2010
|
| Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States
|
scientific article published in July 2014
|
| Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine
|
scientific article published on 4 August 2009
|
| A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
|
scientific article published on 3 August 2009
|
| Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
|
scientific article published on 3 April 2009
|
| An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS.
|
scientific article published on 13 March 2009
|
| Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus
|
scientific article published on 25 December 2008
|
| A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics
|
scientific article published on 16 December 2008
|
| Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).
|
scientific article published in December 2008
|
| Human and murine CD4 T cell epitopes map to the same region of the malaria circumsporozoite protein: Limited immunogenicity of sporozoites and circumsporozoite protein
|
research work
|
| A live attenuated turkey rhinotracheitis virus vaccine. 2. The use of the attenuated strain as an experimental vaccine
|
scientific article published in July 1989
|
| A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.
|
scientific article published on 29 July 2008
|
| Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity
|
scientific article published in May 2008
|
| A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats
|
scientific article published on 2 June 2008
|
| Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.
|
scientific article published on 12 May 2008
|
| Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies
|
scientific article published on 13 March 2008
|
| Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults
|
research work
|
| Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
|
scientific article published on 24 October 2007
|
| Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine
|
scientific article
|
| Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge
|
scientific article
|
| Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant
|
scientific article
|
| Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013.
|
scientific article
|
| Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
|
scientific article
|
| Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice
|
scientific article
|
| Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate
|
scientific article
|
| Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine
|
scientific article
|
| Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model
|
scientific article published on 30 January 2007
|
| Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus
|
scientific article published in January 2007
|
| A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.
|
scientific article published on 4 January 2007
|
| Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
|
scientific article published on 2 August 2006
|
| Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep
|
scientific article published on 5 September 2006
|
| Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine
|
scientific article published on 20 September 2006
|
| Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation
|
scientific article published on 27 June 2006
|
| Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults
|
scientific article published in July 2006
|
| The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.
|
scientific article published on 18 April 2006
|
| Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
|
scientific article published on 20 February 2006
|
| A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
|
scientific article
|
| Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults
|
scientific article
|
| Comparative immune responses in Japanese flounder, Paralichthys olivaceus after vaccination with viral hemorrhagic septicemia virus (VHSV) recombinant glycoprotein and DNA vaccine using a microarray analysis
|
scientific article
|
| Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus
|
scientific article
|
| CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
|
scientific article
|
| Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice
|
scientific article
|
| Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
|
scientific article published on 13 April 2005
|
| Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine
|
scientific article
|
| Protection of cultured Cyprinus carpio against a lethal viral disease by an attenuated virus vaccine
|
scientific article
|
| A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus
|
scientific article
|
| Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.
|
scientific article published on 25 December 2004
|
| Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
|
scientific article published in March 2005
|
| Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
|
scientific article published in March 2005
|
| Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine
|
scientific article
|
| Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
|
scientific article published in November 2004
|
| Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy
|
scientific article published in October 2004
|
| A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine
|
scientific article published in June 2004
|
| Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep
|
scientific article published in March 2004
|
| Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice
|
scientific article published in January 2004
|
| Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine
|
scientific article published in July 1960
|
| Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination
|
scientific article published in July 1960
|
| Present status of attenuated live-virus poliomyelitis vaccine
|
scientific article published in December 1956
|
| Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).
|
scientific article published in December 1956
|
| Clonal vaccinia virus grown in cell culture as a new smallpox vaccine
|
scientific article published on 17 August 2003
|
| Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara
|
scientific article published in August 2003
|
| Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme
|
scientific article published on May 15, 2003
|
| Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.
|
scientific article published in June 2003
|
| Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis
|
scientific article published on June 2, 2003
|
| Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates
|
scientific article published in February 2003
|
| Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity
|
scientific article published on 6 January 2003
|
| Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.
|
scientific article published in January 2003
|
| The theoretical population-level impact of a prophylactic human papilloma virus vaccine
|
scientific article published in November 2002
|
| Parental vaccine safety concerns in 2009.
|
scientific article published in March 2010
|
| Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|
scientific article published in January 2002
|
| Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children
|
scientific article published in December 2001
|
| Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
|
scientific article published in December 2001
|
| An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
|
scientific article published in September 2001
|
| Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers
|
scientific article published on 10 April 2001
|
| Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting
|
scientific article published in April 2001
|
| Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
|
scientific article published on 18 January 2001
|
| Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
|
scientific article published in November 2000
|
| Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.
|
scientific article published in August 2000
|
| Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly
|
scientific article published in May 2000
|
| Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years
|
scientific article published on 20 June 2012
|
| Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
|
scientific article published in March 2000
|
| Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults
|
scientific article published in February 2000
|
| Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
|
scientific article published in February 2000
|
| A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group
|
scientific article published in November 1999
|
| Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts
|
scientific article published in October 1999
|
| A plant-derived edible vaccine against hepatitis B virus.
|
scientific article published in October 1999
|
| A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group
|
scientific article published in August 1999
|
| Mutants of pertussis toxin suitable for vaccine development
|
scientific article published on 01 October 1989
|
| Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign
|
scientific article published on 01 September 1989
|
| Development of a live attenuated vaccine against coccidiosis of poultry
|
scientific article published on 01 March 1989
|
| Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine
|
scientific article published on 01 January 1989
|
| Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine
|
scientific article published on 01 June 1989
|
| Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures
|
scientific article published on 01 April 1987
|
| Field trial of rhesus rotavirus vaccine in infants
|
scientific article published on 01 September 1988
|
| Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein
|
scientific article published on 01 August 1986
|
| Acellular pertussis vaccine in adults: adverse reactions and immune response
|
scientific article published on 01 February 1987
|
| A Prototype Live Oral Cholera Vaccine
|
scientific article published on March 12, 1971
|
| Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment
|
scientific article published on 01 January 1985
|
| The role of secondary vaccine failures in measles outbreaks
|
scientific article published on 01 April 1989
|
| Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine
|
scientific article published on 01 December 1985
|
| Pneumococcal vaccine efficacy in selected populations in the United States
|
scientific article published on 01 January 1986
|
| Pneumococcal vaccine and patients with chronic lung disease
|
scientific article published on 01 January 1986
|
| Trachoma vaccine studies in monkeys
|
scientific article published on 01 May 1967
|
| Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men
|
scientific article published on 01 July 1986
|
| Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic
|
scientific article published on 01 February 1985
|
| Biodegradable microspheres as a vaccine delivery system
|
scientific article published on 01 March 1991
|
| Evaluation of a combined rotavirus and enterotoxigenic Escherichia coli vaccine in cattle
|
scientific article published on 01 July 1986
|
| Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation
|
scientific article published on 01 January 1980
|
| Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
|
scientific article published on 01 March 1987
|
| A single vaccine for the control of capripox infection in sheep and goats
|
scientific article published on 01 January 1987
|
| Field Trials with a Bivalent Vaccine (HVT and SB-1) against Marek's Disease
|
scientific article published on 01 July 1983
|
| Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge
|
scientific article published on 01 December 1983
|
| Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus
|
scientific article published on 01 November 1988
|
| Live attenuated varicella vaccine. Efficacy for children with leukemia in remission
|
scientific article published on July 20, 1984
|
| The newly licensed hepatitis B vaccine. Characteristics and indications for use
|
scientific article published on 01 April 1982
|
| Vaccine for Enterotoxigenic Escherichia coli Based on Synthetic Heat-Stable Toxin Crossed-Linked to the B Subunit of Heat-Labile Toxin
|
scientific article published on 01 February 1983
|
| Summary of Clinical Trials of Inactivated Influenza Vaccine--1978
|
scientific article published on 01 July 1983
|
| Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children
|
scientific article published on 01 December 1986
|
| A Reassessment of Pneumococcal Vaccine
|
scientific article published on 01 March 1984
|
| Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen
|
scientific article published on 01 May 1982
|
| Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response
|
scientific article published on 01 May 1984
|
| Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development
|
scientific article published on 01 October 1987
|
| Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati)
|
scientific article published on 01 July 1984
|
| Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa
|
scientific article published on 01 August 1983
|
| Previous hospital care as a risk factor for pneumonia. Implications for immunization with pneumococcal vaccine
|
scientific article published on 01 October 1982
|
| Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates
|
scientific article published on 01 January 1993
|
| Safety and immunogenicity of hepatitis A vaccine in healthy children
|
scientific article published on 01 May 1993
|
| Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs
|
scientific article published on 01 June 1984
|
| Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two
|
scientific article published on 01 August 1993
|
| Adult immunization with acellular pertussis vaccine
|
scientific article published on 01 January 1993
|
| The Development of a Vaccine against Avian Infectious Laryngotracheitis IV. Immunization of Chickens with a Modified Laryngotracheitis Vaccine in the Drinking Water
|
scientific article published on 01 April 1971
|
| Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model
|
scientific article published on 01 January 1993
|
| Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine
|
scientific article published on 01 April 1993
|
| Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin
|
scientific article published on 01 April 1993
|
| Monoclonal idiotope vaccine against Streptococcus pneumoniae infection
|
scientific article published on 01 December 1984
|
| Candidate recombinant vaccine for human B19 parvovirus
|
scientific article published on 01 May 1993
|
| Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure
|
scientific article published on 01 December 1984
|
| Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine
|
scientific article published on June 25, 1981
|
| Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group
|
scientific article published on 01 January 1996
|
| Measles immunization some factors affecting non-acceptance of vaccine
|
scientific article published on 01 July 1981
|
| Protection against papillomavirus with a polynucleotide vaccine
|
scientific article published on 01 February 1996
|
| Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly
|
scientific article published on 01 February 1996
|
| Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential
|
scientific article published on 01 September 1995
|
| The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices
|
scientific article published on 01 April 1996
|
| Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults
|
scientific article published on 01 April 1996
|
| Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults
|
scientific article published on 01 July 1984
|
| Pneumococcal vaccine in normal children. Primary and secondary vaccination
|
scientific article published on 01 September 1983
|
| Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine
|
scientific article published on 01 February 1971
|
| Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants
|
scientific article published on 01 May 1996
|
| A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma
|
scientific article published on 01 June 1996
|
| Gene composition of high-yielding influenza vaccine strains obtained by recombination
|
scientific article published on 01 March 1980
|
| Increased response of asthmatic subjects to methacholine after influenza vaccine
|
scientific article published on 01 November 1965
|
| Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis
|
scientific article published on 01 November 1965
|
| Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
|
scientific article published on 01 July 1996
|
| Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group
|
scientific article published on 01 August 1996
|
| Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers
|
scientific article published on 01 February 1967
|
| Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine
|
scientific article published on 01 February 1996
|
| Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
|
scientific article published on 01 March 1996
|
| Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection
|
scientific article published on 01 December 1982
|
| Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group
|
scientific article published on 01 June 1996
|
| The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations
|
scientific article published on 01 September 1996
|
| Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease
|
scientific article published on 01 June 1995
|
| Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma
|
scientific article published on 01 July 1996
|
| Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants
|
scientific article published on 01 February 1996
|
| Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells
|
scientific article published on 01 January 1994
|
| The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men
|
scientific article published on 01 September 1982
|
| Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation
|
scientific article published on 01 October 1982
|
| The varicella vaccine. Vaccine development
|
scientific article published on 01 September 1996
|
| Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants
|
scientific article published on 01 August 1996
|
| Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
|
scientific article published on 01 July 1996
|
| Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
|
scientific article published on 01 July 1996
|
| Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care
|
scientific article published on 01 October 1995
|
| Lectin-bearing polymerized liposomes as potential oral vaccine carriers
|
scientific article published on 01 September 1996
|
| Efficacy of high-titer live attenuated varicella vaccine in healthy young children
|
scientific article published on 01 November 1996
|
| Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1
|
scientific article published on 01 October 1995
|
| Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus
|
scientific article published on 01 September 1995
|
| Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine
|
scientific article published on 01 June 1983
|
| A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours
|
scientific article published on 01 May 1995
|
| Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
|
scientific article published on 01 December 1996
|
| Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants
|
scientific article published on 01 December 1996
|
| Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine
|
scientific article published on 01 December 1996
|
| The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams
|
scientific article published on 01 February 1995
|
| Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG
|
scientific article published on 01 February 1995
|
| Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure
|
scientific article published on 01 January 1997
|
| Vaccination against measles: clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Second report to the medical research council by the measles vaccines committee
|
scientific article published on 01 May 1968
|
| Studies on the development of a live vaccine against rhinopneumonitis (mare abortion) of horses
|
scientific article published on 01 April 1968
|
| Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine
|
scientific article published on 01 September 1980
|
| A second-generation vaccine protects against the psychoactive effects of cocaine
|
scholarly article
|
| Vaccinations in patients with immune-mediated inflammatory diseases
|
scientific article
|
| Anthrax spores make an essential contribution to vaccine efficacy
|
scientific article
|
| Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine
|
scientific article
|
| Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus
|
scientific article
|
| Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
|
scientific article
|
| Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously
|
scientific article
|
| Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults
|
scientific article
|
| Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine
|
scientific article
|
| Immunogenicity of a 26-valent group A streptococcal vaccine.
|
scientific article
|
| Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine
|
scientific article
|
| A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice
|
scientific article
|
| In vivo mechanisms of vaccine-induced protection against HPV infection
|
scientific article
|
| Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis.
|
scientific article
|
| Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?
|
scientific article
|
| A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
|
scientific article
|
| Prevalence of high-risk indications for influenza vaccine varies by age, race, and income
|
scientific article
|
| Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
|
scientific article
|
| Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis
|
scientific article
|
| High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion
|
scientific article
|
| Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
|
scientific article
|
| Global use of Haemophilus influenzae type b conjugate vaccine
|
scientific article
|
| AIDS/HIV. A boost for HIV vaccine design
|
scientific article
|
| Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans
|
scientific article
|
| Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine
|
scientific article
|
| Developing a nontypeable Haemophilus influenzae (NTHi) vaccine
|
scientific article
|
| Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology
|
scientific article
|
| Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany
|
scientific article
|
| Diversity considerations in HIV-1 vaccine selection
|
scientific article
|
| Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development
|
scientific article published on November 1, 1976
|
| The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise
|
scientific article
|
| Herpes simplex viruses: is a vaccine tenable?
|
scientific article
|
| Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes
|
scientific article
|
| Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study
|
scientific article
|
| Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
|
scientific article
|
| Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
|
scientific article
|
| Capsular polysaccharides as vaccine candidates
|
scientific article
|
| Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine.
|
scientific article
|
| Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer
|
scientific article
|
| Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
|
scientific article
|
| Review of dengue virus and the development of a vaccine
|
scientific article
|
| Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults
|
scientific article
|
| Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine
|
scientific article published on 13 December 2010
|
| Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.
|
scientific article
|
| Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine
|
scientific article
|
| Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults
|
scientific article
|
| Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs
|
scientific article
|
| Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine
|
scientific article
|
| Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design
|
scientific article
|
| Immunoglobulin-binding proteins in ticks: new target for vaccine development against a blood-feeding parasite.
|
scientific article
|
| Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
|
scientific article
|
| Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN
|
scientific article
|
| A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses
|
scientific article
|
| Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
|
scientific article
|
| Targeting regulatory T cells to improve vaccine immunogenicity in early life
|
scientific article
|
| The Good Behavior Game: a best practice candidate as a universal behavioral vaccine
|
scientific article
|
| Epidemiology of vaccine hesitancy in the United States
|
scientific article
|
| Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives
|
scientific article
|
| V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Tria
|
scientific article
|
| Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus
|
scientific article
|
| Tuberculosis vaccine development: recent progress
|
scientific article
|
| CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection
|
scientific article
|
| Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.
|
scientific article
|
| Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi
|
scientific article
|
| Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein
|
scientific article
|
| Alphavirus vectors: applications for DNA vaccine production and gene expression
|
scientific article
|
| Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis
|
scientific article
|
| Vaccine herd effect
|
scientific article
|
| The RTS,S vaccine candidate for malaria
|
scientific article
|
| Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
|
scientific article
|
| gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
|
scientific article
|
| A prophylactic hepatitis B vaccine with a novel adjuvant system
|
scientific article
|
| Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic
|
scientific article
|
| Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine
|
scientific article
|
| Addressing the vaccine confidence gap.
|
scientific article
|
| Field evaluation of vaccine efficacy
|
scientific article
|
| Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic
|
scientific article
|
| Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands
|
scientific article
|
| Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
|
scientific article
|
| Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen
|
scientific article
|
| Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children
|
scientific article
|
| Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge
|
scientific article
|
| A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine
|
scientific article
|
| Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
|
scientific article
|
| Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees
|
scientific article
|
| Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza
|
scientific article
|
| Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries
|
scientific article
|
| Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
|
scientific article
|
| Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2.
|
scientific article
|
| Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
|
scientific article published on September 29, 1977
|
| Shigella isolates from the global enteric multicenter study inform vaccine development
|
scientific article
|
| Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
|
scientific article
|
| Live vaccine used to prevent the spread of varicella in children in hospital
|
scientific article published in November 1974
|
| Vaccine-associated feline sarcomas
|
scientific article
|
| Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
|
scientific article
|
| Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants
|
scientific article
|
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
|
scientific article
|
| Medicine. The need for a global HIV vaccine enterprise
|
scientific article
|
| Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
|
scientific article
|
| Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies
|
scientific article
|
| Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial
|
scientific article published in July 1999
|
| Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity
|
scientific article published in February 1999
|
| Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons
|
scientific article published in January 1999
|
| Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
|
scientific article published in December 1998
|
| Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
scientific article published in June 2013
|
| Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants
|
scientific article published in December 1997
|
| Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts
|
scientific article published in October 1997
|
| Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
|
scientific article published in October 1996
|
| Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus
|
scientific article published in January 1997
|
| Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.
|
scientific article published in September 1996
|
| The immunogenicity of influenza virus vaccine in solid organ transplant recipients
|
scientific article published in February 1996
|
| Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev
|
scientific article published in February 1996
|
| Experimental quantification of vaccine-induced reduction in virus transmission
|
scientific article published in June 1994
|
| Attenuated varicella virus vaccine in children with renal transplants
|
scientific article published in April 1994
|
| A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]
|
scientific article
|
| Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine
|
scientific article
|
| A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children
|
scientific article
|
| Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus
|
scientific article
|
| The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine
|
scientific article
|
| Live attenuated varicella virus vaccine. Efficacy trial in healthy children
|
scientific article published in May 1984
|
| Reactions to Live-Measles-Virus Vaccine in Children Previously Inoculated with Killed-Virus Vaccine
|
scientific article published in August 1967
|
| Correlated Studies of a Recombinant Influenza-Virus Vaccine. I. Derivation and Characterization of Virus and Vaccine
|
scientific article published on November 1, 1971
|
| Respiratory and systemic cellular and humoral immune responses to influenza virus vaccine administered parenterally or by nose drops
|
scientific article published on February 1, 1972
|
| Immunologic response, virus excretion, and joint reactions with rubella vaccine. A study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5).
|
scientific article published in January 1971
|
| Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population
|
scientific article published in April 1969
|
| Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine
|
scientific article published in April 1969
|
| Impact of wastage on single and multi-dose vaccine vials: Implications for introducing pneumococcal vaccines in developing countries
|
scientific article
|
| Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
|
scientific article
|
| Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine
|
scientific article
|
| Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission
|
scientific article
|
| Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit
|
scientific article
|
| In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
|
scientific article
|
| Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results
|
scientific article published on 19 July 2011
|
| Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial
|
scientific article published in April 1991
|
| Vaccine-induced escape mutant of hepatitis B virus
|
scientific article published in August 1990
|
| Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens
|
scientific article published on May 1, 1991
|
| Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine
|
scientific article published on July 15, 1992
|
| Duration of humoral immunity to common viral and vaccine antigens
|
scientific article published in November 2007
|
| A plant-based multicomponent vaccine protects mice from enteric diseases
|
scientific article
|
| Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation
|
scientific article
|
| Immunization of Pregnant Women with Influenza A/New Jersey/76 Virus Vaccine: Reactogenicity and Immunogenicity in Mother and Infant
|
scientific article published on August 1, 1979
|
| Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC).
|
scientific article published on 15 June 2010
|
| Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.
|
scientific article published in February 2013
|
| Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates.
|
scientific article published on 22 April 2010
|
| Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.
|
scientific article
|
| Validity and reliability of a survey to identify vaccine-hesitant parents.
|
scientific article
|
| Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.
|
scientific article
|
| Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.
|
scientific article published on 30 June 2006
|
| Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.
|
scientific article
|
| What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine.
|
scientific article
|
| Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis.
|
scientific article
|
| Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
|
scientific article
|
| Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
|
scientific article published on 22 March 2011
|
| Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage.
|
scientific article published on 18 June 2012
|
| The influence of vaccine-critical websites on perceiving vaccination risks.
|
scientific article published in April 2010
|
| Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease
|
scientific article
|
| Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study
|
scientific article published on 22 November 2011
|
| Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells
|
scientific article published in March 2009
|
| Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity
|
scientific article published on 8 December 2009
|
| Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge
|
scientific article published in May 1989
|
| Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
|
scientific article published on 19 November 2003
|
| Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants
|
scientific article published in April 1987
|
| Mechanism of action of licensed vaccine adjuvants
|
scientific article published on 5 February 2009
|
| Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle.
|
scientific article published in March 2004
|
| Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects
|
scientific article
|
| A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection
|
scientific article
|
| Interpretation and estimation of vaccine efficacy under heterogeneity
|
scientific article published on August 1, 1992
|
| Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
|
scientific article published on 9 September 2008
|
| Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study
|
scientific article published on 23 July 2014
|
| Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
|
scientific article
|
| Parental decision making about the HPV vaccine
|
scientific article
|
| Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine
|
scientific article published in December 2008
|
| Vaccine responses in newborns
|
scientific article
|
| Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
|
scientific article
|
| Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants
|
scientific article published in February 2011
|
| Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
|
scientific article published in June 2004
|
| Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen
|
scientific article published in April 2008
|
| Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea
|
scientific article
|
| Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
|
scientific article
|
| HPV vaccine against anal HPV infection and anal intraepithelial neoplasia
|
scientific article
|
| A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant
|
scientific article published in April 2005
|
| Assessing the effect of an influenza vaccine in an encouragement design
|
scientific article published in March 2000
|
| Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies
|
scientific article published on 21 October 2011
|
| HIV vaccine design and the neutralizing antibody problem
|
scientific article published in March 2004
|
| Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis
|
scientific article published on 3 December 2008
|
| Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein
|
scientific article published in June 2005
|
| Oral immunization of broiler chickens against necrotic enteritis with an attenuated Salmonella vaccine vector expressing Clostridium perfringens antigens
|
scientific article published on 17 June 2008
|
| A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal
|
scientific article published in October 1997
|
| BCG vaccine. WHO position paper
|
scientific article published in January 2004
|
| Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children
|
scientific article published in March 1997
|
| Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals
|
scientific article published in September 2010
|
| Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States
|
scientific article published on 29 August 2009
|
| Impact of the pneumococcal conjugate vaccine on otitis media
|
scientific article published in January 2003
|
| Engineering poliovirus as a vaccine vector for the expression of diverse antigens
|
scientific article published in September 1994
|
| Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|
scientific article published in December 2001
|
| Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy
|
scientific article published in August 2005
|
| Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose
|
scientific article published in July 2005
|
| Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study
|
scientific article published on 20 July 2012
|
| TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).
|
scientific article published on 18 July 2005
|
| Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
|
scientific article published in October 2009
|
| Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups
|
scientific article published on December 1, 1983
|
| The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
|
scientific article
|
| Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
|
scientific article published on June 2007
|
| Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
|
scientific article published on March 2013
|
| Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial
|
scientific article published on 6 April 2011
|
| Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
|
scientific article published on 25 November 2010
|
| A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
|
scientific article published on 27 October 2010
|
| Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep
|
scientific article published on 12 May 2010
|
| Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.
|
scientific article published on 23 September 2005
|
| The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
|
scientific article
|
| Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
|
scientific article published on September 2008
|
| Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.
|
scientific article published on 4 December 2006
|
| Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine.
|
scientific article published on 2 October 2006
|
| Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
|
scientific article
|
| Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
|
scientific article
|
| The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.
|
scientific article
|
| Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
|
scientific article
|
| Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
|
scientific article
|
| Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice
|
scientific article
|
| Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine
|
scientific article
|
| A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
|
scientific article published on May 2005
|
| Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
|
scientific article published on April 2005
|
| A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
|
scientific article published on April 2004
|
| Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants
|
scientific article published on August 2004
|
| Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants
|
scientific article published on July 2004
|
| Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.
|
scientific article published on June 2004
|
| Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage
|
scientific article published on 11 September 2015
|
| External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing
|
scientific article published on June 2004
|
| Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti
|
scientific article published on 3 October 2003
|
| Clinical responses to undiluted and diluted smallpox vaccine
|
scientific article published on 28 March 2002
|
| Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
|
scientific article published on April 1997
|
| A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
|
scientific article published on February 1996
|
| Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
|
scientific article published on May 2016
|
| A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
|
scientific article published on 4 November 2002
|
| Control of meningococcal meningitis with meningococcal vaccines
|
scientific article published on July 1, 1975
|
| Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group
|
scientific article published on September 1993
|
| Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.
|
scientific article published on 31 March 2010
|
| Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine
|
scientific article published on May 1, 1975
|
| An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
|
scientific article published on April 1969
|
| Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine
|
scientific article published on May 1998
|
| Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States
|
scientific article published on 14 November 2015
|
| Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine
|
scientific article published on January 1, 1991
|
| Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices
|
scientific article published on March 2015
|
| Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
|
scientific article published on 10 June 2015
|
| Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
|
scientific article published on 20 March 2015
|
| Epidemiology of pneumococcal carriage in children under five years of age in Accra, Ghana
|
scholarly article
|
| A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague
|
scientific article published on September 2004
|
| A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model
|
scientific article published on November 1995
|
| Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001
|
scholarly article by Joseph J Sacco et al published 2 April 2016 in Human Vaccines & Immunotherapeutics
|
| Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
|
scientific article published on February 1991
|
| Paralysis after oral poliomyelitis vaccine.
|
scientific article published on October 1962
|
| Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
|
scientific article published on 2 April 2015
|
| gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
|
scientific article published on 14 January 2008
|
| Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines
|
scientific article published on September 1969
|
| Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge
|
scientific article published on August 2005
|
| Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults
|
scientific article published on 28 April 2015
|
| Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
|
scientific article
|
| Modeling the dynamics of oral poliovirus vaccine cessation
|
scientific article
|
| Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.
|
scientific article
|
| A formalin-inactivated whole SIV vaccine confers protection in macaques
|
scientific article
|
| Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study
|
scientific article published on August 2014
|
| Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study
|
scientific article published on 18 July 2014
|
| Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial
|
scientific article published on 10 July 2014
|
| Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites
|
scientific article published on 18 June 2014
|
| Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany
|
scientific article published on 10 June 2014
|
| A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice
|
scientific article published on 17 June 2014
|
| Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand
|
scientific article published on 5 June 2014
|
| Use of Vibrio cholerae vaccine in an outbreak in Guinea
|
scientific article published on May 2014
|
| Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance
|
scientific article published on 30 March 2014
|
| A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses
|
scientific article published on 18 March 2014
|
| WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 20
|
scientific article published on 28 February 2014
|
| Maternal influenza vaccine and risks for preterm or small for gestational age birth
|
scientific article published on 26 February 2014
|
| Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China
|
scientific article published on February 2014
|
| Ending AIDS--is an HIV vaccine necessary?
|
scientific article published on February 2014
|
| Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants
|
scientific article published on 25 December 2013
|
| Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial
|
scientific article published on 28 January 2014
|
| Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
|
scientific article published on November 12, 1983
|
| Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine
|
scientific article published on 19 January 2014
|
| Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
|
scientific article published on 29 October 2013
|
| Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy
|
scientific article published on July 1, 1984
|
| Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match
|
scientific article published on 8 November 2013
|
| The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting.
|
scientific article published on 7 October 2013
|
| Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study
|
scientific article published on October 2013
|
| Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months
|
scientific article published on 16 December 2013
|
| A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain
|
scientific article published on 19 November 2013
|
| Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine
|
scientific article published on September 2013
|
| Live attenuated influenza vaccine, but not pneumococcal conjugate vaccine, protects against increased density and duration of pneumococcal carriage after influenza infection in pneumococcal colonized mice.
|
scientific article published on 11 July 2013
|
| Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial
|
scientific article published on November 2013
|
| Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults
|
scientific article published on 13 June 2013
|
| Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques
|
scientific article published on 19 October 2013
|
| Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies
|
scientific article published on 15 May 2013
|
| A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity
|
scientific article published on October 2013
|
| The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials
|
scientific article published on 12 September 2013
|
| Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine
|
scientific article published on March 2013
|
| Radiation therapy to convert the tumor into an in situ vaccine
|
scientific article published on November 2012
|
| Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
|
scientific article published on 7 September 2013
|
| Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort
|
scientific article published on 13 March 2013
|
| H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus
|
scientific article published on 26 August 2013
|
| Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis
|
scientific article published on 9 January 2013
|
| Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
|
scientific article published on 20 December 2012
|
| Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity
|
scientific article
|
| Genetic basis for variation of vaccine response: our studies with rubella vaccine
|
scientific article
|
| Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants
|
scientific article
|
| Antibacterial vaccine design using genomics and proteomics
|
scientific article
|
| Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults
|
scientific article
|
| Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial
|
scientific article
|
| Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep
|
scientific article
|
| Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys.
|
scientific article
|
| A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.
|
scientific article
|
| Efficacy of a canarypox virus-vectored vaccine against feline leukaemia
|
scientific article
|
| Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine
|
scientific article published on February 19, 1970
|
| Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant
|
scientific article
|
| Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
|
scientific article
|
| Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag
|
scientific article
|
| Evolutionary game theory and social learning can determine how vaccine scares unfold
|
scientific article
|
| Ebola virus: from discovery to vaccine
|
scientific article
|
| In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles
|
scientific article
|
| Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
|
scientific article
|
| Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
|
scientific article
|
| Scaffolding to build a rational vaccine design strategy
|
scientific article
|
| The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
|
scientific article
|
| Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative
|
scientific article
|
| Development of a pertussis component vaccine in Japan
|
scientific article published on January 21, 1984
|
| New insights for development of a safe and protective RSV vaccine
|
scientific article
|
| Network-based analysis of vaccine-related associations reveals consistent knowledge with the vaccine ontology.
|
scientific article
|
| Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.
|
scientific article
|
| Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide
|
scientific article
|
| Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
|
scientific article
|
| Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis
|
scientific article
|
| In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response
|
scientific article
|
| A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts
|
scientific article
|
| Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening
|
scientific article
|
| Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus
|
scientific article
|
| Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein
|
scientific article
|
| Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuatedPlasmodium falciparumsporozoite vaccine
|
scientific article published on November 1, 2003
|
| Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).
|
scientific article
|
| Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen
|
scientific article
|
| Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children
|
scientific article
|
| The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens
|
scientific article
|
| B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
|
scientific article
|
| Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries
|
scientific article
|
| DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation
|
scientific article
|
| Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles
|
scientific article
|
| Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine
|
scientific article
|
| Influenza vaccine--outmaneuvering antigenic shift and drift
|
scientific article
|
| Public health. A sound rationale needed for phase III HIV-1 vaccine trials
|
scientific article
|
| Coxsackievirus A16: epidemiology, diagnosis, and vaccine
|
scientific article
|
| A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge
|
scientific article
|
| MMR vaccine and autism: an update of the scientific evidence
|
scientific article
|
| WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 201
|
scientific article
|
| A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys
|
scientific article
|
| Stool microbiota and vaccine responses of infants
|
scientific article
|
| The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials
|
scientific article
|
| Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine
|
scientific article
|
| Vaccine protection against simian immunodeficiency virus infection
|
scientific article
|
| Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
|
scientific article
|
| Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
|
scientific article
|
| Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice
|
scientific article
|
| Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus
|
scientific article
|
| Immune modulation by helminth parasites of ruminants: implications for vaccine development and host immune competence
|
scientific article
|
| The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.
|
scientific article
|
| Development of Toxoplasma gondii vaccine: A global challenge
|
scientific article
|
| Lassa fever vaccine
|
scientific article
|
| GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis
|
scientific article
|
| Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|
scientific article
|
| Computer aided selection of candidate vaccine antigens
|
scientific article
|
| Identification of a universal Group B streptococcus vaccine by multiple genome screen
|
scientific article
|
| Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs
|
scientific article
|
| Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study
|
scientific article
|
| Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes
|
scientific article
|
| The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over
|
scientific article
|
| A Caries Vaccine? The state of the science of immunization against dental caries
|
scientific article
|
| A "universal" human influenza A vaccine
|
scientific article
|
| Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design
|
scientific article
|
| From genome to vaccine: in silico predictions, ex vivo verification.
|
scientific article
|
| Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.
|
scientific article
|
| Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells
|
scientific article
|
| Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
|
scientific article
|
| Progress on new vaccine strategies for the immunotherapy and prevention of cancer
|
scientific article
|
| Exploiting M cells for drug and vaccine delivery
|
scientific article
|
| A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine
|
scientific article
|
| Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories
|
scientific article
|
| Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen
|
scientific article
|
| Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product
|
scientific article
|
| Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population
|
scientific article
|
| Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine
|
scientific article
|
| Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory
|
scientific article
|
| HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future
|
scientific article
|
| Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
|
scientific article
|
| A vaccine against coccidioidomycosis is justified and attainable
|
scientific article
|
| Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication
|
scientific article
|
| Forecasting the economic value of an Enterovirus 71 (EV71) vaccine
|
scientific article
|
| Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine
|
scientific article
|
| Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.
|
scientific article
|
| Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities
|
scientific article
|
| Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee
|
scientific article
|
| Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
|
scientific article
|
| Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.
|
scientific article
|
| Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness
|
scientific article
|
| Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial
|
scientific article
|
| Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine
|
scientific article published on 01 April 1994
|
| Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States
|
scientific article published on 01 October 1980
|
| Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype
|
scientific article published on 01 April 1995
|
| Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine
|
scientific article published on 01 May 1994
|
| Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine
|
scientific article published on 01 September 1994
|
| Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases
|
scientific article published on 01 May 1995
|
| Genetically determined differences in the response of alpha1-antitrypsin levels in human serum to typhoid vaccine
|
scientific article published on 01 January 1968
|
| Exploring transgenic plants as a new vaccine source
|
scientific article published on 01 May 1995
|
| Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis
|
scientific article published on 01 September 1993
|
| Brucella melitensis Rev-1 vaccine as a cause of human brucellosis
|
scientific article published on 01 September 1993
|
| Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine
|
scientific article published on 01 May 1995
|
| Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
|
scientific article published on 01 June 1995
|
| An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation
|
scientific article published on 01 March 1995
|
| Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine
|
scientific article published on 01 March 1995
|
| The impact of conjugate vaccine on carriage of Haemophilus influenzae type b
|
scientific article published on 01 January 1995
|
| Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine
|
scientific article published on 01 August 1969
|
| Pneumococcal vaccine and otitis media
|
scientific article published on 01 September 1980
|
| Hepatitis B vaccine: immune responses in haemodialysis patients
|
scientific article published on 01 December 1980
|
| Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)
|
scientific article published on 01 February 1981
|
| Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff
|
scientific article published on 01 February 1981
|
| Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine
|
scientific article published on April 11, 1981
|
| Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine
|
scientific article published on 01 June 1994
|
| Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine
|
scientific article published on 01 April 1969
|
| Immune response in neonates to hepatitis B vaccine
|
scientific article published on 01 January 1982
|
| Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine
|
scientific article published on 01 January 1969
|
| HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals
|
scientific article published on 01 November 1994
|
| Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy
|
scientific article published on 01 August 1982
|
| Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously
|
scientific article published on 01 November 1994
|
| Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine
|
scientific article published on 01 November 1993
|
| Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial
|
scientific article published on 01 December 1983
|
| Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants
|
scientific article published on 01 March 1984
|
| Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine
|
scientific article published on 01 November 1993
|
| Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study
|
scientific article published on 01 April 1984
|
| Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine
|
scientific article published on 01 May 1984
|
| Fatal post-splenectomy sepsis despite prophylaxis with penicillin and pneumococcal vaccine
|
scientific article published on 01 May 1984
|
| Symptoms after primary immunisation with DTP and with DT vaccine
|
scientific article published on 01 July 1984
|
| Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides
|
scientific article published on July 28, 1984
|
| A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants
|
scientific article published on 01 March 1995
|
| A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess
|
scientific article published on 01 March 1995
|
| Jitters jeopardize AIDS vaccine trials
|
scientific article published on 01 November 1993
|
| Clinical evaluation of a recombinant hepatitis B vaccine
|
scientific article published on November 24, 1984
|
| Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin
|
scientific article published on 01 December 1994
|
| A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine
|
scientific article published on 01 November 1994
|
| Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence
|
scientific article published on 01 December 1994
|
| Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production
|
scientific article published on 01 December 1981
|
| Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials
|
scientific article published on 01 December 1993
|
| Immunogenicity of new virosome influenza vaccine in elderly people
|
scientific article published on 01 July 1994
|
| Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains
|
scientific article published on 01 October 1993
|
| Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants
|
scientific article published on 01 February 1994
|
| Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNA
|
scientific article published on 01 June 1984
|
| Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy
|
scientific article published on 01 August 1984
|
| Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs
|
scientific article published on 01 August 1994
|
| Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants
|
scientific article published on 01 September 1993
|
| Construction of genetically marked Vibrio cholerae O1 vaccine strains
|
scientific article published on 01 July 1993
|
| A new vaccine for Babesia argentina infection prepared in splenectomised calves
|
scientific article published on 01 December 1966
|
| [Evolution of anti-rota virus antibodies in the milk of cows treated in the last month of pregnancy either by adjuvated rotavirus vaccine or by the adjuvant fraction of the vaccine (author's transl)]
|
scientific article published on 01 January 1981
|
| Progress toward a live, attenuated human hepatitis A vaccine
|
scientific article published on 01 May 1982
|
| Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|
scientific article published on 01 January 1993
|
| Enhancement of DNA vaccine potency by electroporation in vivo
|
scientific article published on 01 September 2000
|
| Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella
|
scientific article published on 01 August 1999
|
| Over a decade of experience with a yeast recombinant hepatitis B vaccine
|
scientific article published on 01 August 1999
|
| Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children
|
scientific article published on 01 August 1999
|
| Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers
|
scientific article published on 01 August 1999
|
| IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii
|
scientific article published on 01 October 1999
|
| Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|
scientific article published on 01 January 1997
|
| Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice
|
scientific article published on 01 March 2003
|
| Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine
|
scientific article published on 01 January 1997
|
| The altered reactivity of mice after immunization with Hemophilus pertussis vaccine
|
scientific article published on 01 April 1953
|
| Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2
|
scientific article published on 01 February 1997
|
| An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine
|
scientific article published on 01 January 2000
|
| Plant-derived vaccine protects target animals against a viral disease
|
scientific article published on 01 March 1997
|
| HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb
|
scientific article published on 01 March 2003
|
| Edmonston-Zagreb measles vaccine: A good vaccine with an image problem
|
scientific article published on 01 November 1999
|
| The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine
|
scientific article published on 01 February 1997
|
| Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?
|
scientific article published on 01 March 2003
|
| Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression
|
scientific article published on 01 December 1999
|
| Withdrawal of rotavirus vaccine recommendation
|
scientific article published on 01 November 1999
|
| A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine
|
scientific article published on 01 October 1999
|
| Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B
|
scientific article published on 01 December 1999
|
| Transcutaneous immunization: a human vaccine delivery strategy using a patch
|
scientific article published on 01 December 2000
|
| Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert
|
scientific article published on 01 January 2000
|
| Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax
|
scientific article published on 01 December 1999
|
| A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord
|
scientific article published on 01 November 1999
|
| Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus
|
scientific article published on 01 November 2000
|
| Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults
|
scientific article published on 01 November 2000
|
| An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults
|
scientific article published on 01 January 2000
|
| Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein
|
scientific article published on 30 April 2003
|
| Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis
|
scientific article published on 01 May 2003
|
| Is it time to give influenza vaccine to healthy infants?
|
scientific article published on 01 January 2000
|
| Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
|
scientific article published on 01 June 2003
|
| Vaccine protocols to optimise the protective efficacy of BCG
|
scientific article published on 01 January 1999
|
| Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse
|
scientific article published on 01 February 2001
|
| Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
|
scientific article published on 01 February 2000
|
| Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates
|
scientific article published on 01 February 1997
|
| An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
|
scientific article published on 01 February 2000
|
| Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses
|
scientific article published on 01 March 2000
|
| Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control
|
scientific article published on 01 March 2000
|
| Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers
|
scientific article published on 01 June 2003
|
| Attitudes about human papillomavirus vaccine in young women
|
scientific article published on 01 May 2003
|
| Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
|
scientific article published on 01 February 2000
|
| Biologic and Biophysical Markers of a Live Varicella Vaccine Strain (Oka): Identification of Clinical Isolates from Vaccine Recipients
|
scientific article published on June 1, 1984
|
| Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
|
scientific article published in September 2013
|
| Catecholate receptor proteins in Salmonella enterica: role in virulence and implications for vaccine development.
|
scientific article
|
| Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.
|
scientific article
|
| Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
|
scientific article
|
| Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.
|
scientific article
|
| Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
|
scientific article
|
| Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the Southeastern United States.
|
scientific article
|
| Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate.
|
scientific article
|
| Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
|
scientific article published in November 2000
|
| Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
|
scientific article published in March 2000
|
| Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys.
|
scientific article
|
| Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
|
scientific article
|
| Public engagement with science? Local understandings of a vaccine trial in the Gambia.
|
scientific article
|
| A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
|
scientific article published in July 2005
|
| The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination.
|
scientific article
|
| Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.
|
scientific article
|
| Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
|
scientific article published on 17 August 2013
|
| Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
|
scientific article published on 28 November 2005
|
| Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
|
scientific article published on 7 December 2005
|
| The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
|
scientific article published on 25 September 2010
|
| Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
|
scientific article published in January 1997
|
| Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.
|
scientific article published in October 2007
|
| Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians.
|
scientific article published in November 2004
|
| A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents.
|
scientific article published on 8 February 2006
|
| Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
|
scientific article published in September 2000
|
| Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.
|
scientific article published on 9 February 2006
|
| HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.
|
scientific article published in February 2006
|
| Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
|
scientific article published on 6 December 2008
|
| The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.
|
scientific article published on 7 April 2005
|
| A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
|
scientific article published on 27 December 2005
|
| The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study.
|
scientific article published in April 2004
|
| Developments in the formulation and delivery of spray dried vaccines.
|
scientific article published on 19 September 2017
|
| Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.
|
scientific article published on 17 November 2017
|
| Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
|
scientific article published on 6 November 2017
|
| Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.
|
scientific article published on 31 October 2017
|
| Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection.
|
scientific article published on 5 April 2009
|
| A survey of UK parental attitudes to the MMR vaccine and trust in medical authority.
|
scientific article
|
| Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes.
|
scientific article published in September 2008
|
| Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine.
|
scientific article published in July 2004
|
| Enhancement of DNA vaccine potency in rhesus macaques by electroporation.
|
scientific article published in June 2004
|
| College women's HPV vaccine decision narratives.
|
scientific article published on 14 September 2010
|
| Finding a new vaccine in the ricin protein fold.
|
scientific article published in April 2004
|
| Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.
|
scientific article published in June 2004
|
| Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia
|
scientific article published on December 8, 2003
|
| Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group.
|
scientific article published in June 2004
|
| Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
|
scientific article published in May 2004
|
| Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.
|
scientific article published in July 2004
|
| The Global Fight to Develop Antipoverty Vaccines in the Antivax Era.
|
scientific article published on 2 February 2018
|
| Outside in - inside out. Creating focus on the patient - a vaccine company perspective.
|
scientific article published on 17 January 2018
|
| Moving ahead an HIV vaccine: to neutralize or not, a key HIV vaccine question.
|
scientific article published on 11 October 2011
|
| Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
|
scientific article published in June 2004
|
| Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.
|
scientific article published in June 2004
|
| Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati
|
scientific article published in June 2004
|
| Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
|
scientific article published in June 2009
|
| Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine.
|
scientific article
|
| Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.
|
scientific article
|
| Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
|
scientific article
|
| A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.
|
scientific article
|
| From empiricism to rational design: a personal perspective of the evolution of vaccine development.
|
scientific article
|
| Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
|
scientific article published in May 2004
|
| Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro.
|
scientific article published in May 2004
|
| Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
|
scientific article
|
| Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.
|
scientific article
|
| Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.
|
scientific article published in May 2004
|
| Response to hepatitis B vaccine: multiple HLA genes are involved.
|
scientific article published in June 1998
|
| Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
|
scientific article published on 16 April 2009
|
| Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA.
|
scientific article
|
| Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
|
scientific article published in June 2003
|
| Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
|
scientific article published on 27 May 2009
|
| Delivery of epitopes by the Salmonella type III secretion system for vaccine development.
|
scientific article published in July 1998
|
| A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.
|
scientific article
|
| A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major.
|
scientific article
|
| Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
|
scientific article
|
| Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter.
|
scientific article published in March 2004
|
| Immunogenicity of the pentavalent rotavirus vaccine in African infants
|
research work
|
| A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.
|
scientific article published on 30 May 2007
|
| Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation.
|
scientific article published on 2 February 2007
|
| Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.
|
scientific article
|
| Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.
|
scientific article
|
| Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.
|
scientific article
|
| Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.
|
scientific article published in August 1999
|
| Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens.
|
scientific article published in August 1999
|
| Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
|
scientific article published in January 2000
|
| Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
|
scientific article published on 14 January 2008
|
| Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles.
|
scientific article published in October 2000
|
| Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.
|
scientific article published on 24 January 2001
|
| New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
|
scientific article published on 18 September 2008
|
| Rationale for development of a synthetic vaccine against plasmodium falciparum malaria
|
research work
|
| A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
|
scientific article published in March 1988
|
| The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.
|
scientific article published on 14 May 2009
|
| Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
|
scientific article published in January 2002
|
| A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.
|
scientific article published on 14 February 2002
|
| Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
|
scientific article published in May 1985
|
| Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria.
|
scientific article published in August 2002
|
| Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.
|
scientific article published in April 1988
|
| Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
|
scientific article published in August 1987
|
| CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.
|
scientific article published on 21 November 2009
|
| Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.
|
scientific article published in April 1987
|
| Vaccine adjuvants: a priority for vaccine research.
|
scientific article published on 9 January 2010
|
| Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine
|
scientific article
|
| The application of exosomes as a nanoscale cancer vaccine
|
scientific article
|
| Yellow fever vector live-virus vaccines: West Nile virus vaccine development
|
scientific article
|
| Parent perceptions important for HPV vaccine initiation among low income adolescent girls
|
scientific article
|
| Differential mortality by measles vaccine titer and sex.
|
scientific article
|
| Biomaterials for nanoparticle vaccine delivery systems
|
scientific article
|
| An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine
|
scientific article
|
| An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
|
scientific article
|
| Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
scientific article
|
| Purified and inactivated human hepatitis B vaccine: progress report
|
scientific article published on September 1, 1975
|
| The rise (and fall?) of parental vaccine hesitancy
|
scientific article
|
| Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis
|
scientific article
|
| Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
|
scientific article
|
| Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells
|
scientific article
|
| Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.
|
scientific article
|
| Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques
|
scientific article
|
| Adenoviruses as vaccine vectors
|
scientific article
|
| Determinants of release rate of tetanus vaccine from polyester microspheres.
|
scientific article
|
| Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
|
scientific article
|
| Generation of a parvovirus B19 vaccine candidate
|
scientific article
|
| Vaccine adjuvants: current state and future trends
|
scientific article
|
| Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine
|
scientific article
|
| Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isol
|
scientific article
|
| Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial
|
scientific article
|
| Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
|
scientific article
|
| Parental vaccine concerns, information source, and choice of alternative immunization schedules
|
scientific article
|
| ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy
|
scientific article
|
| Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine
|
scientific article
|
| Immunomodulation of atherosclerosis: implications for vaccine development
|
scientific article
|
| Evidence for the involvement of VAR2CSA in pregnancy-associated malaria
|
research work
|
| Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
|
scientific article
|
| Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection
|
scientific article
|
| History of BCG Vaccine.
|
scientific article
|
| Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology
|
scientific article
|
| Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine
|
scientific article
|
| Understanding reduced rotavirus vaccine efficacy in low socio-economic settings
|
scientific article
|
| Nonmedical vaccine exemptions and pertussis in California, 2010.
|
scientific article
|
| Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial
|
scientific article
|
| Development of Vi conjugate - a new generation of typhoid vaccine
|
scientific article
|
| Imperfect vaccine-induced immunity and whooping cough transmission to infants
|
scientific article
|
| Plague vaccine research and development
|
scientific article
|
| Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response
|
scientific article
|
| Chitosan and its derivatives in mucosal drug and vaccine delivery
|
scientific article
|
| Epidemiology of human noroviruses and updates on vaccine development
|
scientific article
|
| Factors affecting human papillomavirus vaccine use among White, Black and Latino parents of sons
|
scientific article
|
| An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells
|
scientific article
|
| Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.
|
scientific article
|
| Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies
|
scientific article
|
| Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons
|
scientific article
|
| Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice
|
scientific article
|
| Towards a human Lassa fever vaccine
|
scientific article
|
| Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains
|
scientific article
|
| Current concepts and progress in RSV vaccine development.
|
scientific article
|
| Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group
|
scientific article
|
| Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
|
scientific article
|
| Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity
|
scientific article
|
| Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
|
scientific article
|
| Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
|
scientific article
|
| Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection
|
scientific article
|
| A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
|
scientific article
|
| Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination
|
scientific article
|
| MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load
|
scientific article
|
| Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections
|
scientific article published in February 2014
|
| Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.
|
scientific article
|
| Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine
|
scientific article published on June 1, 1977
|
| Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production
|
scientific article
|
| Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
|
scientific article
|
| Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer
|
scientific article
|
| Use of viral vectors for vaccine production in plants
|
scientific article
|
| Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
|
scientific article
|
| Successes and challenges in varicella vaccine
|
scientific article
|
| Liposomes as vaccine delivery systems: a review of the recent advances
|
scientific article
|
| Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats
|
scientific article
|
| Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs
|
scientific article
|
| Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
|
scientific article
|
| Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
|
scientific article
|
| Buccal and sublingual vaccine delivery
|
scientific article
|
| Pneumococcal vaccine for asthma
|
scientific article
|
| A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.
|
scientific article
|
| Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
|
scientific article
|
| Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.
|
scientific article
|
| Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine
|
scientific article
|
| Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus
|
scientific article
|
| Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster
|
scientific article
|
| Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans
|
scientific article
|
| Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life
|
scientific article
|
| Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer
|
scientific article
|
| Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
|
scientific article
|
| Efficacy of high-dose versus standard-dose influenza vaccine in older adults
|
scientific article
|
| Update on recommendations for use of herpes zoster vaccine
|
scientific article
|
| A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge
|
scientific article
|
| Vaccines to protect against HSV diseases
|
scientific article
|
| Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
|
scientific article
|
| Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
scientific article
|
| Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine
|
scientific article published on July 1, 1992
|
| Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses
|
scientific article
|
| Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.
|
scientific article
|
| Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection
|
scientific article
|
| Efficacy of a tetravalent dengue vaccine in children in Latin America.
|
scientific article
|
| Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies
|
scientific article
|
| The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine
|
scientific article published on 01 March 2000
|
| Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
|
scientific article published on 01 January 2001
|
| Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine
|
scientific article published on 01 July 1997
|
| Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant
|
scientific article published on 01 March 2000
|
| Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults
|
scientific article published on 01 February 2001
|
| Identification of substrains of BCG vaccine using multiplex PCR
|
scientific article published on 01 February 2001
|
| Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project
|
scientific article published on 01 March 2001
|
| Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine
|
scientific article published on 01 January 2000
|
| A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers
|
scientific article published on 01 May 2000
|
| Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
|
scientific article published on 01 May 2000
|
| Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine
|
scientific article published on 01 July 2003
|
| Parent attitudes toward participation of their children in polio vaccine trials
|
scientific article published on 01 December 1954
|
| Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer
|
scientific article published on 01 May 2000
|
| Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group
|
scientific article published on 01 September 1997
|
| The effectiveness of the varicella vaccine in clinical practice
|
scientific article published on 01 March 2001
|
| Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits
|
scientific article published on 01 April 2001
|
| Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine
|
scientific article published on 01 May 2000
|
| Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
|
scientific article published on 01 October 1997
|
| Equine influenza vaccine efficacy: the significance of antigenic variation
|
scientific article published on 01 May 2000
|
| Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls
|
scientific article published on 01 April 2001
|
| Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules
|
scientific article published on 01 May 2001
|
| Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela
|
scientific article published on 01 October 1997
|
| CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants
|
scientific article published on 01 September 1997
|
| Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered
|
scientific article published on 01 September 2003
|
| Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
|
scientific article published on 01 May 2001
|
| High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801
|
scientific article published on 01 May 2001
|
| Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial
|
scientific article published on 01 June 2000
|
| Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center
|
scientific article published on 01 November 1997
|
| Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial
|
scientific article published on 01 October 1997
|
| A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine
|
scientific article published on 01 January 1998
|
| Detection of delayed vaccinations: a new approach to visualize vaccine uptake
|
scientific article published on 01 April 2002
|
| Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice
|
scientific article published on 01 July 2001
|
| Mechanisms of cytokine synergy essential for vaccine protection against viral challenge
|
scientific article published on 01 July 2001
|
| [Antibody picture of variola vaccine infection. I. Varying antibody formation in the vaccine infection of rabbits, monkeys and humans]
|
scientific article published on 01 June 1956
|
| Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain
|
scientific article published on 01 October 2000
|
| Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group
|
scientific article published on 01 February 1998
|
| Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis
|
scientific article published on 01 September 2000
|
| Antigenic potency of poliomyelitis vaccine; influence on degree and duration of vaccine effect
|
scientific article published on 01 December 1956
|
| Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model
|
scientific article published on 01 July 2002
|
| HIV-1 diversity and vaccine development
|
scientific article published on 01 June 2002
|
| Efficacy of a food plant-based oral cholera toxin B subunit vaccine
|
scientific article published on 01 March 1998
|
| Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants
|
scientific article published on 01 July 2002
|
| Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program
|
scientific article published on 01 April 1998
|
| Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations
|
scientific article published on 01 March 1998
|
| Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors
|
scientific article published on 01 September 2001
|
| Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine
|
scientific article published on 01 July 2002
|
| Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle
|
scientific article published on 01 July 2002
|
| Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
|
scientific article published on 01 April 1998
|
| Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle
|
scientific article published on 01 April 1998
|
| Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T)
|
scientific article published on 01 April 1998
|
| Properties and behavior of orally administered attenuated poliovirus vaccine
|
scientific article published on 01 July 1957
|
| Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine
|
scientific article published on 01 April 1998
|
| Novel pneumococcal surface proteins: role in virulence and vaccine potential
|
scientific article published on 01 March 1998
|
| Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up
|
scientific article published on 01 May 1998
|
| Factors influencing vaccine uptake in Italy
|
scientific article published on 01 October 2001
|
| Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine
|
scientific article published on 01 February 1999
|
| Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
|
scientific article published on 01 February 1998
|
| Aluminum-containing vaccine associated adverse events: role of route of administration and gender
|
scientific article published on 01 May 2002
|
| Vaccine R&D success rates and development times
|
scientific article published on 01 May 1996
|
| Relationship of the anaphylaxis sensitizing and adjuvant properties of Hemophilus pertussis vaccine
|
scientific article published on 01 September 1957
|
| Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis
|
scientific article published on 01 October 1997
|
| Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60
|
scientific article published on 01 September 2002
|
| Vaccine preventable diseases and immunisations: a qualitative study of mothers' perceptions of severity, susceptibility, benefits and barriers
|
scientific article published on 01 June 1998
|
| Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques
|
scientific article published on 01 July 1998
|
| A study of the public's acceptance of the Salk vaccine program
|
scientific article published on 01 February 1958
|
| Immunization against scrub typhus. II. Preparation of lyophilized living vaccine
|
scientific article published on 01 May 1951
|
| Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
|
scientific article published on 01 February 2004
|
| ANTI-RABIES VACCINE OF TISSUE CULTURE ORIGIN
|
scientific article published on 01 September 1963
|
| EFFECTS OF MEASLES, GAMMA-GLOBULIN-MODIFIED MEASLES AND VACCINE MEASLES ON THE TUBERCULIN TEST
|
scientific article published on 01 February 1964
|
| Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease
|
scientific article published on 01 August 1998
|
| Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine
|
scientific article published on 01 August 1998
|
| FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION
|
scientific article published on 01 February 1965
|
| Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine
|
scientific article published on 01 August 1998
|
| The first combined vaccine against hepatitis A and B: an overview
|
scientific article published on 01 March 1999
|
| Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination
|
scientific article published on 01 December 2001
|
| A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice
|
scientific article published on 01 March 1999
|
| Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|
scientific article published on 01 March 1999
|
| The efficacy and economic benefits of Paracox, a live attenuated anticoccidial vaccine, in commercial trials with standard broiler chickens in the United Kingdom
|
scientific article published on 01 February 1999
|
| Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory
|
scientific article published on 01 June 1999
|
| Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF
|
scientific article published on 01 January 2002
|
| Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at
|
scientific article published on 01 December 1998
|
| Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development
|
scientific article published on 01 October 1998
|
| Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity
|
scientific article published on 01 January 2002
|
| Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
|
scientific article published on 01 December 1998
|
| Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age
|
scientific article published on 01 November 1998
|
| AIDS vaccine models: challenging challenge viruses
|
scientific article published on 01 March 2002
|
| Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen
|
scientific article published on 01 May 1999
|
| Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers
|
scientific article published on 04 March 2002
|
| Toward an HIV type 1 vaccine that generates potent, broadly cross-reactive neutralizing antibodies
|
scientific article published on 01 May 1999
|
| Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies
|
scientific article published on 01 June 1999
|
| Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens
|
scientific article published on 01 August 1999
|
| Intussusception among recipients of rotavirus vaccine--United States, 1998-1999
|
scientific article published on 01 July 1999
|
| Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations from the Task Force on Community Preventive Services
|
scientific article published on 01 June 1999
|
| A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant
|
scientific article published on 01 October 1999
|
| Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity
|
scientific article published on 01 October 2002
|
| The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population
|
scientific article published on 01 November 2002
|
| A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs
|
scientific article published on 01 May 1955
|
| Persistence of immunity after administration of formalin-treated poliovirus vaccine
|
scientific article published on 01 October 1960
|
| Tularemia vaccine study. II. Respiratory challenge
|
scientific article published on 01 May 1961
|
| Tularemia vaccine study. I. Intracutaneous challenge
|
scientific article published on 01 May 1961
|
| Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model.
|
scientific article published on 3 April 2012
|
| Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.
|
scientific article published in December 2003
|
| One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
|
scientific article published on 3 May 2009
|
| Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development.
|
scientific article published in January 1996
|
| The annual production cycle for influenza vaccine.
|
scientific article published in May 2003
|
| Protection against malaria by MSP3 candidate vaccine.
|
scientific article published in September 2011
|
| Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali.
|
scientific article published in August 2004
|
| A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
|
scientific article published in March 2004
|
| Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.
|
scientific article published in March 2004
|
| Crystal structure of the malaria vaccine candidate apical membrane antigen 1.
|
scientific article published on 24 February 2005
|
| Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.
|
scientific article published in May 1994
|
| Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.
|
scientific article published in June 1995
|
| Plasmodium yoelii can ablate vaccine-induced long-term protection in mice.
|
scientific article published in August 2005
|
| Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
|
scientific article published in December 2005
|
| Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion.
|
scientific article published on 18 April 2006
|
| Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
|
scientific article published on 10 August 2006
|
| A protein particle vaccine containing multiple malaria epitopes.
|
scientific article published in November 1997
|
| Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum.
|
scientific article published in April 1996
|
| Construction of an attenuated Pseudomonas fluorescens strain and evaluation of its potential as a cross-protective vaccine.
|
scientific article published on 25 April 2009
|
| Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
|
scientific article
|
| Live attenuated vaccine-based control of necrotic enteritis of broiler chickens.
|
scientific article published on 11 November 2005
|
| Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine
|
scientific article published on December 1, 1977
|
| Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum.
|
scientific article
|
| HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
|
scientific article
|
| Stage of adoption of the human papillomavirus vaccine among college women.
|
scientific article
|
| Using message framing to promote acceptance of the human papillomavirus vaccine.
|
scientific article published in November 2007
|
| Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine
|
scientific article published on December 4, 1981
|
| Motivations for participating in an HIV vaccine efficacy trial.
|
scientific article published in July 2005
|
| Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.
|
scientific article published on 18 January 2018
|
| Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff.
|
scientific article
|
| In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.
|
scientific article published in August 1997
|
| A vaccine targeting mutant IDH1 induces antitumour immunity.
|
scientific article published on 25 June 2014
|
| A framework for assessing immunological correlates of protection in vaccine trials.
|
scientific article published on 2 October 2007
|
| Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis
|
scientific article published on August 13, 1983
|
| The Australian model of immunization advice and vaccine funding.
|
scientific article published in April 2010
|
| Efficacy of a therapeutic cocaine vaccine in rodent models.
|
scientific article published in October 1996
|
| Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
|
scientific article published on 26 November 2009
|
| Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
|
scientific article published on 17 December 2010
|
| Improved design and intranasal delivery of an M2e-based human influenza A vaccine.
|
scientific article published on 12 June 2006
|
| The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.
|
scientific article
|
| Universal influenza A vaccine: optimization of M2-based constructs.
|
scientific article published in June 2005
|
| A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.
|
scientific article published in August 2004
|
| Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
|
scientific article published in December 2008
|
| Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
|
scientific article published in December 2008
|
| Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.
|
scientific article published on 27 May 2012
|
| Recombinant neuraminidase vaccine protects against lethal influenza.
|
scientific article published in April 1996
|
| Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
|
scientific article published on 8 November 2011
|
| Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.
|
scientific article published in July 2013
|
| Fundamentals and Methods for T- and B-Cell Epitope Prediction.
|
scientific article
|
| Chemical Modification of Chitosan for Efficient Vaccine Delivery.
|
scientific article published on 25 January 2018
|
| Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases.
|
scientific article published in March 2018
|
| Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle.
|
scientific article published on 24 October 2007
|
| A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine.
|
scientific article published in November 2005
|
| Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children
|
scientific article published on October 2, 2003
|
| A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer's patch dendritic cells.
|
scientific article
|
| Influenza vaccine effectiveness among elderly nursing home residents: a cohort study.
|
scientific article published in July 2001
|
| Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.
|
scientific article
|
| Effect of genetics, vaccine dosage, and postvaccination sampling interval on early antibody response to Salmonella enteritidis vaccine in broiler breeder chicks.
|
scientific article published in February 1998
|
| Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.
|
scientific article published in December 1994
|
| Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine
|
scientific article published on August 1, 1992
|
| Optimizing influenza vaccine distribution.
|
scientific article
|
| Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.
|
scientific article
|
| Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.
|
scientific article published in November 1991
|
| Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.
|
scientific article published in June 1989
|
| Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
|
scientific article published in June 1987
|
| An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice.
|
scientific article published in January 1987
|
| Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection.
|
scientific article published in September 1984
|
| Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.
|
scientific article published on 14 February 2018
|
| Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.
|
scientific article published in June 1999
|
| Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.
|
scientific article published in April 2014
|
| Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains.
|
scientific article published in September 1990
|
| Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine.
|
scientific article published in August 1990
|
| Omission bias and vaccine rejection by parents of healthy children: implications for the influenza A/H1N1 vaccination programme.
|
scientific article published on 21 April 2010
|
| Controlled field trials of a vaccine against New World cutaneous leishmaniasis.
|
scientific article published in December 1986
|
| Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection.
|
scientific article published on 6 December 2009
|
| Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
|
scientific article published in September 1982
|
| Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.
|
scientific article
|
| High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts.
|
scientific article published in March 2004
|
| Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
|
scientific article published on 28 February 2006
|
| Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
|
scientific article published in March 2004
|
| A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.
|
scientific article published in August 2009
|
| Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.
|
scientific article published in September 2004
|
| Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.
|
scientific article published in July 2005
|
| Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.
|
scientific article published on 2 April 2007
|
| Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.
|
scientific article
|
| Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma.
|
scientific article published on 25 October 2006
|
| Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
|
scientific article published on 2 June 2013
|
| A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with menin
|
scientific article published on 21 February 2006
|
| Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
|
scientific article published on 30 May 2013
|
| Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age.
|
scientific article published on 30 May 2013
|
| Cost-effectiveness of the influenza vaccine in a healthy, working-age population.
|
scientific article published in May 1997
|
| Barriers to and facilitators of child influenza vaccine - perspectives from parents, teens, marketing and healthcare professionals.
|
scientific article published on 31 January 2012
|
| A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
|
scientific article
|
| Health communication and vaccine hesitancy.
|
scientific article published on 17 April 2015
|
| Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
|
scientific article published in June 2011
|
| Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity.
|
scientific article published on 26 March 2007
|
| HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques.
|
scientific article published on 26 April 2013
|
| A mixture model with detection limits for regression analyses of antibody response to vaccine.
|
scientific article published in December 1995
|
| Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
|
scientific article published on 16 April 2013
|
| Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.
|
scientific article published on 10 April 2013
|
| HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design.
|
scientific article published on 19 January 2007
|
| Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
|
scientific article published on 27 November 2006
|
| Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
|
scientific article published in June 2007
|
| Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.
|
scientific article published in December 2007
|
| Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
|
scientific article published in September 2008
|
| Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development.
|
scientific article published in June 1994
|
| Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults.
|
scientific article published on 31 December 2009
|
| Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
|
scientific article published on 20 October 2009
|
| A survey of children's preferences for influenza vaccine attributes.
|
scientific article published on 19 April 2011
|
| Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.
|
scientific article published in November 1990
|
| Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
|
scientific article published on 5 January 2012
|
| Why does drug resistance readily evolve but vaccine resistance does not?
|
scientific article
|
| The case test-negative design for studies of the effectiveness of influenza vaccine.
|
scientific article published on 23 April 2013
|
| Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
|
scientific article published on 23 February 2018
|
| Sorting through search results: a content analysis of HPV vaccine information online.
|
scientific article published on 19 October 2011
|
| An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs.
|
scientific article published on 8 December 2009
|
| Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK.
|
scientific article published in September 2013
|
| A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.
|
scientific article published in April 2005
|
| Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.
|
scientific article published on 18 September 2012
|
| Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.
|
scientific article published in September 2004
|
| Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
|
scientific article published on 8 December 2003
|
| Effects of a SARS-associated coronavirus vaccine in monkeys.
|
scientific article published in December 2003
|
| Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.
|
scientific article published in September 2003
|
| Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
|
scientific article published on 7 February 2015
|
| The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK.
|
scientific article published on 22 May 2008
|
| Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.
|
scientific article published on 17 July 2014
|
| Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
|
scientific article published in January 2002
|
| Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
|
scientific article published in April 2009
|
| Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
|
scientific article published on 9 March 2009
|
| Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.
|
scientific article published in November 2003
|
| Attitudes about human papillomavirus vaccine among family physicians.
|
scientific article published in December 2005
|
| Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
|
scientific article published in May 2010
|
| Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.
|
scientific article published in December 2005
|
| Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios.
|
scientific article published in September 2008
|
| Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
|
scientific article published on 19 June 2013
|
| Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
|
scientific article published on 3 November 2009
|
| Long-term presence of memory B-cells specific for different vaccine components.
|
scientific article published on 30 September 2009
|
| A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.
|
scientific article published on 5 July 2007
|
| Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
|
scientific article published on 27 January 2006
|
| HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
|
scientific article published on 16 October 2008
|
| Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
|
scientific article published in May 2008
|
| Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
|
scientific article published on 17 July 2007
|
| Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
|
scientific article published on 14 February 2007
|
| Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persi
|
scientific article published on 2 October 2006
|
| Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
|
scientific article published in October 2005
|
| Measles outbreaks in a population with declining vaccine uptake.
|
scientific article published in August 2003
|
| Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.
|
scientific article published in April 1998
|
| Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.
|
scientific article published in December 1997
|
| Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.
|
scientific article published in November 1995
|
| Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.
|
scientific article published in January 1974
|
| Vaccine adverse events: causal or coincidental?
|
scientific article published in February 1998
|
| Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
|
scientific article published in June 1984
|
| Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team.
|
scientific article published in January 1999
|
| Lymph node macrophages and reticulum cells in the immune response. I. The primary response to paratyphoid vaccine
|
scientific article published on August 25, 1978
|
| Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors.
|
scientific article published in January 1994
|
| Efficacy of acellular pertussis vaccine in early childhood after household exposure.
|
scientific article published in January 1996
|
| Relative incidence estimation from case series for vaccine safety evaluation.
|
scientific article published in March 1995
|
| The Influence of Vaccine on Febrile Seizure.
|
scientific article
|
| Maternal Vaccination as an Essential Component of Life-Course Immunization and Its Contribution to Preventive Neonatology.
|
scientific article
|
| Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
|
scientific article published on 6 April 2018
|
| Current Challenges and Achievements in Maternal Immunization Research.
|
scientific article published on 6 March 2018
|
| The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.
|
scientific article published on 2 March 2018
|
| Recent advances in veterinary applications of structural vaccinology.
|
scientific article published on 15 March 2018
|
| Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
|
scientific article published on 18 July 2005
|
| Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae).
|
scientific article published on 2 August 2005
|
| A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.
|
scientific article published in September 1984
|
| The recurrence of whooping cough: possible implications for assessment of vaccine efficacy
|
scientific article published on March 20, 1982
|
| Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
|
scientific article published on 7 March 2018
|
| Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
|
scientific article published on 18 August 2011
|
| Human hepatitis B vaccine from recombinant yeast
|
scientific article published on January 12, 1984
|
| Estimation of vaccine effectiveness using the screening method.
|
scientific article published in August 1993
|
| The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells.
|
scientific article published on 22 October 2012
|
| Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting.
|
scientific article published in July 1996
|
| Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects.
|
scientific article published in November 1996
|
| Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function.
|
scientific article published on 29 May 2001
|
| Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine.
|
scientific article published in March 2002
|
| The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis.
|
scientific article published on 12 November 2002
|
| Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
|
scientific article published on 16 July 2003
|
| Is the development of a new tuberculosis vaccine possible?
|
scientific article published in September 2000
|
| Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia.
|
scientific article published in April 2005
|
| Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
|
scientific article
|
| TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.
|
scientific article published in December 2006
|
| Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
|
scientific article published on 18 April 2007
|
| A global pandemic influenza vaccine action plan.
|
scientific article published in September 2006
|
| PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.
|
scientific article published on 6 April 2011
|
| 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
|
scientific article published on 18 October 2013
|
| Hepatitis E vaccine debuts.
|
scientific article
|
| Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.
|
scientific article
|
| Vaccine hesitancy: Definition, scope and determinants.
|
scientific article published on 17 April 2015
|
| Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.
|
scientific article published on 5 September 2006
|
| Hitting HIV where it hurts: an alternative approach to HIV vaccine design.
|
scientific article
|
| Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.
|
scientific article
|
| alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
|
scientific article
|
| A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.
|
scientific article
|
| HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice
|
scientific article published on October 15, 2003
|
| Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
|
scientific article published on March 14, 1992
|
| The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
|
scientific article
|
| Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine.
|
scientific article published in February 2002
|
| Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
|
scientific article
|
| Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
|
scientific article
|
| Attenuated Measles Vaccine in Children with Acute Leukemia
|
scientific article published on 01 March 1962
|
| Viral Sexually Transmitted Disease Vaccine Acceptability Among College Students
|
scientific article published on 01 October 2003
|
| Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju
|
scientific article published on 07 October 2003
|
| Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens
|
scientific article published on 01 December 2003
|
| Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine
|
scientific article published on 01 November 2006
|
| Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom
|
scientific article published on 08 November 2006
|
| Modulation of the infant immune responses by the first pertussis vaccine administrations
|
scientific article published on 03 November 2006
|
| Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
|
scientific article published on 01 December 2006
|
| Trachoma vaccine studies on Taiwan
|
scientific article published on 01 March 1962
|
| Histamine shock in mice sensitized with Hemophilus pertussis vaccine
|
scientific article published on 01 April 1948
|
| Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity
|
scientific article published on 08 December 2006
|
| Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
|
scientific article published on 22 January 2007
|
| Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial
|
scientific article published on 05 June 2006
|
| AIDS research. Did Merck's failed HIV vaccine cause harm?
|
scientific article published on 01 November 2007
|
| Duration of Immunity Conferred by Typhoid Vaccine: Results of Re-vaccination by Intracutaneous Injection of Typhoid Vaccine
|
scientific article published on 01 February 1939
|
| Use of Alum-Treated Pertussis Vaccine, and of Alum-Precipitated Combined Pertussis Vaccine and Diphtheria Toxoid, for Active Immunization
|
scientific article published on 01 June 1942
|
| Pertussis Vaccine Prepared with Phase-I Cultures Grown in Fluid Medium
|
scientific article published on 01 April 1946
|
| Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
|
scientific article published on 01 November 2007
|
| MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications
|
scientific article published on 06 March 2007
|
| A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine
|
scientific article published on 12 July 2006
|
| Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
|
scientific article published on 07 March 2007
|
| Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine
|
scientific article published on 01 April 2007
|
| The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects
|
scientific article published on 05 June 2006
|
| Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination
|
scientific article published on 20 March 2007
|
| Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants
|
scientific article published on 01 June 2004
|
| Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins
|
scientific article published on 06 March 2007
|
| Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults
|
scientific article published on 01 February 2004
|
| Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin
|
scientific article published on 20 November 2007
|
| Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs
|
scientific article published on 01 September 2006
|
| Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109
|
scientific article published on 17 August 2006
|
| Introducing HPV vaccine in developing countries--key challenges and issues
|
scientific article published on 01 May 2007
|
| Outbreak of mumps in a vaccinated child population: a question of vaccine failure?
|
scientific article published on 01 July 2004
|
| Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment
|
scientific article published on 01 September 2006
|
| Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A
|
scientific article published on 26 April 2007
|
| The Meningitis Vaccine Project
|
scientific article published on 07 May 2007
|
| Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com
|
scientific article published on 08 May 2007
|
| The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children
|
scientific article published on 01 August 2004
|
| A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
|
scientific article published on 01 August 2004
|
| Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
|
scientific article published on 01 August 2004
|
| Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease
|
scientific article published on 21 May 2007
|
| A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques
|
scientific article published on 01 September 2004
|
| Herd immunity and pneumococcal conjugate vaccine: a quantitative model
|
scientific article published on 22 May 2007
|
| Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran
|
scientific article published on 01 September 2004
|
| Trust and experience as predictors of HPV vaccine acceptance
|
scientific article published on 19 April 2007
|
| Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers
|
scientific article published on 01 October 2004
|
| Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying
|
scientific article published on 16 July 2007
|
| A cross-sectional survey to assess community attitudes to introduction of Human papillomavirus vaccine
|
scientific article published on 01 June 2007
|
| Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life
|
scientific article published on 13 September 2004
|
| Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy
|
scientific article published on 01 October 2004
|
| Weathering the influenza vaccine crisis
|
scientific article published on 18 October 2004
|
| A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis
|
scientific article published on 01 October 2004
|
| Dose sparing with intradermal injection of influenza vaccine
|
scientific article published on 03 November 2004
|
| Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans
|
scientific article published on 25 July 2007
|
| A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity
|
scientific article published on 01 December 2004
|
| Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics
|
scientific article published on 01 October 2005
|
| Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine
|
scientific article published on 01 November 2004
|
| Barriers to participating in an HIV vaccine trial: a systematic review
|
scientific article published on 01 November 2004
|
| Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine
|
scientific article published on 18 August 2005
|
| Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains
|
scientific article published on 17 August 2007
|
| Epidermal DNA vaccine for influenza is immunogenic in humans
|
scientific article published on 19 August 2005
|
| CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study
|
scientific article published on 01 November 2004
|
| Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season
|
scientific article published on 07 September 2005
|
| Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation
|
scientific article published on 19 August 2005
|
| Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial
|
scientific article published on 01 January 2005
|
| Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates
|
scientific article published on 07 May 2008
|
| Lessons from failure--preparing for future HIV-1 vaccine efficacy trials
|
scientific article published on 27 January 2005
|
| Real-time vaccine safety surveillance for the early detection of adverse events
|
scientific article published on 01 October 2007
|
| Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
|
scientific article published on 01 October 2005
|
| Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method
|
scientific article published on 27 January 2005
|
| Plant based HIV-1 vaccine candidate: Tat protein produced in spinach
|
scientific article published on 01 March 2005
|
| Seroprevalence and immunization history of selected vaccine preventable diseases in medical students
|
scientific article published on 01 March 2005
|
| Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
|
scientific article published on 02 October 2007
|
| Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- d
|
scientific article published on 01 March 2005
|
| MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
|
scientific article published on 01 March 2005
|
| Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B
|
scientific article published on 01 March 2005
|
| Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens
|
scientific article published on 16 November 2005
|
| Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
|
scientific article published on 28 November 2005
|
| A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults
|
scientific article published on 01 May 2005
|
| Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model
|
scientific article published on 01 May 2005
|
| HIV vaccine research: the way forward
|
scientific article published on 01 July 2008
|
| Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
|
scientific article published on 26 July 2008
|
| Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents
|
scientific article published on 01 July 2004
|
| Multicomponent Lyme vaccine: three is not a crowd
|
scientific article published on 01 May 2005
|
| Development of a live attenuated vaccine against turkey rhinotracheitis
|
scientific article published on 01 March 1991
|
| Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis
|
scientific article published on 01 July 2005
|
| Dendritic cells in vivo: a key target for a new vaccine science
|
scientific article published on 01 September 2008
|
| Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands
|
scientific article published on 01 January 2006
|
| Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine
|
scientific article published on 18 November 2010
|
| Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina
|
scientific article published on 09 January 2010
|
| Efficacy of a killed vaccine for the control of paratuberculosis in Australian sheep flocks
|
scientific article published on 03 February 2006
|
| Selection and characterization of vaccine strain for Enterovirus 71 vaccine development
|
scientific article published on 04 December 2011
|
| The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies
|
scientific article published on 07 December 2011
|
| Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN
|
scientific article published on 30 December 2010
|
| Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
|
scientific article published on 20 January 2009
|
| Vaccine-derived polioviruses
|
scientific article published on 02 May 2006
|
| T cell responses are better correlates of vaccine protection in the elderly
|
scientific article published on 01 May 2006
|
| Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media
|
scientific article published on 08 May 2006
|
| Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers
|
scientific article published on 10 April 2012
|
| Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006
|
scientific article published on 18 April 2009
|
| Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes
|
scientific article published on 01 June 2006
|
| A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation
|
scientific article
|
| Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.
|
scientific article published in December 1997
|
| Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.
|
scientific article
|
| Protection against tuberculosis by a plasmid DNA vaccine.
|
scientific article
|
| Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
|
scientific article
|
| Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
|
scientific article
|
| Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.
|
scientific article published in September 2000
|
| A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
|
scientific article
|
| Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.
|
scientific article published in October 1961
|
| Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation?
|
scientific article
|
| The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.
|
scientific article
|
| Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
|
scientific article
|
| Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.
|
scientific article
|
| Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administe
|
scientific article published on 27 March 2013
|
| Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
|
scientific article published on 8 October 2009
|
| Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.
|
scientific article published on 21 May 2010
|
| National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.
|
scientific article published in September 2006
|
| Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
|
scientific article
|
| Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: subunit vaccine vs DNA vaccine.
|
scientific article published on 19 January 2011
|
| A multistage tuberculosis vaccine that confers efficient protection before and after exposure.
|
scientific article
|
| United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.
|
scientific article
|
| Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
|
scientific article published on 4 April 2007
|
| Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine
|
scientific article published on April 1, 1974
|
| Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.
|
scientific article
|
| Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine.
|
scientific article
|
| Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
|
scientific article
|
| A novel recombinant vaccine which protects mice against ricin intoxication.
|
scientific article
|
| Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
|
scientific article
|
| De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.
|
scientific article
|
| Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1.
|
scientific article
|
| Efficacy of an acellular pertussis vaccine among adolescents and adults.
|
scientific article
|
| Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
|
scientific article
|
| FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007
|
scientific article published in August 2008
|
| Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
|
scientific article
|
| Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.
|
scientific article
|
| Effectiveness over time of varicella vaccine.
|
scientific article
|
| Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
|
scientific article
|
| Live attenuated versus inactivated influenza vaccine in infants and young children.
|
scientific article
|
| Human papillomavirus vaccine and sexual behavior among adolescent and young women.
|
scientific article
|
| Polyvalent vaccines: High-maintenance heroes.
|
scientific article
|
| Veterinary and human vaccine evaluation methods.
|
scientific article published on 16 April 2014
|
| Adverse events of vaccines and the consequences of non-vaccination: a critical review.
|
scientific article
|
| Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
|
scientific article published on 28 March 2018
|
| Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk-benefit balance.
|
scientific article published in April 2018
|
| Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation.
|
scientific article
|
| Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
|
scientific article
|
| Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.
|
scientific article
|
| Taking a New Shot At a TB Vaccine
|
scientific article
|
| History of Sabin attenuated poliovirus oral live vaccine strains
|
article
|
| Adverse Effects of Vaccines: Evidence and Causality
|
Book published by National Academies Press
|
| A Rotavirus Vaccine for Prevention of Severe Diarrhoea of Infants and Young Children: Development, Utilization and Withdrawal
|
article
|
| Weaponized Health Communication: Twitter Bots and Russian Trolls Amplify the Vaccine Debate
|
scientific article published on 23 August 2018
|
| A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vac
|
|
| Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate
|
scholarly article by Hong-Ru Chen published in July 2018
|
| Maternal Acceptance of Human Papillomavirus Vaccine in Malaysia
|
scientific article published on 08 February 2009
|
| International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
|
article
|
| Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons
|
article
|
| Vaccine-Associated Paralytic Poliomyelitis
|
scientific article published in The Journal of the American Medical Association
|
| Efficacy of Virosome Hepatitis A Vaccine in Young Children in Nicaragua: Randomized Placebo‐Controlled Trial
|
article by Orlando Mayorga Pérez et al published September 2003 in Journal of Infectious Diseases
|
| Malaria vaccine: WHO position paper-January 2016
|
article
|
| Tick-borne encephalitis after vaccination: Vaccine failure or misdiagnosis
|
article
|
| Progress in HIV-1 vaccine development
|
article
|
| Intranasal Influenza Vaccine in a Working Population
|
|
| Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia
|
article
|
| A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis
|
article
|
| From genome to vaccine—new immunoinformatics tools for vaccine design
|
article by Anne Searls De Groot & Jay A Berzofsky published December 2004 in Methods
|
| Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
|
scientific article published in The Lancet
|
| Diversity and Antibiotic Resistance among Nonvaccine Serotypes ofStreptococcus pneumoniaeCarriage Isolates in the Post–Heptavalent Conjugate Vaccine Era
|
article
|
| Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis
|
article
|
| Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions
|
article
|
| The insulin receptor is a transmission blocking veterinary vaccine target for zoonotic Schistosoma japonicum
|
article
|
| Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis
|
scholarly article by Albina Poljak et al published 19 June 2012 in Vaccine
|
| A Protective Vaccine Delivery System for In Vivo T Cell Stimulation Using Nanoengineered Polymer Hydrogel Capsules
|
article
|
| Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis
|
|
| Binding, Internalization, and Antigen Presentation of Vaccine-Loaded Nanoengineered Capsules in Blood
|
article
|
| Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
|
|
| Vaccination of mice with DNA vaccine induces the immune response and partial protection against T. spiralis infection
|
article
|
| Immunogenicity and Safety of a Booster Dose of the 10-valent Pneumococcal Haemophilus Influenzae Protein D Conjugate Vaccine Coadministered With the Tetravalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine in Toddlers
|
|
| Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
|
article
|
| Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination
|
scientific article published on 01 December 2004
|
| Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen
|
scientific article published on 01 May 1995
|
| Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
|
article
|
| Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12
|
article
|
| Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor
|
|
| Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens
|
scientific article published on 01 June 2007
|
| Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age
|
article by T Vesikari et al published March 1990 in American Journal of Diseases of Children
|
| Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger
|
article
|
| Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children
|
scholarly article by Karine Lacombe et al published December 2004 in Vaccine
|
| Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)
|
article
|
| Why worry: Vitamin A with DTP vaccine?
|
|
| Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development
|
article
|
| A Candidate Dengue Vaccine Walks a Tightrope
|
|
| Pre- or post-pandemic influenza vaccine?
|
|
| An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity
|
article by Olga J.A.E Ophorst et al published August 2004 in Vaccine
|
| Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs
|
scientific article published on 31 July 2018
|
| Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions
|
scientific article published on 31 July 2018
|
| Eimeria species parasites as novel vaccine delivery vectors: Anti-Campylobacter jejuni protective immunity induced by Eimeria tenella-delivered CjaA
|
article
|
| Respiratory syncytial virus vaccine development
|
article
|
| Progress in respiratory virus vaccine development
|
article
|
| Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010
|
article
|
| Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
|
scientific article published on 15 May 2006
|
| Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years
|
scientific article published on 21 April 2006
|
| Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
|
scientific article published on 22 April 2010
|
| Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine
|
scientific article published on 01 May 2010
|
| Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine
|
scientific article published on 01 October 2010
|
| Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
|
scientific article published on 07 July 2010
|
| Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial
|
scientific article published on 09 August 2011
|
| Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education
|
scientific article published on 01 August 2011
|
| RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe
|
scientific article published on 29 October 2009
|
| Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old
|
scientific article published on 29 October 2009
|
| Trial of Whooping-cough Vaccine
|
scientific article published on 01 August 1945
|
| Trials of Live Influenza Vaccine in the Royal Air Force
|
scientific article published on 01 April 1962
|
| A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
|
scientific article published on 06 October 2011
|
| Oil-in-water emulsion adjuvant with influenza vaccine in young children
|
scientific article published on 01 October 2011
|
| Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection
|
scientific article published on 12 October 2011
|
| Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine
|
scientific article published on 02 November 2012
|
| Assessing the State of Vaccine Confidence in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015 [corrected]
|
scientific article published on 01 November 2015
|
| Vaccine hesitancy among parents of adolescents and its association with vaccine uptake
|
scientific article published on 07 February 2015
|
| Global Vaccine Action Plan. Decade of vaccine collaboration
|
scientific article published on 01 April 2013
|
| Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP)
|
scientific article published on 18 April 2015
|
| Vaccine Special Issue on Vaccine Hesitancy
|
scientific article published on 18 April 2015
|
| Timely development of vaccines against SARS-CoV-2
|
scientific article published on 8 March 2020
|
| Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
|
scientific article published on 25 February 2020
|
| Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
|
scholar article
|
| Milieu intérieur: Defining the boundaries of a healthy immune response for improved vaccination strategies
|
scientific article published on 24 July 2018
|
| Design and Efficacy of Nanogels Formulations for Intranasal Administration
|
scientific article published on 23 May 2018
|
| Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
|
scientific article published on 29 June 2018
|
| Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach
|
scientific article published on 28 February 2020
|
| Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
|
scientific article published on 19 July 2019
|
| Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications
|
scientific article published on 23 September 2019
|
| Anomeric O-Functionalization of Carbohydrates for Chemical Conjugation to Vaccine Constructs
|
scientific article published on 17 July 2018
|
| Vaccines for colorectal cancer: an update
|
scientific article published on 09 December 2018
|
| Sex differences in vaccine-induced humoral immunity
|
scientific article published on 13 December 2018
|
| Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
|
scientific article published on 19 March 2020
|
| First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines
|
scientific article published on 01 August 2018
|
| The SARS-CoV-2 Vaccine Pipeline: an Overview
|
scientific article published on 03 March 2020
|
| News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
|
scientific article published on 30 March 2020
|
| Human challenge studies to accelerate coronavirus vaccine licensure
|
scientific article published on 31 March 2020
|
| Parent perspectives on childhood vaccination: How to deal with vaccine hesitancy and refusal?
|
scientific article published on 14 January 2019
|
| The COVID-19 vaccine development landscape
|
scientific article published on 09 April 2020
|
| Developing vaccines against epidemic-prone emerging infectious diseases
|
scientific article published on 01 January 2020
|
| Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery
|
scientific article published on 01 January 2019
|
| Understanding vaccine acceptance and demand-and ways to increase them
|
scientific article published on 01 January 2020
|
| Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
|
scientific article published on 29 April 2019
|
| Non-specific effects of BCG vaccine on viral infections
|
scientific article published on 02 May 2019
|
| Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination
|
scientific article published on 11 December 2019
|
| Formulation technologies for oral vaccines
|
scientific article published on 08 August 2019
|
| Vaccine Adjuvants Derived from Marine Organisms
|
scientific article published on 03 August 2019
|
| Toward precision adjuvants: optimizing science and safety
|
scientific article published on 01 February 2020
|
| RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: A case-control study
|
research work
|
| "Running the Gauntlet": Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a "Call to Action"
|
scientific article published on 10 July 2019
|
| Plant-based vaccines for Alzheimer's disease
|
scientific article published on 01 January 2019
|
| The art of partnerships for vaccines
|
scientific article published on 22 August 2019
|
| The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses
|
scientific article published on 24 August 2019
|
| Vaccines for emerging pathogens: prospects for licensure
|
scientific article published on 11 April 2019
|
| Dengue vaccine: WHO position paper, September 2018 - Recommendations
|
scientific article published on 10 November 2018
|
| Malaria vaccine deployment in Africa: focus on Ghana
|
research work
|
| Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine
|
|
| Intrauterine Rubella Infection Following Immunization With Rubella Vaccine
|
scientific article published on July 27, 1970
|
| Rapid COVID-19 vaccine development
|
scientific article published on 08 May 2020
|
| Aluminum compounds as vaccine adjuvants
|
|
| Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine
|
|
| Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
|
scientific article published on 19 May 2020
|
| Report of the 1st African Enteric Viruses Genome Initiative data and Bioiniformatics workshop on whole genome analysis of some African rotavirus strains held in Bloemfontein, South Africa
|
research work
|
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|
scientific article published on 20 July 2020
|
| Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project
|
scientific article published on 23 July 2020
|
| The Impact of the Microbiome on Immunity to Vaccination in Humans
|
scientific article published on 01 August 2020
|
| SARS-CoV-2 vaccines in development
|
scientific article published on 23 September 2020
|
| COVID-19: Coronavirus Vaccine Development Updates
|
scholarly article by Jing Zhao published in 2020
|
| Myanmar's coup risks a flood of vaccine-preventable disease
|
scientific article published in 2022
|
| Preparing health-care systems for future pandemics
|
Increased vigilance in hospitals, better data sharing and training drills can help ready the world to respond to infectious-disease outbreaks.
|
| Decision tree based ensemble machine learning model for the prediction of Zika virus T-cell epitopes as potential vaccine candidates
|
scholarly article
|
| Stand on the Same Side Against Covid – 19: Scientific Evidence on Vaccine for Covid-19
|
scholarly article published on Substantia in 2021
|
| Stand on the Same Side Against Covid – 19, the Future Strategies Against an Unknown Enemy
|
scholarly article published on Substantia in 2020
|
| Determinants of Measles-Rubella Immunization in Muchinga Province of Zambia
|
scholarly article
|
| Despite Safe and Effective Vaccine, Measles Cases and Deaths Increased Worldwide From 2021 to 2022
|
scientific article published on 20 December 2023
|
| Denmark invests in mucosal vaccines
|
scientific article published in January 2024
|
| A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia
|
article
|
| Exploring the presentation of news information about the HPV vaccine: a content analysis of a representative sample of U.S. newspaper articles
|
article
|
| Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--response
|
article
|
| Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine
|
article
|
| Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer
|
article
|
| A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
|
article
|
| Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles
|
article
|
| Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4
|
scientific article published on 31 May 2005
|
| Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb
|
article
|
| Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
|
scientific article published in Nature
|
| Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals
|
scientific article published on 01 November 1998
|
| Immunity's yin and yang. A successful vaccine must first avoid being eliminated by pre-existing immunity before it can promote a protective immune response
|
article
|
| HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization
|
article
|
| Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial
|
scientific article published in The Journal of the American Medical Association
|
| Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization
|
scientific article published on 01 March 2011
|
| Should healthcare workers have the swine flu vaccine?
|
scientific article published in the British Medical Journal
|
| Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein
|
scientific article published on 20 January 2012
|
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
|
article
|
| Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
|
scientific article
|
| Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children
|
article
|
| Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
|
article
|
| Elite control of HIV infection: implications for vaccine design
|
article
|
| The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response
|
article
|
| Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
|
scientific article published on 01 January 2006
|
| Protection against hepatitis A by an inactivated vaccine
|
scientific article published in The Journal of the American Medical Association
|
| A global perspective on vaccine safety and public health: The Global Advisory Committee on Vaccine Safety
|
research work
|
| Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: Identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine
|
scientific article published on 22 January 2007
|
| Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization
|
scholarly article by Voranush Chongsrisawat et al published 7 September 2006 in Tropical Medicine and International Health
|
| Development and production aspects of a recombinant yeast-derived hepatitis B vaccine
|
article
|
| Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs
|
article
|
| Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis
|
article
|
| Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine
|
scientific article published on 01 September 1987
|
| Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51
|
|
| Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
|
article
|
| Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential
|
scientific article published on 01 January 2005
|
| Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants
|
scientific article published on 06 January 2006
|
| Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis
|
article
|
| New Vaccine Technologies to Combat Outbreak Situations
|
scholarly article by Susanne Rauch et al published 19 September 2018 in Frontiers in Immunology
|
| Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
|
scientific article published in Nature
|
| Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
|
scientific article published on 01 November 2002
|
| Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine
|
article
|
| SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques
|
article
|
| Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
|
scientific article published on 01 April 2004
|
| Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
|
article
|
| Strategies for improved stability of Peste des Petits Ruminants Vaccine
|
|
| Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia
|
article
|
| Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting
|
article
|
| Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen
|
article published in 2010
|
| Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector
|
article
|
| European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences
|
article by N Goris et al published 30 April 2007 in Vaccine
|
| Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers
|
|
| An elementary school outbreak of varicella attributed to vaccine failure: policy implications
|
article by Brian R Lee et al published 1 August 2004 in Journal of Infectious Diseases
|
| Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons
|
scientific article published on 01 December 1995
|
| Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak
|
scientific article published on 01 March 1994
|
| A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
|
article by A Werzberger et al published 13 August 1992 in The New England Journal of Medicine
|
| Technology transfer hub for pandemic influenza vaccine
|
|
| Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007
|
article
|
| Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain
|
scientific article published in The Lancet
|
| Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal
|
article published 2003 in Drugs in R & D
|
| Vaccine safety
|
article
|
| A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
|
scientific article published on 01 July 1999
|
| Design and Analysis of Vaccine Studies
|
article
|
| Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing Models
|
article
|
| The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia O
|
article
|
| Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle
|
scientific article published on 30 January 2006
|
| The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine
|
|
| Exploring the relationship between environmental enteric dysfunction and oral vaccine responses
|
scientific article published in July 2018
|
| Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season
|
article
|
| Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era
|
article
|
| Therapeutic DNA Vaccine againstTrypanosoma cruziInfection in Dogs
|
scientific article published on 01 December 2008
|
| Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice
|
scientific article published on 09 December 2005
|
| Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani
|
scientific article published on 20 March 2006
|
| Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics
|
article
|
| Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens fromMycobacterium tuberculosis
|
article
|
| Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex
|
scientific article published on 01 June 1997
|
| Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity
|
article
|
| A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms
|
scientific article published on 01 October 2009
|
| Investigation of vaccine reactions and breakdowns after feline calicivirus vaccination
|
scientific article published on 01 April 1993
|
| Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study
|
scientific article published in The Lancet
|
| Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life
|
article by Thomas V Adamkiewicz et al published March 2008 in Pediatrics
|
| Freeing vaccine adjuvants from dangerous immunological dogma
|
scholarly article by Nikolai Petrovsky published February 2008 in Expert Review of Vaccines
|
| Towards a Fully Synthetic Carbohydrate-Based Anticancer Vaccine: Synthesis and Immunological Evaluation of a Lipidated Glycopeptide Containing the Tumor-Associated Tn Antigen
|
scholarly article by Therese Buskas et al published 19 September 2005 in Angewandte Chemie International Edition
|
| Parental acceptance of the human papillomavirus vaccine
|
|
| Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes
|
article
|
| FURTHER OBSERVATIONS ON THE TREATMENT OF HAY FEVER BY HYPODERMIC INOCULATIONS OF POLLEN VACCINE
|
scientific article published in The Lancet
|
| Response to pneumococcal vaccine in chronic obstructive lung disease—The effect of ongoing, systemic steroid treatment
|
article
|
| Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
|
article
|
| Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis
|
scientific article published on 02 March 2006
|
| Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults
|
article
|
| Motivational interviewing: A promising tool to address vaccine hesitancy
|
scientific article published on 26 July 2018
|
| Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine
|
article
|
| The reporting sensitivities of two passive surveillance systems for vaccine adverse events
|
|
| Varicella Vaccine Update
|
|
| A therapeutic HIV vaccine: how good is good enough?
|
article
|
| Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
|
scientific article published on 01 August 2010
|
| Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old
|
article
|
| Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
|
scientific article published on 12 March 2007
|
| Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population
|
scientific article published on 10 August 2005
|
| Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old Children
|
article
|
